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vABSTRACT
Influencing factors of the in-hospital mortality of stroke and acute 
myocardial infarction: An application of the algebra effectiveness model
Ischemic stroke, hemorrhagic stroke, and acute myocardial infarction (AMI) are 
diseases that occur during the so-called golden hour. These diseases need timely treatment 
and quick response to reduce mortality. Although the government has made efforts to 
improve survival, 30-day in-hospital mortality rates due to stroke and AMI are high.
This study aimed to identify and compare factors that affect 7-day, 30-day, and in-
hospital mortality in patients who had a stroke and have AMI who are admitted via the 
emergency department.
This study used the Korean National Health Insurance claims data from 2002 to 
2013. The study sample included 7,693 patients who had an ischemic stroke, 2,828 
patients who had a hemorrhagic stroke, and 4,916 patients with AMI who were admitted 
via the emergency departments of a superior general hospital and general hospital, did not 
transfer to another hospital or come from another hospital, and were aged ≥20 years. This 
study was analyzed by using Cox’s proportional hazards frailty model.
500 (6.5%) patients were dead of 7,693 patients with ischemic stroke, 569 (20.1%) 
vi
patients were dead of 2,828 patients with hemorrhagic stroke, and 399 (8.1%) patients 
were dead of 4,916 patients with AMI.  The analysis of the association between patient 
characteristics and mortality, clinical factors were associated with 7-day mortality such as 
age, sex, hypertension, and diabetes in all three diseases. Non-clinical factors such as 
individual household income and health insurance type were associated with 30-day 
mortality and in-hospital mortality. In the analysis of the association between treatment 
characteristics and mortality, performing PCI was associated with reducing adjusted 
hazard ratio (aHR) for 7-day, 30-day and in-hospital mortality (aHR,0.40; 95% CI,0.29-
0.54; aHR, 0.35; 95% CI, 0.23-0.55; aHR, 0.43; 95% CI, 0.27-0.67, respectively) among 
AMI patients. In patients with AMI and ischemic stroke, the adjusted hazard ratio of 
patient who utilized intensive care unit service was high for 7-day, 30-day and in-hospital 
mortality comparing to those who did not utilize intensive care unit service. There was a 
weekend effect in AMI and ischemic stroke. In patients with hemorrhagic stroke, the risk 
of mortality for patients who received surgical interventions such as trephination and 
craniotomy was high than those who received medical interventions such as 
administration of mannitol and intravenous antihypertensive agents to control intracranial 
pressure (eg., for 30-day mortality; aHR, 2.42; 95% CI, 1.36-4.32 for patients who 
received mannitol; aHR, 3.30; 95% CI, 1.80-6.04 for patients who received trephination; 
aHR, 5.27; 95% CI, 2.49-11.17 for patients who received craniotomy). In the analysis of 
the association between hospital characteristics and mortality, characteristic of funding 
source and number of patients per one nurse was associated with reducing risk of 
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mortality for 7-day, 30-day and in-hospital mortality in patients with ischemic stroke. In 
all three diseases, greater volume was associated with reducing the risk of mortality, and 
greater transferred rated was associated with increasing the risk of mortality in patients 
with hemorrhagic stroke.
These findings suggest that focus should be on preventing hypertension in stroke 
and preventing diabetes in AMI. Health-care providers should make efforts to provide 
consistent care like that provided on weekdays. Especially health policy makers and 
health-care providers should seek ways to obtain personal resources that can provide 
highly technical interventions such as percutaneous coronary intervention (PCI). At the 
same time, ways that can reflect the real hospital context have been developed to improve 
the quality of hospital care.
Keywords: stroke, acute myocardial infarction, in-hospital mortality, algebra 
effectiveness model
1Ⅰ. Introduction
1. Background 
Cardiovascular and cerebrovascular diseases accounts for a quarter of the 
total mortality. These diseases were the second and third leading causes of 
mortality, being responsible for 52.4 and 48.2 deaths per 1,000,000 people in 
Korea, respectively1. Especially stroke is the first leading cause of mortality as 
single disease in Korea1, and is the second leading cause of death worldwide2. 
With increases in the aging population and the prevalence of chronic diseases such 
as hypertension3-9, diabetes6-10, and hyperlipidemia7-9 associated with stroke and 
acute myocardial infarction (AMI). In addition, many patients remain in a
disabled condition after having a stroke and AMI. Consequently, the health-care 
cost and disease burden have increased in the country. The nationwide total cost 
for stroke increased from $3.3 billion in 2005 to $3.94 billion in 2010, with a 54.7% 
increase in the total cost for admission and outpatient visits for stroke between 
2005 and 2009 in Korea11-13. 
The health policy makers in Korea are starting to realize the severity of the 
2problems due to cardiovascular and cerebrovascular diseases, and have 
established medium- and long-term plans for Health Plan 2020 under the goals of
reducing the incidence of, mortality in, and disability due to cardiovascular and 
cerebrovascular diseases14. The Korean government is proceeding with the 
implementation of the project by focusing on primary, secondary, and tertiary  
prevention15. Tertiary prevention includes reinforcing emergent coping skills for 
cardiac arrest and early stroke, consideration medical care capability such as 
introduction certification of cardiocerebral center, and constructing infrastructures 
such as standardizing clinical process and developing insurance benefit criteria. 
At the same time, health-care providers and clinical experts have also made 
efforts to reduce mortality due to these diseases by using the clinical guidelines 
and critical pathway. AMI and stroke are diseases that occur during the so-called 
golden hour16-20. Time to treatment with tissue plasminogen activator (tPA)13,21
and decompression of intracranial pressure22,23 is crucial to outcomes among 
patients with ischemic stroke and acute myocardial infarction (AMI), and 
hemorrhagic stroke. According to previous studies, the time to reperfusion in AMI 
and acute ischemic stroke is in the first hour of AMI and 3 hours of acute ischemic 
stroke significantly reduce mortality rates. As AMI and stroke are a time-
dependent disease, the importance of early hospital arrival and treatment in the
3emergency department is well known among health-care professionals. The 
Health Insurance Review and Assessment Service (HIRA) demonstrated pay for 
performance (P4P) from July 2007 to December 2010 for AMI and stroke for 
superior general hospitals. Throughout the demonstration program, the HIRA 
expanded to an official project and evaluated general hospitals, including superior 
general hospitals in 201124. Despite several advances in AMI and stroke care over 
the last decade, in-hospital mortality remains common and is linked to disease 
burden. In case of AMI, despite the decrease in age-sex standardized 30-day 
mortality due to the efforts of the government and professional experts, from 8.1% 
in 2007 to 6.4% in 2009, 30-day mortality remained higher, at 5.0% in 2007 and 
5.4% in 2009, than the average for other member countries of the Organization for 
Economic Co-operation and Development (OECD)25. By contrast, the 
achievement for stroke was great. In 2009, the age-sex standardized 30-day 
mortality was 1.8% in Korea, while the average age-sex standardized 30-day 
mortality in the OECD countries was 5.2% for ischemic stroke25. The age-sex 
standardized 30-day mortality was 9.9% in Korea and 19.0% for hemorrhagic 
stroke in the OECD countries25. However, the absolute level of 9.9% was still 
high.
In addition, according to Crossing the Quality Chasm by the Institute of 
4Medicine, the Institute of Medicine (IOM) identified problems of quality as a 
systems problem, not as an issue of individual competence or incompetence26. The 
report suggested that health-care quality required an overhaul of existing systems 
of care at all levels of the system.
52. Objectives
    The purpose of this study was to identify and compare hospital 
characteristics that affect the in-hospital mortality of patients who were admitted 
via the emergency department because of stroke and AMI.
  The detailed objectives of this study were as follows:
     (1) To identify patient characteristics that affect 7-day mortality (acute 
health outcome), 30-day mortality (sub-acute health outcome), and 
in-hospital mortality (latent health outcome), stratified to diseases.
    (2) To identify treatment characteristic that affect 7-day mortality (acute 
health outcome), 30-day mortality (sub-acute health outcome), and 
in-hospital mortality (latent health outcome), stratified to diseases.
     (3) To identify hospital characteristics that affect 7-day mortality (acute 
health outcome), 30-day mortality (sub-acute health outcome), and 
in-hospital mortality (latent health outcome), stratified to diseases.
6Ⅱ. Literature Review
1. Definition of Quality of Care
The growing demand for health care, increasing treatment costs, 
constrained resources, and evidence of variations in clinical practice have 
increased the interest in measuring and improving the quality of health care in 
many countries27. Quality of care can be defined in various ways depending on
perspectives, and how quality is to be defined is an important issue. Many 
definitions are available, and much effort has already been spent on refuting and 
defending old definitions. Hence, approaches for assessment of quality can be 
differed according to the definition of quality of care. Each definition of quality of 
care has not only one meaning, and each one may be defined as a set of properties 
that must be met to achieve good health outcomes. Quality has been defined as 
multidimensional attributes28-33 (Table 1).
The first definition, suggested by Lee & Jones34, was “good medical care is 
the kind of medicine practiced and taught by the recognized leaders of the medical 
profession at a given time or period of social, cultural, and professional
development in a community or population group.”35. According to Myers28, 
7quality of care includes accessibility, quality, continuity, and efficiency. 
Donabedian stated that the balance of health benefits and harm is the essential 
core of the definition of quality and established theory of quality of care36. 
According to Donabedian’s theory, quality of care consists of three elements, 
namely technical aspect, interpersonal aspect, and amenity, and seven attributes, 
namely efficacy, effectiveness, efficiency, optimality, acceptability, legitimacy, 
and equity. In its technical aspect, quality of care is the application of science of 
medicine to solve health problems, in its interpersonal aspect, that is, management 
of social and psychiatric interactions between patients and physicians. Final, 
amenity means comfort such as that of the waiting room environment, a clean bed, 
and meals. The IOM suggested a comprehensive definition of quality as follows: 
“quality of care is the degree to which health services for individuals and 
populations increase the likelihood of desired health outcomes and are consistent 
with current professional knowledge”37. IOM explained health-care quality as the 
following six main concepts: safe, effective, patient-centered, timely, efficient, 
and equitable33. The Joint Commission also identified the following dimensions of 
clinical performances that could be used to categorize indicators: appropriateness, 
availability, continuity, effectiveness, efficacy, efficiency, respect and caring, 
safety, and timeliness38.
8Table 1. Dimensions that used for defining quality of care
Myers, 
196928
Vuori, 198229 Maxwell,198430 Donabedian,199031 HSRG, 199232 IOM, 200133
Joint 
Commission38
Accessibility Accessibility Accessibility
Safe Safe
Patient-centeredness Patient-
centeredness
Respect and 
caring
Effectiveness Effectiveness Effectiveness Effectiveness Effectiveness Effectiveness Effectiveness
Efficiency Efficiency Efficiency Efficiency Efficiency Efficiency
Continuity Continuity/
co-ordination
Continuity
Efficacy Efficacy
Acceptability Acceptability
Equity Equity Equitable
Legitimacy
Comprehensiveness
Relevance
Appropriateness Appropriateness
Quality 
improvement
Scientific 
technique
Timely Timely
Availability
92. Conceptual Framework for Approach to Measuring Quality
Until 1980s, basic approach for measuring of quality of care was to use a 
model of Donabedian in aspects of structure, process, and outcome. According to 
Donabedian, structure, process and outcome can be indicator of quality of care. 
However, looking at history of quality assurance, approach for measuring of 
quality of care changed gradually that quality of care measured in terms of 
structure in early stage, and measured in aspect of process, and tendency have 
showed that measuring of quality of care emphasized on outcomes. Measuring 
structure and process is relative easy but there is a limitation in terms of indirect 
assessment. In contrast, measuring outcomes as quality of care has an advantage 
that can directly evaluate an effectiveness of quality of care.
(1) Donabedian’s framework 
As Avedis Donabedian was a pioneer in the field of health-care quality, his 
framework became the basis of all other definitions or framework for defining
quality of care. Donabedian’s view has guided works regarding the elements used 
to evaluate and compare health-care quality39. For good quality of care, technical 
performance, management of interpersonal relationship, and amenities are 
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needed36,40. Technical performance refers to how well current scientific medical 
knowledge and technology are applied in a given situation40,41. Technical 
performance depends on the knowledge and judgment used in arriving at the 
appropriate strategies of care and on the skill in implementing the strategies. 
Interpersonal relationship is also important because of how it can affect technical 
performance. A clinician who relates well to a patient is better able to elicit from 
the patient a more complete and accurate medical history40. Privacy, 
confidentiality, informed choice, concern, empathy, honesty, tact, and sensitivity, 
among others, are virtues expected in interpersonal relationship. The amenities of 
care are the desirable attributes of the setting within which care is provided. They
include convenience, comfort, quiet, and privacy40. If these elements and their 
attributes are met, care can be considered of good quality according to 
Donabedian’s definition.
Donabedian first proposed a systems-based framework of structure, process,
and outcome how to evaluate the quality of care (Figure 1)42. Structures are 
usually thought to affect processes, which in turn produce desirable or undesirable 
outcomes39. This three-part approach to quality assessment is possible only 
because good structure increases the likelihood of a good process, and a good 
process increases the likelihood of a good outcome40. Structure can explain the 
11
context and refers to the organizational factors that define the health system under 
which care is provided43. Structure denotes the attributes of the setting in which 
care occurs. This includes the attributes of material resources such as facilities, 
equipment, and money of human resources such as the number and qualifications 
of personnel and organizational structure such as medical staff organization, 
methods of peer review, and methods of reimbursement41. Process denotes what is 
actually done in giving and receiving care. It includes the patients’ activities in 
seeking care and carrying it out, and the practitioner’s activities in making a 
diagnosis and recommending or implementing treatment. Outcome denotes the 
effects of care on the health status of patients and populations40. It includes 
mortality, morbidity, and patient’s satisfaction. This three-part approach to quality 
assessment is possible only because good structure increases the likelihood of 
good process, and good process increases the likelihood of a good outcome40. He 
convinced that the activity of quality assessment is not itself designed to establish 
the presence of these relationships. 
12
Figure 1. Donabedian’s conceptual framework for measuring quality of care42
(2) Algebra Effectiveness
Donabedian’s classic framework delineated three dimensions as follows: 
structure, process, and outcome43. The three dimensions are intertwined, but their 
relative utility depends on context44. Outcomes that are not linked to specific 
medical practices provide little guidance for developing quality-improvement 
strategies45. Furthermore, comparing outcomes across groups frequently requires 
adjustment for patient risk and the recognition that some patients are sicker than 
others46. For these reasons, Lisa Iezzoni provides a conceptual model of the 
summation of patient factors, treatment effects, and random events that produce 
health outcomes46,47. This conceptual model is referred to as the “Algebra 
Effectiveness”47. This model is based on the viewpoint that in-hospital patient 
outcome is caused by the sum of three components. To assess hospital net quality, 
13
factors such as patient factors are removed that could affect health outcome. This 
concept is a risk adjustment. Lisa Iezzoni mathematized these concepts (Formula 
1) and developed a risk-adjustment framework (Figure 2)47. In the framework, 
treatment effectiveness includes both treatment and organization characteristics. 
The treatment costs for patients with more severe illnesses or more health-related 
risks are higher, and these patients do less well than their healthier counterparts. 
The characteristics of persons treated with different clinical interventions, 
providers, or health plans vary. These differences have consequences. The purpose 
of risk adjustment aims to account for differences in intrinsic health risks that 
patients bring to their health-care encounters. Therefore, according to the
“Algebra of Effectiveness” conceptual framework, to identify the association 
between hospital characteristics and health outcome, patient’s risk factors should 
be found well based on accurate data.
----------  (Formula1)
14
Figure 2. Algebra Effectiveness model47
Figure 2. Algebra Effectiveness model47
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3. Variations in Health Outcome
The Agency for Healthcare Research and Quality (AHRQ) classified quality 
problems according to four concepts as follows: overuse, underuse, misuse, and 
variation. According to each defined concept by AHRQ, overuse leads to 
unnecessary services, which add costs, and to complications that undermine the 
health of patients48. Overuse can lead to circumstances in which its potential for 
harm exceeds the possible benefits. Underuse is failure to provide a needed 
service, which can lead to additional complications, higher costs, and premature 
deaths. Misuse implies that errors in health-care delivery lead to missed or 
delayed diagnosis, higher costs, and unnecessary injuries and deaths. Variation is 
the difference between an observed event and a standard or norm49. In this study, 
we are willing to focus on variations of health outcomes caused by hospital 
characteristics.
Without this standard, or best practice, measurement of variation offers little 
beyond a description of the observations, with minimal, if any, understanding of 
what they mean. Variation can be either random or assignable49. According to 
Wheeler50, random variation is a physical attribute of the event or process, 
addressing the laws of probability, that cannot be traced to a root cause. He called 
16
this “background noise” or “expected variation.” Common-cause variation 
appears as random variation in all measures from health-care processes. 
Assignable variation arises from a single or small set of causes that are not part of 
the event or process and can therefore be traced, identified, and implemented or 
eliminated51. 
Variation can explain to divide into four dimensions: process variation, 
outcome variation, performance variation, and variation in medical care52. Process 
variation is the difference in procedure throughout an organization. To reduce 
process variation, health-care providers may use clinical guidelines and critical 
pathway. The purpose of use is to standardize process. Outcome variation is the 
difference in the results of any single process. Performance variation is the 
difference between any given result and the optimal or ideal result53. To identify
and compare a performance variation, optimal or ideal result should be defined, or 
threshold, best practice, and standard should be followed.
Variations in health care can occur due to various reasons. Mant J. explained 
causes of variation according to the following four major categories: (1)
differences in the type of patient as confounded by patient characteristics; (2) 
differences in measurement as ascertainment and definition of cases, outcome,
and risk factors; (3) chance as random variation, influenced by the number of 
17
cases and frequency with which outcome occurs; and (4) differences in quality of 
care as use of proven interventions54. In addition, the King’s Fund suggested a 
map of causes of variation after recognizing that variations represent evidence of 
inappropriate care (Figure 3)55. Figure 3 presents the complexities and interactions 
of possible causes. The variation can be caused by various paths as follows: data 
inaccuracy, demand, supply, and random variation. The sources of demand 
variation included general practitioner decisions, patient decisions, morbidity, 
commissioning priorities, and determinants of illness. Clinical decisions, 
government policy, resource availability, private provision (payment), service 
configuration, prevailing custom, and clinical guidelines could be resources of 
supply variation.
18
Figure 3. Mapping causes of variation55
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4. Review Previous Studies
In Donabedian’s framework, process is the clinical service provided to a 
patient. Organizational processes are the activities undertaken by an organization 
in pursuit of its objectives. Structure-outcome was by far the most common paring, 
in previous studies. Differences in predictor and outcome variable pairing become 
apparent when distinguished by the organizational level of analysis. Hospital-level 
studies are predominantly focused on structure-outcome relationships, particularly
the relationship of volume, staffing, and ownership on mortality. Similarly, unit-
level studies favor structure-outcome pairings; however, these studies have 
favored the relationship between staffing and medical errors. Team/subunit 
analyses are predominantly focused on process-outcome relationships.  The most 
common predictor variables at the team/subunit level were cultural features of the 
team/subunit (e.g., commitment to/support of total quality management), 
communication, and collaboration. 
By contrast, structure-process and process-outcome pairings have fewer 
non-significant findings and more robust effects across the levels of analysis. The 
structure-process pairing has the most robust, positive relationship across all 
levels of analysis. Considerable variation exists in the way process variables are 
20
measured, even within the same level of analysis. Reviewed articles focused 
predominantly on quality deficiencies, and all study relationships used mortality 
or adverse events as an outcome. The most variation is observed in the adverse 
events category, but even methods of measuring mortality varied across studies, 
ranging from crude mortality rates to case-mix adjusted, excess mortality rates.
21
Table 2. Summary of previous studies
Study Data
Research 
design
Structure-
Process-
Outcome
Outcome 
variables
Organizational 
Variable of 
Interest
Main Finding
Relationship 
with Quality
Aiken et 
al.56
(2000)
Magnet 
hospitals 
for 
Medicare 
Patients 
from 
HCFA
Cross-
sectional 
Structure-
outcome
Mortality Magnet 
hospital 
designation
lowered mortality rate among 
Medicare patients
Positive
Aiken et 
al.57
(2002)
Hospitals 
survey data
Cross-
sectional
Structure-
outcome
Adverse 
events
Average 
patient/med-
surgical nurse 
ratio
adequate nurse staffing and 
organizational/managerial support 
for nursing are key to improving 
the quality of patient care
Positive
AI-Haider 
& Wan58
(1991)
Hospital 
data from 
HCFA 
Cross-
sectional 
Structure-
outcome
Mortality Size the effect of hospital size and 
specialization on mortality was a 
spurious. 
No association
The 
American 
Hospital 
Association 
file
Specialization No association
the Area 
Resources 
File
Service 
intensity
a positive association existed 
between service intensity and 
hospital mortality
Positive
case-mix 
index for 
study 
hospitals
For-profit 
status
a slightly higher mortality rate in 
for-profit hospitals than in not-
for-profit hospitals
Negative
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Table 2. Summary of previous studies (Continued)
Study Data
Research 
design
Structure-
Process-
Outcome
Outcome 
variables
Organizational 
Variable of 
Interest
Main Finding
Relationshi
p with 
Quality
Alexander 
JA et al.59
(2006) 
Hospital QI 
practices 
from  survey 
of all 6150 
US hospitals
Cross-
sectional
Process-
Outcome
Adverse events Intensity of use of 
statistical and 
process 
measurement
appropriate organizational 
infrastructure and 
financial support are 
significantly associated 
with greater scope and 
intensity of hospital-level 
QI implementation.
Positive
Bach et 
al.60
(2001)
Surveillance, 
epidemiology, 
and ends 
results 
(SEER) 
Cancer 
registries
Longitudinal Structure-
outcome
Mortality Hospital volume patients who undergo 
resection for lung cancer 
at hospitals that perform 
large numbers of such 
procedures are likely to 
survive longer than 
patients who have such 
surgery at hospitals with a 
low volume. 
Positive
Basu,
Friedman, 
&
Burstin61
(2004)
Hospital 
discharge 
data from 
HCUP, 
AHRQ
Cross-
sectional,
quantitative
Structure-
outcome
Adverse events Size HMO enrollment was 
associated with fewer 
preventable admissions 
than marker admissions, 
compared to fee-for-
service
No 
association
Teaching hospital Negative
Urban hospital No 
association
Berner et 
al.62
(2003)
Patients 
enrolled a 
tranditional 
Health Care 
Quality 
Imrpovement 
Program
Group-
randomized 
controlled 
trial
Structure-
process
Quality 
improvement
Quality 
improvement
program with 
opinion
leader
The influence of 
physician opinion leaders 
was unequivocally 
positive for only of five 
quality indicators. 
Positive
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Table 2. Summary of previous studies (Continued)
Study Data
Research 
design
Structure-
Process-
Outcome
Outcome 
variables
Organizational 
Variable of 
Interest
Main Finding
Relationship 
with Quality
Birbeck,
Zingmond,
Cui, &
Vickrey63
(2006)
Adminstra
tive 
discharge 
databases 
from all 
acute, 
non-
federal 
hospital in 
California
Cross-
sectional,
quantitativ
e
Structure-
outcome
Mortality Dedicated 
stroke unit
Dedicated, multispecialty stroke 
services are underutilized despite 
their association with reduced 
stroke mortality at bot academic 
and non-academic hospitals.
Positive
Adoption of 
stroke 
guidelines
No association
Stroke 
specialist on 
staff
No association
Byrne et 
al.64
(2004)
Facility-
level data 
from 
Veterans 
Health 
Affairs
Longitudi
nal,
quantitativ
e
Structure-
outcome
Adverse 
events
Presence of 
service line
structure
Health care organizations are 
implementing innovative 
organizational structures in hopes 
of improving quality of care and 
reducing resource utilization
Negative
Duration of 
service line 
structure
Negative
Grossbart65
(2006)
Data from 
premier 
Hospital 
Quality 
Initiative 
Demonstr
ation 
Project 
Participan
ts
Longitudi
nal,
quantitativ
e
Structure-
outcome
Quality 
improvement
Participation in 
pay-for
performance
program
the findings show that 
participation in the pay-for-
performance initiative had a 
significant impact on the rate and 
magnitude of performance 
improvement
Positive
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Table 2. Summary of previous studies (Continued)
Study Data
Research 
design
Structure
-Process-
Outcome
Outcome 
variables
Organizational 
Variable of 
Interest
Main Finding
Relationshi
p with 
Quality
Kovner &
Gergen66
(1998)
Survey data 
from US 
community 
hospitals
Cross-
sectional,
quantitative
Structure-
outcome
Adverse 
events
RN FTEs
Inverse relationships
between nurse staffing 
and these adverse events
Positive
Mark,
Harless,
McCue,
& Xu67
(2004)
Secondary data 
from the 
American 
Hospital 
Association
Longitudinal,
quantitative
Structure-
outcome
Adverse 
events
Mortality
Change in RN FTE The findings provide 
limited support for the 
prevailing notion that 
improving registered 
nurse (RN) staffing 
unconditionally improves 
quality of care
Positive
Change in LPN FTE No 
association
Change in non-
nurse FTE
No 
association
Poon et al.68
(2004)
Survey of senior 
managers from 
26 hospitals Cross-
sectional,
quantitative
Process-
process
Quality 
improvement
Leadership
Outside the hospital, 
financial incentives and 
public pressures 
encouraged computerized 
physician order entry 
(CPOE).
Positive
Physician 
champions
Positive
Leveraging house 
staff/hospitalists
Positive
Tu et al.69
(2004)
Telephone 
interview from 
29 acute 
hospitals in 
Connecticut Cross-
sectional,
quantitative
structure-
process
Quality 
improvement
Development and 
use of
evidence-based 
clinical
pathway
Hospitals applying all 
four social influence QI 
strategies showed a 
greater-than-average 
increase in delivery of 
antibiotics within 8 hours 
of patients' hospital 
arrival
Positive
Use of physician
champions
Positive
Use of 
multidisciplinary
teams
Positive
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Ⅲ. Study Methods
1.  Framework of Study
     This study suggested two models about an approach for measuring of 
quality of care. This study used an algebra effectiveness model as approach to 
measure hospital performance. Unlike Donabedian’s model in terms of structure, 
process and outcome model that three aspects can be one of quality indicators and 
patient’s factors are treated as Antecedent factors, the algebra effectiveness model 
was to more emphasize the outcome rather than structure and process. So that 
patient’s risk adjustment is important in algebra effectiveness model. The aim of 
this study was identify the factors that affect mortality summation of patient 
characteristics and treatment characteristics including variations. Therefore, to 
evaluate the factors, this study was determined that algebra effectiveness model 
was fitted for this study’s purpose. By using the study design framework (Figure 
4), this study aimed to identify patient, treatment, and hospital factors that affect 
mortality as outcomes for each condition. First, in this study, the study population 
for each condition was determined, and the clinical factors were distinguished
from the non-clinical factors among the patient factors. In case of treatment 
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effectiveness, treatment characteristics were treated as clinical factors and hospital 
characteristics were treated as non-clinical factors. Despite of the same health 
outcome such as 7-day mortality, this study examined how the factors such as 
patient, treatment, and hospital factors affected 7-day mortality differently 
according to each condition. In addition, despite the same condition such ischemic 
stroke, this study determined how each factor affected mortality differently 
according to 7-day mortality (acute health outcome), 30-day mortality (subacute 
health outcome), and in-hospital mortality (latent health outcome). 
27
Figure 4. Framework of this study
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2. Data Source 
    The dataset was obtained from the Korean National Health Insurance 
(KNHI) claims database from 2002 to 2013. The National Health Insurance 
Corporation collects cohort data representative of the country’s population. These 
data include information on 10,250,340 patients. These subjects represent a 
stratified random sample selected according to age, sex, region, health insurance 
type, income quintile, and individual total medical costs based on the year 2002. 
The database includes information on reimbursement for each medical service, 
including basic patient information, an identifier for the clinic or hospital, a 
disease code, costs incurred, results of health screening, personal/family history, 
health behaviors, and information related to death. These data are publicly 
available for research purposes. Ethical approval for this study was granted by the 
institutional review board of the Graduate School of Public Health, Yonsei 
University (2-1040939-AB-N-01-2016-402).
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3. Study Sample
The total number of individuals admitted to acute care hospitals, including 
superior general hospitals and general hospitals, via the emergency department
without dropping by other health-care institutions due to ischemic stroke, 
hemorrhagic stroke, and AMI. The Korean health-care delivery system is 
classified into 3 steps base on fee-for-services as the reimbursement mechanism as 
follows: clinics function as primary care institutions, hospitals function as 
secondary care institutions, and general hospitals function as tertiary care 
institutions. The exclusion criteria were necessary to ensure study population 
homogeneity and were selected because clinics were likely to receive only low-
risk or a limited number of patients, and patients who were transferred to superior 
hospitals. In case of transferring patients, each hospital’s net quality or 
performance cannot be measured, and time to treatment was delayed. To 
determine real stroke and AMI patients, patients with stroke and AMI as a 
principal or secondary diagnosis were identified by searching for codes of the 
International Classification of Diseases, 10th Revision (ICD-10); medication 
information; and clinical test information. According to the assessment report for 
AMI and stroke quality, in cases of ischemic stroke and AMI, the administration
rates of anticoagulants and antiplatelet agents within 48 hours and aspirin within 
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24 hours are both almost close to 100%. In the case of AMI, almost all patients 
with suspected AMI received tests for cardiac enzymes such as creatine kinase 
MB fraction (CK-MB), troponins T and I, and myoglobin. In the case of 
hemorrhagic stroke, approximately 90% of these patients received intravenous 
antihypertensive drugs according to the guideline for hemorrhagic stroke. 
Otherwise, patients received mannitol to control their conditions or craniotomy to 
decrease intracranial pressure as intervention. To identify patients who had a real 
stroke and AMI, these factors were used.
To determine patients who had an ischemic stroke, the following criteria 
should be met: 1) patients who were admitted via the emergency department 
because of ischemic stroke classified as I63 (cerebral infarction) and G45 
(transient cerebral ischemic attacks and related syndrome) of the ICD-10 codes, 2) 
patients who received anticoagulants and antiplatelet agents, 3) patients admitted 
to the general hospital and superior hospital without transferring to another 
hospital, and 4) patients aged >20 years. The total number of individuals who 
were admitted via the emergency department because of ischemic stroke were 
14,127. Of these patients, 4,642 did not receive anticoagulants and antiplatelet 
agents and 1,792 were excluded, including the 1,135 patients transferred to 
another hospital, 642 patients who used long-term facilities, hospitals and clinics;
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and 15 patients aged <20 years. The final study sample with ischemic stroke 
included 7,693 participants (Figure 5).
Figure 5. Flowchart of study sample who were ischemic stroke
To determine hemorrhagic stroke, the following criteria should be met: 1) 
patients admitted via the emergency department because of hemorrhagic stroke 
classified as I60 (subarachnoid hemorrhage), I61 (intracerebral hemorrhage), and 
I62 (other non-traumatic intracranial hemorrhage) of the ICD-10 codes; 2) 
patients who received intravenous antihypertensive agents, mannitol, or 
craniotomy; 3) patients who used general hospitals and superior hospitals without 
14,127 patients who admitted 
via emergency department due 
to ischemic stroke        
(ICD-10; I63 and G45), and 
4,642 patients did not receive 
anticoagulants and antiplatelet 
agents
Initial selection        
N=9,485
Final study sample     
N=7,693
Excluding: Total 1,792 patients were excluded.                                  
▪ 1,135patients who were transferred to another 
hospital                                   
▪ 642 patients who used long-term facilities, 
hospitals and clinics.                         
▪ 15 patients who were less than 20-year old
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transferring to another hospital; and 4) patients aged >20 years (Figure 6). The 
total number of individuals who were admitted via the emergency department due 
to AMI was 4,405. Of these patients, 743 did not receive intravenous 
antihypertensive agents, mannitol, or craniotomy. Then, 834 patients were 
excluded, among whom 701 were transferred to another hospital; 98 used long-
term facilities, hospitals and clinics; and 35 were <20 years of age.
Figure 6. Flowchart of study sample who were hemorrhagic stroke
To identify acute myocardial patients, the following criteria should be met: 
1) patients admitted via the emergency department because of AMI classified as 
I21 (AMI), I22 (subsequent myocardial infarction), and I25.2 (old myocardial 
4,405 patients who admitted via 
emergency department due to 
hemorrhagic stroke        
(ICD-10; I60, I61 and I62), and 
743 patients did not receive 
intravenous antihypertensive 
agents, mannitol or craniotomy 
Initial selection        
N=3,662
Final study sample     
N=7,693
Excluding: Total 834 patients were excluded.            
▪ 701 patients who were transferred to another 
hospital                                   
▪ 98 patients who used long-term facilities, 
hospitals and clinics.                         
▪ 35 patients who were less than 20-year old
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infarction) of the ICD-10 codes; 2) patients who received aspirin; 3) patients who 
underwent a cardiac enzyme test such as those for CK-MB, troponins T and I, and 
myoglobin; 4) patients who used general hospital and superior hospital without 
transferring to another hospital; and 5) patients aged >20 years (Figure 7). The 
total number of individuals admitted via the emergency department because of
AMI was 6,575. Of these patients, 614 did not receive aspirin and 1,045 were 
excluded, among whom 400 did not receive a clinical cardiac enzyme test; 514 
were transferred to another hospital; 122 used long-term facilities, hospitals, and 
clinics; and 9 were aged <20 years.
Figure 7. Flowchart of study sample who were acute myocardial infarction
6,575 patients who admitted via 
emergency department due to 
acute myocardial infarction 
(ICD-10; I21, I22 and I25.2), 
and 614 patients did not receive 
aspirin
Initial selection        
N=5,961
Final study sample     
N=4,916
Excluding: Total 1,045 patients were excluded.     
▪ 400 patients did not receive cardiac enzyme test.                                 
▪ 1135patients who were transferred to another 
hospital                                   
▪ 642 patients who used long-term facilities, 
hospitals and clinics.                         
▪ 15 patients who were less than 20-year old
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4. Variables
(1) Dependent variables
    The dependent variable in the present study was mortality upon in-hospital 
admission, and at 7 and 30 days after admission. Death was assumed to be the 
outcome of interest. Death was determined by linking inpatient records with death 
certificate records from the national death registry. The death certificate records 
indicated only the month and year of death; we had to determine whether the 
patient was dead at discharge. We defined in-hospital, 7-day, and 30-day 
mortalities as follows: First, we matched the discharge and death dates. If the 
discharge data month/year was the same as the death date, we determined if the 
patients acquired discharge medication or used any medical services after the 
discharge date. If they did not, we included them as cases as mortalities.
(2) Independent variables
   Patient, treatment, and hospital characteristics were classified as covariates. 
Patient characteristics included age; sex; health insurance type (national health 
insurance or medical aid); income level; residential area 
(metropolitan/urban/rural); Charlson comorbidity index (CCI ≤ 1, 2, 3, or ≥4);
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arrival route (by emergency team/others); disability status (none/mild/severe);
presence or absence of hypertension/hypertensive complications, diabetic 
complications, and hyperlipidemia; and admission on a weekend or weekday. 
Treatment characteristics included administration of an intervention such as 
embolization, balloon, or stent (yes/no); administration of intravenous 
thrombolytic agents in case of ischemic diseases; use of intensive care unit service 
(yes/no); and administration of surgical procedures (yes/no) in case of 
hemorrhagic stroke. Hospital characteristics included ownership 
(public/educational/private), total number of patients admitted via the emergency 
department because of a corresponding condition per year (quintiles 1–5), 
proportion of transferred patients to another hospital (<5/5–9/10–14/15–19/≥20), 
number of beds (quintiles 1–5), patient-to-physician ratio (2.5:1/ 3.5:1/ 5.5:1/
8.5:1/ >8.5:1), patient-to-nurse ratio (2.0:1/ 2.5:1/ 3.0:1/ 3.5:1/ 4.0:1/ 4.5:1/
>6.0:1), and hospital function (superior general hospital/general hospital). Only 
the comorbidity component of the CCI was calculated from entry of cohort to 
before occurrence of interested conditions. In addition, when we calculated CCI, 
we extracted diabetes scores. The weekend effect was investigated by determining
whether patients were admitted via the emergency department on a Saturday or 
Sunday. In addition, patients who were admitted on an official national holiday 
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were regarded as weekend admissions. Table 3 shows the variables that used in 
this study.
Table 3. Definitions of main variables in this study
Variables Definitions
Outcome variable
In-hospital mortality Patient was dead at discharge after admission. 
1) matched the discharge date month/year and death date 
month/year and then determining whether two date was the 
same or not.
2) if that was the same, identifying whether discharge 
medication or utilization any medical services existed or 
not. 
Independent variables
Patient characteristics
Age Classified as 5 categories: 20-39 year-old patients were 
included as one group, the others divided into 4 categories 
according to 10 age-intervals in adults who were more than 
20 year-old. 
Health Insurance type National health insurance, and medical aid
Individual household  income Used health insurance premium as proxy for individual 
household income.
Low,  0-30 percentile; Middle, 31-70 percentile; high, 71-
100 percentile
Residential area Used a zip-code where patients lived.  
Metropolitan (Seoul, Incheon, Daejeon, Daegu, Ulsan, 
Busan, and Kwangju)
City (were included that zip-code was “Dong”)
Rural (were included that zip-code was “Up and Myun”). 
Charlson comorbidity index Classified as 4 categories;  ≤1, 2, 3, or ≥4.
To calculate CCI, this study extracted age score and 
diabetes, hypertension and dyslipidemia. 
Disabled status Severe included patients with 1 or 2 disabled grade
Mild included patients with disabled grade of 3-6
None included patients without disabled grade
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Table 3. Definitions of main variables in this study (Continued)
Variables Definitions
Patient characteristics
Hypertension Defined using ICD-10 code from outpatient and inpatient 
claims data before occurring of stroke and AMI attack 
Without hypertensive complication included following 
ICD-10 codes: I10.x
With hypertensive complication included following ICD-
10 codes: I11.x, I12.x, and I13.x
No: without above mentioning codes.
diabetes Defined using ICD-10 code from outpatient and inpatient 
claims data before occurring of stroke and AMI attack 
No: without E10.x-E14.x as ICDd-10 codes
Without diabetic complication included following ICD-10 
codes: E1x.0, E1x.1 E1x.6, E1x.8, and E1x.9
With diabetic complication included following ICD-10 
codes: E1x.2, E1x.3, E1x.4, E1x.5, and E1x.7
dyslipidemia Defined using ICD-10 code from outpatient and inpatient 
claims data before occurring of stroke and AMI attack 
Yes: with E78 of ICD-10 code
No: without E78 of ICD-10 code
Treatment Characteristics
Intensive care unit service Defined using service billing information from claims data 
based on fee-for-service.
This study used yearly health insurance benefit cost as 
reference from Health Insurance Review & Assessment 
Service.
Intravenous thrombolytic 
agents
Intravenous antihypertensive 
agents
Use of Mannitol
Defined using drug billing information relevant 
intravenous thrombolytic agents from claims data based on 
fee-for-service.
Intravenous thrombolytic agents were selected according 
to stroke and AMI guideline from each Association. 
Weekend admission This study treated Saturday, Sunday and national official 
holidays as weekend. 
Percutaneous 
coronary/cerebrovascular 
intervention
was included the following as percutaneous transluminal 
coronary angioplasty, percutaneous transcatheter 
placement of intracoronary stent, percutaneous 
transluminal coronary atherectomy, percutaneous 
transluminal cerebral angioplasty, percutaneous cerebral 
angioplasty with drug (installation of metallic stent), and 
percutaneous intravascular atherectomy.
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Table 3. Definitions of main variables in this study (Continued)
Variables Definitions
Treatment characteristics
Trephination
Craniotomy
Trephination was included the following burr hole 
or trephination including for exploration, subdural 
or epidural, intracerebral, and others.
Craniotomy was included the following craniotomy 
or craniectomy including for exploration, 
decompression, excision of cranial lesion.
Hospital characteristics
Characteristics of foundation Classified 3 categories;
Public: foundation was based on national, public, 
special, religious, social welfare, juridical, 
corporation, and company.
School: educational university including national 
university
Private: medical corporation and private
volume Calculated yearly total patients who admitted via 
emergency department due to stroke and AMI and 
then classified 5 categories according to quintile.
Transferred rate Divided yearly total transferred patients by yearly 
total patients who admitted via emergency due to 
stroke and AMI, and then classified 5 categories 
according to quintile.
The number of beds per one doctor Divided total bed sizes into the total number of 
doctors.
Ratio of beds per one nurse Defined using service billing information from 
claims data based on fee-for-service.
This study used yearly health insurance benefit cost 
as reference from Health Insurance Review & 
Assessment Service.
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5.  Statistical Analysis
Descriptive statistics were computed for all variables as follows: 
Frequencies and percentages of categorical variables were determined by using 
the chi-square test. The cumulative incidence for each dependent was estimated 
by using the Kaplan-Meier product limit method with log-rank tests. To 
investigate the association between patient/treatment/hospital characteristics and 
mortality, we performed a survival analysis by using Cox’s proportional hazards 
frailty model, which included random effects to account for covariate hierarchy. 
This approach used a random effect to test for a hospital effect. This random effect 
can be thought of as a “frailty,” which increases a hospital’s susceptibility to a 
short survival time when it is large and decreases this susceptibility when it is 
small. We determined the mortality variance and p-values among the hospitals. 
The variance and p values were 0.126 and 0.050 for ischemic stroke, 0.081 and 
0.04 for AMI, and 0.109 and 0.021 for hemorrhagic stroke, respectively.
The equation λ (t|x) = zλ0(t)exp(xβ) describes the frailty model, where x is 
the covariate matrix, β is the fixed effect vector, and Z is a random variable 
representing an unknown random effect related to each hospital, with unit mean 
and variance ξ. These random effects act multiplicatively on the baseline hazard, 
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and large ξ values reflect a great degree of heterogeneity among hospitals. For
model distribution purposes, we assumed that the frailties were distributed 
according to a gamma distribution. One attractive feature of the gamma 
distribution is that it is mathematically tractable.
In addition, we performed a multilevel logistic regression analysis to 
investigate the model fitness to identify powerful factors that affect mortality 
according to acute, subacute, and latent health outcomes. All the statistical 
analyses were performed by using SAS 9.4 (SAS institute, Inc., Cary, NC, USA).
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Ⅳ. Results
1. General Description 
(1) Patient Characteristics
Table 4 shows how the three diseases differ in distribution and the general 
characteristics used in this study. The proportion of individuals who had a 
hemorrhagic stroke (≥70) was lower than that of patients who had an ischemic 
stroke and AMI (30.2%, 49.0%, and 41.4%, respectively). Regarding sex, the 
proportion of males was highest among those with AMI, followed by ischemic 
and hemorrhagic stroke (63.0%, 54.0%, and 49.6%, respectively). The distribution 
of patients with high income levels was as follows: 43.5%, 34.6%, and 27.5% for 
ischemic stroke, AMI, and hemorrhagic stroke, respectively. The distribution of 
CCI of ≥4 was similar between ischemic stroke and AMI, and lowest for 
hemorrhagic stroke (38.3%, 34.3%, and 26.7%, respectively). The proportions of 
patients without hypertension were 27.7%, 29.4%, and 43.6% among those who 
had an ischemic stroke, AMI, and hemorrhagic stroke, respectively. For diabetes 
mellitus, the proportions of patients without diabetes were 57.3%, 57.6%, and 
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74.0% among those who had an ischemic stroke, AMI, and hemorrhagic stroke, 
respectively.
(2) Treatment Characteristics
    Table 5 shows the proportion of treatments stratified according to the 
disease treated. The proportion of patients admitted to the intensive care unit was 
highest among those who had a hemorrhagic stroke, followed by those who had 
an AMI and ischemic stroke (79.2%, 58.8%, and 13.0%, respectively). For 
ischemic stroke and AMI, which have common characteristic as ischemic diseases, 
the distribution of administration of intravenous thrombolytic agents was 11.5% 
for ischemic stroke and 4.1% for ischemic stroke. The distribution of performing 
of percutaneous coronary/cerebrovascular intervention was 2.1% for ischemic 
stroke and 47.4% for AMI. The proportions of patients who underwent 
craniotomy and those who received mannitol were 3.4% and 83.1%, respectively,
for hemorrhagic stroke. The distribution of patients who were admitted on a 
weekend was as follows: 28.6%, 26.7%, and 29.0% for ischemic stroke, AMI, and 
hemorrhagic stroke.
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Table 4. Patient characteristics who admitted via emergency department, stratified by disease 
Ischemic Stroke
Hemorrhagic 
Stroke
Acute Myocardial 
Infarction
Patient Characteristics, n(%) (N=7,693) (N=2,828) (N=4,916)
Age 
20-39 173 (2.3) 200 (7.1) 140 (2.9)
40-49 504 (6.6) 482 (17.0) 534 (10.9)
50-59 1,178 (15.3) 634 (22.4) 938 (19.1)
60-69 2,067 (26.9) 657 (23.2) 1,268 (25.8)
≥70 3,771 (49.0) 855 (30.2) 2,036 (41.4)
Sex
Male 4,155 (54.0) 1,403 (49.6) 3,097 (63.0)
Female 3,538 (46.0) 1,425 (50.4) 1,819 (37.0)
Health insurance type
National health insurance 7,350 (95.5) 2,659 (94.0) 4,739 (96.4)
Medical aid 343 (4.5) 169 (6.0) 177 (3.6)
Individual household income
Low 1,876 (24.4) 575 (20.3) 853 (17.4)
Middle 2,468 (32.1) 1,476 (52.2) 2,361 (48.0)
High 3,349 (43.5) 777 (27.5) 1,702 (34.6)
Residential area
Metropolitan 3,128 (40.7) 1,196 (42.3) 2,144 (43.6)
City 3,430 (44.6) 1,252 (44.3) 2,112 (43.0)
Rural 1,135 (14.8) 380 (13.4) 660 (13.4)
Charlson comorbidity indexa
0-1 2,315 (30.1) 1,238 (43.8) 1,274 (25.9)
2-3 2,434 (31.6) 834 (29.5) 1,464 (29.8)
4-5 1,728 (22.5) 450 (15.9) 1,124 (22.9)
>5 1,216 (15.8) 306 (10.8) 1,054 (21.4)
Hypertension
No 2,127 (27.7) 1,234 (43.6) 1,443 (29.4)
Without hypertensive complication 3,816 (49.6) 1,180 (41.7) 2,284 (46.5)
With hypertensive complication 1,750 (22.8) 414 (14.6) 1,189 (24.2)
Diabetes Mellitus
No 4,406 (57.3) 2,093 (74.0) 2,833 (57.6)
Without diabetic complication 1,653 (21.5) 429 (15.2) 961 (19.6)
With diabetic complication 1,634 (21.2) 306 (10.8) 1,122 (22.8)
Dyslipidemia
No 3,953 (51.4) 1,840 (65.1) 1,846 (41.0)
Yes 3,740 (48.6) 988 (34.9) 2,659 (59.0)
Disability
None 6,398 (79.0) 2,209 (78.1) 4,119 (83.8)
Mild 986 (12.2) 289 (10.2) 511 (10.4)
Severe 716 (8.8) 330 (11.7) 286 (5.8)
a, calculated comorbidity components; age score and diabetes scores were extracted.
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ICP denotes intracranial pressure.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous 
transcatheter placement of intracoronary stent, percutaneous transluminal coronary atherectomy, 
percutaneous transluminal cerebral angioplasty, percutaneous cerebral angioplasty with drug 
(installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table 5. Treatment characteristics, stratified by diseases
Ischemic Stroke
Hemorrhagic 
Stroke
Acute myocardial 
infarction
Treatment Characteristics, n(%) (N=7,693) (N=2,828) (N=4,916)
Intensive care unit service
No use 6,690 (87.0) 587 (20.8) 2,027 (41.2)
Use 1,003 (13.0) 2,241 (79.2) 2,889 (58.8)
Intravenous thrombolytic agents
No 6,808 (88.5) 4,714 (95.9)
Yes 885 (11.5) 202 (4.1)
Percutaneous coronary 
/cerebrovascular interventiona
No 7,530 (97.9) 2,588 (52.6)
Yes 163 (2.1) 2,328 (47.4)
Weekend admissionb
Weekday admission 5,495 (71.4) 2,157 (71.0) 3,601 (73.3)
Weekend admission 2,198 (28.6) 879 (29.0) 1,315 (26.7)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
352 (12.5)
Use of mannitol 1,691 (59.8)
Endovascular coiling 459 (16.2)
Trephination 229 (8.1)
Craniotomy 97 (3.4)
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(3) Hospital Characteristics 
     Table 6 shows the proportion of hospital characteristics that the patients 
used, stratified according to disease. Regarding funding source, the proportion of 
funding of private nature was highest for ischemic stroke, followed by AMI and 
hemorrhagic stroke (93.5%, 88.7%, and 55.3%, respectively). The median of 
number of beds was 402 ± 414.0 for ischemic stroke, 504.5 ± 462.0 for AMI, 
and 503.0 ± 466.0 for hemorrhagic stroke. The median annual hospital volume 
was 9.0 ± 30.0 for ischemic stroke, 6.0 ± 25.0 for AMI, and 6.0 ± 20.0 for 
hemorrhagic stroke. The proportion of transfer rates to other hospital of ≥20% was 
highest for hemorrhagic stroke at 28.1%, followed by 15.8% for ischemic stroke 
and 13.5% for AMI, respectively. The distribution of patients admitted to a 
superior general hospital was 13.5% for ischemic stroke, 11.3% for AMI, and 15.3% 
for hemorrhagic stroke.
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Table 6. Hospital characteristics that patients visited, stratified by diseases
Ischemic Stroke
Hemorrhagic 
Stroke
Acute Myocardial 
Infarction
Hospital Characteristics, n(%) (N=311) (N=235) (N=238)
Characteristic of foundation
Public 7 (2.3) 8 (3.4) 14 (5.9)
Educational foundation 13 (4.2) 97 (41.3) 13 (5.5)
Private 291 (93.5) 130 (55.3) 211 (88.7)
The number of beds (Median±IQR) 402.0±414.0 503.0±466.0 504.5±462.0
The number of beds
Quintile 1 57 (18.3) 39 (16.6) 47 (19.8)
Quintile 2 71 (22.8) 39 (16.6) 48 (20.2)
Quintile 3 59 (19.0) 44 (18.7) 47 (19.8)
Quintile 4 63 (20.3) 40 (17.0) 48 (20.2)
Quintile 5 61 (19.6) 73 (31.1) 48 (20.2)
Volume of patient (Median±IQR) 9.0 ±30.0   6.0 ±20.0   6.0 ±25.0
Volume of patient
Quintile 1 67 (21.5) 91 (38.7) 44 (18.5)
Quintile 2 55 (17.7) 38 (16.2) 46 (19.3)
Quintile 3 67 (21.5) 32 (13.6) 51 (21.4)
Quintile 4 59 (19.0) 54 (23.0) 49 (20.6)
Quintile 5 63 (20.3) 20 (8.5) 48 (20.2)
Proportion of transferred patient to 
other hospital
<5% 167 (53.7) 98 (41.7) 175 (73.5)
5-9% 47 (15.1) 21 (8.9) 15 (6.3)
10-14% 32 (10.3) 28 (11.9) 10 (4.2)
15-19% 16 (5.1) 22 (9.4) 6 (2.5)
≥20% 49 (15.8) 66 (28.1) 32 (13.5)
The number of beds per one doctor 
(Median±IQR)
9.8±8.8 9.0 ±10.0   8.1±8.6
The number of beds per one doctor
2.5:1 27 (8.7) 27 (11.5) 26 (10.9)
3.5:1 36 (11.6) 35 (14.9) 36 (15.1)
5.5:1 32 (10.3) 29 (12.3) 30 (12.6)
8.5:1 33 (10.6) 25 (10.6) 31 (13.0)
>8.5:1 183 (58.8) 119 (50.6) 115 (48.3)
Ratio of beds per one nurse
2.0:1 4 (1.3) 4 (1.7) 4 (1.7)
2.5:1 21 (6.8) 17 (7.2) 18 (7.6)
3.0:1 60 (19.3) 52 (22.1) 56 (23.5)
3.5:1 47 (15.1) 40 (17.0) 38 (16.0)
4.0:1 47 (15.1) 23 (9.8) 34 (14.3)
4.5:1 26 (8.4) 22 (9.4) 17 (7.1)
>6.0:1 106 (34.1) 77 (32.8) 71 (29.8)
Hospital function
Superior general hospital 42 (13.5) 36 (15.3) 27 (11.3)
General hospital 269 (86.5) 199 (84.7) 211 (88.7)
IQR denotes interquartile range.
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2. The Number of Deaths and the Cumulative Mortality
Table 7 presents the number of deaths stratified according to diseases. In 7-
day mortality, 256 patients (3.3%) died from ischemic stroke, 305 (10.8%) from
hemorrhagic stroke, and 244 (5.0%) from AMI. In 30-day mortality, 440 patients 
(5.7%) died from ischemic stroke, 522 (18.5%) from hemorrhagic stroke, and 375 
(7.6%) from AMI. The number of deaths was highest for hemorrhagic stroke and
two-fold higher than those for ischemic stroke and AMI. In in-hospital mortality, 
500 patients (6.5%) died from ischemic stroke; 399 (8.1%), from AMI; and 569 
(20.1%), from hemorrhagic stroke.
Figure 8 shows the cumulative mortality stratified according to disease. The 
7-day cumulative mortality was 3.8% for ischemic stroke, 11.1% for hemorrhagic 
stroke, and, was 6.0% for AMI. The 7-day cumulative mortality was highest for 
hemorrhagic stroke. The 30-day cumulative mortality was 11.9% ischemic stroke, 
25.7% for AMI, and 21.0% for hemorrhagic stroke. Regarding 30-day cumulative 
mortality, it was highest for AMI. The in-hospital cumulative mortality was 59.4% 
for ischemic stroke, 68.0% for AMI, and 56.5% for hemorrhagic stroke. The in-
hospital cumulative mortality was highest for AMI
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Table 7. Number of deaths according to diseases
Ischemic Stroke Hemorrhagic Stroke Acute Myocardial Infarction
(N=7,693) (N=2,828) (N=4,916)
Mortality
The number of 
death (N, %)
Deaths per 
1,000 PD
The number of 
death (N, %)
Deaths per 
1,000 PD
The number of 
death (N, %)
Deaths per 
1,000 PD
7-day Mortality 256 (3.3) 5.5 305 (10.8) 16.7 244 (5.0) 9.2
30-day Mortality 440 (5.7) 4.7 522 (18.5) 9.4 375 (7.6) 9.4
In-hospital Mortality 500 (6.5) 4.2 569 (20.1) 6.4 399 (8.1) 9.3
PD denotes person-days.
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*, 7-day cumulative mortality;**, 30-day cumulative mortality;***, in-hospital cumulative mortality
Figure 8. The cumulative mortality, stratified by diseases
3.8%*;11.9%**;59.4%*** 6.0%*;25.7%**;68.0%*** 11.1%*;21.0%**;56.5%***
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3. The Factors Influencing Mortality
(1) The patient factors that affect 7-day, 30-day and in-hospital mortality, 
stratified by diseases
     Table 8, Table 9 and Table 10 shows the hazard ratios of 7-day, 30-day, and 
in-hospital mortality from Cox’s proportional frailty hazard model for predicting 
patient characteristics and mortality in ischemic stroke, hemorrhagic stroke, and 
AMI. For ischemic stroke, age, sex, and individual household income were 
associated with 7-day mortality. For AMI, only age and hypertension were 
associated with 7-day mortality. For hemorrhagic stroke, age, CCI, and diabetes 
were associated with 7-day mortality after adjusting for all covariates, including 
treatment and hospital characteristics. For ischemic stroke, the hazard ratio (HR) 
for the males was 0.74 (95% confidence interval [CI], 0.58–0.96) compared with
the females. For AMI and hemorrhagic stroke, the corresponding HR for males
was not associated (Table 8). For ischemic and hemorrhagic stroke, the HRs for 
patients aged 40–49 years were 0.41 (95% CI, 0.20–0.85) and 0.68 (95% CI, 
0.47–0.98), respectively, compared with the patients aged ≥70 years. For AMI, 
the HRs of the patients who had hypertension with and those without hypertensive 
complications were 0.60 (95% CI, 0.39–0.92) and 0.63 (95% CI, 0.44–0.90), 
respectively, compared with the patients without hypertension (Table 8). For 
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hemorrhagic stroke, the HR of the patients who had diabetes mellitus with 
diabetic complication was 1.64 (95% CI, 1.15–2.34) compared with the patients 
without diabetes (Table 8). 
Table 9 presents the association between the patient characteristics and 30-
day mortality. Age, sex, individual household income, hypertension, and disability 
were associated with 30-day mortality for ischemic stroke. Age, hypertension, and 
diabetes were associated with 30-day mortality for AMI. Age, health insurance 
type, CCI, diabetes, and disability were associated with 30-day mortality for 
hemorrhagic stroke. In 30-day mortality, the risk of mortality decreased with the 
patients’ younger age for all three diseases when compared with the reference 
group (age ≥ 70 years), the HR of the patients aged 20–39, 40–49, 50–59, and 
60–69 years were 0.27 (95% CI, 0.08–0.84), 0.35 (95% CI, 0.19–0.63), 0.45 (95% 
CI, 0.31–0.66), and 0.66 (95% CI, 0.52–0.83) for ischemic stroke, respectively. 
Individual household income was strongly associated with 30-day mortality in 
ischemic stroke. Lower income levels significantly increased the risk of mortality
(Table 9). The HRs of the patients with low and middle income levels were 1.31 
(95% CI, 1.02–1.69) and 1.37 (95% CI, 1.10–1.71), respectively. In AMI, factors 
are similar with characteristics that affect 7-day mortality. The HR of any age
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Table 8. Association between patient characteristics and 7-day mortality, stratified by diseases
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Patient Characteristics Adjusted*HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
Age 
20-39 0.19 (0.03-1.40) 0.47 (0.26-0.86) 0.41 (0.13-1.32)
40-49 0.41 (0.20-0.85) 0.68 (0.47-0.98) 0.15 (0.05-0.40)
50-59 0.49 (0.30-0.79) 0.67 (0.49-0.92) 0.49 (0.31-0.78)
60-69 0.59 (0.43-0.82) 0.56 (0.41-0.76) 0.63 (0.45-0.89)
≥70 1.00 1.00 1.00 
Sex
Male 0.74 (0.58-0.96) 1.16 (0.92-1.46) 0.99 (0.75-1.31)
Female 1.00 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00 1.00 
Medical aid 1.34 (0.79-2.39) 0.71 (0.38-1.30) 0.56 (0.23-1.35)
Individual household income
Low 1.21 (0.87-1.70) 1.05 (0.78-1.41) 1.12 (0.76-1.66)
Middle 1.40 (1.05-1.87) 0.99 (0.76-1.29) 0.93 (0.69-1.26)
High 1.00 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 1.00 
City 0.95 (0.72-1.26) 0.94 (0.73-1.21) 0.86 (0.64-1.16)
Rural 0.98 (0.68-1.43) 0.95 (0.68-1.35) 1.02 (0.68-1.52)
Charlson comorbidity index
0-1 1.00 1.00 1.00 
2-3 1.12 (0.78-1.60) 1.11 (0.82-1.49) 0.97 (0.63-1.49)
4-5 1.28 (0.86-1.90) 1.30 (0.90-1.88) 1.46 (0.93-2.28)
>5 1.49 (0.96-2.30) 2.04 (1.38-3.03) 1.29 (0.79-2.14)
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Table 8. Association between patient characteristics and 7-day mortality, stratified by diseases (Continued)
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Patient Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
Hypertension
No 1.00 1.00 1.00 
Without hypertensive complication 1.16 (0.81-1.66) 0.96 (0.71-1.29) 0.63 (0.44-0.90)
With hypertensive complication 1.39 (0.91-2.11) 1.19 (0.81-1.74) 0.60 (0.39-0.92)
Diabetes Mellitus
No 1.00 1.00 1.00 
Without diabetic complication 1.07 (0.78-1.47) 1.19 (0.86-1.66) 1.38 (0.98-1.95)
With diabetic complication 0.92 (0.66-1.30) 1.64 (1.15-2.34) 1.31 (0.93-1.86)
Dyslipidemia
No 1.00 1.00 1.00 
Yes 0.84 (0.63-1.12) 0.79 (0.60-1.05) 0.80 (0.58-1.09)
Disability
None 1.00 1.00 1.00 
Mild 1.09 (0.75-1.58) 1.00 (0.71-1.42) 0.81 (0.51-1.27)
Severe 0.66 (0.40-1.09) 0.70 (0.47-1.03) 1.31 (0.83-2.09)
*: adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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group was lower than that of the reference group (≥70 year old). Moreover, the 
HR of the patients with hypertension who had no hypertensive complication was 
0.71 (95% CI, 0.52–0.97) compared with those without hypertension. In 
hemorrhagic stroke, compared with those with a CCI of 0–1, the HRs of those 
with a CCI of 2 or 3, 4 or 5, and >5 were 1.02 (95% CI, 0.81–1.27), 1.26 (95% CI, 
0.95–1.67), and 2.01 (95% CI, 1.48–2.72), respectively. The tendency showed that 
the risk of 30-day mortality increased as the CCI increased.
Table 10 shows the association between patients’ characteristics and in-
hospital mortality. Age, sex, individual household income, hypertension, and 
disability were associated with in-hospital mortality for ischemic stroke. The 
factors that affected in-hospital mortality were similar with the factors that 
affected 30-day mortality for ischemic stroke. Age and hypertension were 
associated with in-hospital mortality in AMI. The factors that affected in-hospital 
mortality were similar with the factors that affected 7-day mortality in AMI. Age, 
sex, health insurance type, CCI, hypertension, and disability were associated with 
in-hospital mortality in hemorrhagic stroke. The factors that affected in-hospital 
mortality were similar with the factors that affected 30-day mortality for 
hemorrhagic stroke. Individual household income was strongly associated with in-
hospital mortality in hemorrhagic stroke. Lower level of income significantly 
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Table 9. Association between patient characteristics and 30-day mortality, stratified by diseases
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Patient Characteristics Adjusted*HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
Age 
20-39 0.27 (0.08-0.84) 0.56 (0.37-0.85) 0.38 (0.14-1.05)
40-49 0.35 (0.19-0.63) 0.65 (0.49-0.86) 0.16 (0.07-0.37)
50-59 0.45 (0.31-0.66) 0.69 (0.54-0.88) 0.42 (0.28-0.64)
60-69 0.66 (0.52-0.83) 0.57 (0.45-0.72) 0.59 (0.45-0.78)
≥70 1.00 1.00 1.00 
Sex
Male 0.79 (0.65-0.96) 1.16 (0.98-1.38) 0.93 (0.75-1.16)
Female 1.00 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00 1.00 
Medical aid 0.86 (0.53-1.41) 0.54 (0.33-0.87) 0.65 (0.35-1.26)
Individual household income
Low 1.31 (1.02-1.69) 1.03 (0.82-1.29) 1.12 (0.82-1.52)
Middle 1.37 (1.10-1.71) 0.97 (0.79-1.18) 0.88 (0.69-1.12)
High 1.00 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 1.00 
City 1.09 (0.88-1.35) 0.91 (0.75-1.10) 0.99 (0.78-1.25)
Rural 1.11 (0.83-1.47) 0.84 (0.64-1.10) 1.10 (0.80-1.52)
Charlson comorbidity index
0-1 1.00 1.00 1.00 
2-3 0.97 (0.74-1.27) 1.02 (0.81-1.27) 0.75 (0.53-1.07)
4-5 1.18 (0.87-1.58) 1.26 (0.95-1.67) 1.24 (0.87-1.77)
>5 1.28 (0.92-1.77) 2.01 (1.48-2.72) 1.01 (0.68-1.51)
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Table 9. Association between patient characteristics and 30-day mortality, stratified by diseases (Continued)
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Patient Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
Hypertension
No 1.00 1.00 1.00 
Without hypertensive complication 1.12 (0.85-1.48) 1.06 (0.85-1.31) 0.71 (0.52-0.97)
With hypertensive complication 1.40 (1.02-1.93) 1.23 (0.92-1.63) 0.77 (0.54-1.09)
Diabetes Mellitus
No 1.00 1.00 1.00 
Without diabetic complication 0.93 (0.73-1.19) 1.06 (0.82-1.38) 1.35 (1.02-1.78)
With diabetic complication 0.96 (0.74-1.23) 1.58 (1.20-2.08) 1.22 (0.92-1.60)
Dyslipidemia
No 1.00 1.00 1.00 
Yes 0.85 (0.69-1.06) 0.82 (0.66-1.02) 0.80 (0.62-1.03)
Disability
None 1.00 1.00 1.00 
Mild 0.88 (0.66-1.18) 0.89 (0.67-1.18) 0.97 (0.70-1.35)
Severe 0.61 (0.42-0.88) 0.63 (0.47-0.85) 1.18 (0.82-1.70)
*: adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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increased the risk of mortality (Table 10). The HRs of the patients with low and 
middle incomes were 1.30 (95% CI, 1.02–1.65) and 1.33 (95% CI, 1.08–1.64), 
respectively. Regarding sex, the HRs of the males were 0.82 for ischemic stroke
(95% CI, 0.68–0.99) and 1.25 (95% CI, 1.06-1.48) for hemorrhagic stroke
compared with the females. The risk of in-hospital mortality showed contrary 
result in relation to sex. The HR of any age group was lower than that of the 
reference group (≥70 years old) in AMI. In addition, the HR of the patients with 
hypertension who had no hypertensive complication was 0.68 (95% CI, 0.50–0.92) 
compared with the patients without hypertension.
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Table 10. Association between patient characteristics and in-hospital mortality, stratified by diseases
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Patient Characteristics Adjusted*HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
Age 
20-39 0.23 (0.07-0.73) 0.54 (0.36-0.81) 0.36 (0.13-0.98)
40-49 0.38 (0.22-0.64) 0.64 (0.49-0.84) 0.18 (0.08-0.38)
50-59 0.42 (0.29-0.61) 0.65 (0.52-0.83) 0.40 (0.27-0.60)
60-69 0.61 (0.49-0.77) 0.58 (0.46-0.72) 0.58 (0.44-0.76)
≥70 1.00 1.00 1.00 
Sex
Male 0.82 (0.68-0.99) 1.25 (1.06-1.48) 0.95 (0.77-1.17)
Female 1.00 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00 1.00 
Medical aid 0.96 (0.62-1.50) 0.54 (0.34-0.85) 0.68 (0.36-1.28)
Individual household income
Low 1.30 (1.02-1.65) 1.04 (0.84-1.29) 1.13 (0.83-1.53)
Middle 1.33 (1.08-1.64) 0.96 (0.79-1.16) 0.91 (0.72-1.16)
High 1.00 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 1.00 
City 1.07 (0.87-1.31) 0.93 (0.78-1.12) 0.98 (0.78-1.24)
Rural 1.03 (0.78-1.37) 0.90 (0.70-1.16) 1.11 (0.81-1.52)
Charlson comorbidity index
0-1 1.00 1.00 1.00 
2-3 0.99 (0.76-1.28) 1.01 (0.81-1.26) 0.76 (0.54-1.07)
4-5 1.27 (0.96-1.68) 1.30 (1.00-1.70) 1.23 (0.87-1.75)
>5 1.32 (0.97-1.80) 1.97 (1.47-2.64) 1.03 (0.69-1.52)
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Table 10. Association between patient characteristics and in-hospital mortality, stratified by diseases (Continued)
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Patient Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
Hypertension
No 1.00 1.00 1.00 
Without hypertensive complication 1.18 (0.91-1.53) 1.12 (0.91-1.37) 0.68 (0.50-0.92)
With hypertensive complication 1.42 (1.05-1.93) 1.22 (0.93-1.60) 0.78 (0.55-1.10)
Diabetes Mellitus
No 1.00 1.00 1.00 
Without diabetic complication 0.89 (0.71-1.13) 1.03 (0.81-1.32) 1.32 (1.01-1.74)
With diabetic complication 0.93 (0.73-1.18) 1.52 (1.17-1.98) 1.17 (0.89-1.53)
Dyslipidemia
No 1.00 1.00 1.00 
Yes 0.88 (0.72-1.08) 0.82 (0.67-1.01) 0.80 (0.62-1.02)
Disability
None 1.00 1.00 1.00 
Mild 0.89 (0.68-1.17) 0.90 (0.69-1.17) 0.96 (0.70-1.33)
Severe 0.57 (0.40-0.81) 0.61 (0.46-0.81) 1.20 (0.85-1.68)
*: adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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(2) The treatment factors that affect 7-day, 30-day and in-hospital mortality, 
stratified by diseases
     Table11, Table 12 and Table 13 show the association between treatment 
characteristics and 7-day, 30-day, and in-hospital mortality. Regarding the use of 
intensive care unit service, excluding 7-day mortality in hemorrhagic stroke, use 
of intensive care unit service was associated with 7-day, 30-day, and in-hospital 
mortality in all three diseases. As the length of hospital stay increased, the effect 
of use of the intensive care unit service was lowered in ischemic stroke and AMI. 
By contrast, as the length of hospital stay increased, the effect of use of the 
intensive care unit service increased in hemorrhagic stroke. In ischemic stroke, the 
HR of use of the intensive care unit service was 6.88 (95% CI, 5.34–8.86) for 7-
day mortality, 5.86 (95% CI, 4.83–7.09) for 30-day mortality, and 5.54 (95% CI, 
4.61–6.65) for in-hospital mortality. In hemorrhagic stroke, use of mannitol was 
associated with 7-day, 30-day, and in-hospital mortality. The HR of mannitol 
administration was 3.38 (95% CI, 2.05–5.58) for 7-day mortality, 2.73 (95% CI, 
1.87–4.00) for 30-day mortality, and 2.48 (95% CI, 1.73–3.56) for in-hospital 
mortality. We observed that the risk of administration of mannitol tended to 
decrease with longer length of hospital stay. In addition, trephination and 
craniotomy were associated with increasing risks of 7-day, 30-day, and in-hospital 
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mortality. In AMI, the HR of use of the intensive care unit service was 2.17 (95% 
CI, 1.59–2.97) for 7-day mortality, 1.97 (95% CI, 1.54–2.54) for 30-day mortality, 
and 1.92 (95% CI, 1.50–2.45) for in-hospital mortality. In hemorrhagic stroke, the 
HR of use of the intensive care unit service was 1.29 (95% CI, 1.01–1.65) for 30-
day mortality and 1.31 (95% CI, 1.04–1.66) for in-hospital mortality. Weekend 
admission was associated with mortality only in AMI. The HR of weekend 
admission was 1.39 (95% CI, 1.11–1.74) for 30-day mortality and 1.42 (95% CI,
1.14–1.77) for in-hospital mortality. However, weekend admission was not 
associated with 7-day mortality in AMI (HR, 1.24; 95% CI, 0.93–1.65). In 
addition, performing PCI was associated with 7-day, 30-day, and in-hospital 
mortality in AMI. The HR of performing PCI was 0.40 (95% CI, 0.29–0.54) for 7-
day mortality, 0.41 (95% CI, 0.32–0.53), and 0.42 (95% CI, 0.33–0.54) for in-
hospital mortality.
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ICP denotes intracranial pressure.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous transcatheter placement of 
intracoronary stent, percutaneous transluminal coronary atherectomy, percutaneous transluminal cerebral angioplasty, percutaneous 
cerebral angioplasty with drug (installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table 11. Association between treatment characteristics and 7-day mortality, stratified by diseases
Ischemic Stroke Hemorrhagic Stroke Acute Myocardial Infarction
Treatment Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI Adjusted HR* 95% CI
Intensive care unit service
No use 1.00 1.00 1.00 
Use 6.88 (5.34-8.86) 1.04 (0.77-1.40) 2.17 (1.59-2.97)
Intravenous thrombolytic agents
No 1.00 1.00 
Yes 1.17 (0.84-1.64) 1.44 (0.82-2.53)
Percutaneous coronary 
/cerebrovascular intervention
No 1.00 1.00 
Yes 1.17 (0.59-2.30) 0.40 (0.29-0.54)
Weekend admission
Weekday admission 1.00 1.00 1.00 
Weekend admission 1.23 (0.95-1.59) 1.14 (0.89-1.46) 1.24 (0.93-1.65)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
1.00
Use of mannitol 3.38 (2.05-5.58)
Endovascular coiling 2.99 (1.73-5.19)
Trephination 1.08 (0.47-2.47)
Craniotomy 2.45 (1.07-5.61)
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ICP denotes intracranial pressure.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous transcatheter placement of 
intracoronary stent, percutaneous transluminal coronary atherectomy, percutaneous transluminal cerebral angioplasty, percutaneous 
cerebral angioplasty with drug (installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table 12. Association between treatment characteristics and 30-day mortality, stratified by diseases
Ischemic Stroke Hemorrhagic Stroke Acute Myocardial Infarction
Treatment Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI Adjusted HR* 95% CI
Intensive care unit service
No use 1.00 1.00 1.00 
Use 5.86 (4.83-7.09) 1.31 (1.02-1.67) 1.97 (1.54-2.54)
Intravenous thrombolytic agents
No 1.00 1.00 
Yes 1.07 (0.83-1.38) 1.33 (0.82-2.15)
Percutaneous coronary 
/cerebrovascular intervention
No 1.00 1.00 
Yes 1.14 (0.71-1.84) 0.41 (0.32-0.53)
Weekend admission
Weekday admission 1.00 1.00 1.00 
Weekend admission 1.16 (0.95-1.42) 1.05 (0.87-1.27) 1.39 (1.11-1.74)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
1.00 
Use of mannitol 2.73 (1.87-4.00)
Endovascular coiling 1.17 (0.66-2.06)
Trephination 3.04 (2.02-4.57)
Craniotomy 3.41 (1.96-5.92)
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ICP denotes intracranial pressure.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous transcatheter placement of 
intracoronary stent, percutaneous transluminal coronary atherectomy, percutaneous transluminal cerebral angioplasty, percutaneous 
cerebral angioplasty with drug (installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table 13. Association between treatment characteristics and in-hospital mortality, stratified by diseases
Ischemic Stroke Hemorrhagic Stroke Acute Myocardial Infarction
Treatment Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI Adjusted HR* 95% CI
Intensive care unit service
No use 1.00 1.00 1.00 
Use 6.88 (5.34-8.86) 1.34 (1.05-1.70) 1.92 (1.50-2.45)
Intravenous thrombolytic agents
No 1.00 1.00 
Yes 1.17 (0.84-1.64) 1.33 (0.82-2.15)
Percutaneous coronary 
/cerebrovascular intervention
No 1.00 1.00 
Yes 1.17 (0.59-2.30) 0.42 (0.33-0.54)
Weekend admission
Weekday admission 1.00 1.00 1.00 
Weekend admission 1.23 (0.95-1.59) 1.03 (0.86-1.24) 1.42 (1.14-1.77)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
1.00
Use of mannitol 2.48 (1.73-3.56)
Endovascular coiling 1.14 (0.67-1.94)
Trephination 2.84 (1.93-4.18)
Craniotomy 3.10 (1.85-5.21)
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(3) The hospital factors that affect 7-day, 30-day and in-hospital mortality, 
stratified by diseases
     Table 14, Table 15, and Table 16 shows the association between hospital 
characteristics and 7-day, 30-day, and in-hospital mortality. In ischemic stroke, the 
characteristic of the funding source and the patient-to-nurse ratio were associated 
with 7-day mortality. The HR of the characteristic of the funding source that was 
educational in nature was 1.37 (95 % CI, 1.00–1.88; p = 0.05) compared with the 
reference private hospital (Table 14). The HR of the characteristic of the funding 
source that was public in nature was 1.48 (95% CI, 0.96–2.28), but the difference
was not statistically significant. Regarding the patient-to-nurse ratio, the risk of 7-
day mortality decreased as number of nurses increased. Compared with the
reference hospital, where the patient-to-nurse ratio was 2.0:1, the HRs for 2.5:1,
3.0:1, 3.5:1, 4.01:1, 4.5:1, and >6.0:1 were 3.60 (95% CI, 0.44–29.31), 8.23 (95% 
CI, 1.07–63.41), 10.07 (95% CI,1.28–78.99), 10.90 (95% CI, 1.35–87.92), 9.71 
(95% CI, 1.17–80.87), and 14.32 (95% CI, 1.74–118.02), respectively. In ischemic 
stroke, hospital volume was associated with 30-day mortality. The HR of the 
hospitals with a volume within quintile 1 was 1.92 (95% CI, 1.18–3.12) compared
with the hospitals with volumes within quintile 5. In the analysis of the 
association between hospital characteristics and in-hospital mortality for AMI, the 
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results were similar with the results for 30-daymortality.
The characteristic of the funding source, hospital volume, and patient-to-
nurse ratio were associated with in-hospital mortality. In hemorrhagic stroke, 
hospital volume was associated with 7-day, 30-day, and in-hospital mortality. The 
patient-to-nurse ratio was associated with 7-day mortality, and transfer rate was 
associated with 30-day and in-hospital mortality. Compared with the reference 
hospital with a volume within quintile 5, the HRs of the hospitals with volumes
within quintiles 1 and 2 were 2.74 (95% CI, 1.71–4.38) and 1.46 (95% CI, 1.00–
2.12; p = 0.05) for 7-day mortality. In 30-day mortality, the corresponding HR was 
2.74 (95% CI, 1.91–3.93) and 1.40 (95% CI, 1.05–1.87). In in-hospital mortality, 
the corresponding HR was 2.69 (95% CI, 1.17–3.81) and 1.49 (95% CI, 1.13–
1.96). The HR of hospital volume was greater in hemorrhagic stroke and AMI.
In AMI, hospital volume was associated with 7-day, 30-day, and in-hospital 
mortality. The patient-to-physician ratio was associated with only 7-day mortality. 
Compared with the reference hospital, which had a volume within quintile 5, the 
HR of the hospital with a volume within quintile 1 was 1.88 (95% CI, 1.02–3.46) 
for 7-day mortality. However, the differences with the other hospitals that had 
volumes within quintile 2, 3, or quintile 4 were not statistically significant. In 30-
day mortality, the corresponding HR for the hospitals with volumes within
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quintile 1 was 1.92 (95% CI, 1.18–3.12). In in-hospital mortality, the 
corresponding HR for the hospitals with volumes within quintile 1 was 1.88 (95% 
CI, 1.17–3.01). However, no statistically significant differences were found for 
the other hospitals with volumes within quintile 2, 3, or 4 in 7-day, 30-day, and in-
hospital mortality.
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Table 14. Association hospital characteristics and 7-day mortality, stratified by diseases
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
Characteristic of foundation
Public 1.48 (0.96-2.28) 1.07 (0.70-1.62) 1.07 (0.65-1.74)
Educational foundation 1.37 (1.00-1.88) 0.87 (0.65-1.17) 1.13 (0.81-1.58)
Private 1.00 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 1.73 (0.98-3.04) 2.74 (1.71-4.38) 1.88 (1.02-3.46)
Quintile 2 1.52 (0.90-2.57) 1.46 (1.00-2.12) 1.04 (0.55-1.96)
Quintile 3 1.11 (0.63-1.97) 1.36 (0.95-1.96) 0.96 (0.57-1.60)
Quintile 4 0.87 (0.55-1.37) 1.13 (0.79-1.60) 1.02 (0.71-1.46)
Quintile 5 1.00 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 1.00 
5-9% 1.00 (0.68-1.47) 1.37 (0.84-2.22) 1.42 (0.81-2.51)
10-14% 0.81 (0.44-1.49) 0.77 (0.41-1.46) 0.36 (0.09-1.46)
15-19% 0.74 (0.38-1.48) 1.27 (0.79-2.06) 0.81 (0.25-2.65)
≥20% 0.88 (0.42-1.82) 1.36 (0.93-2.00) 1.15 (0.49-2.68)
The number of beds
Quintile 1 1.01 (0.59-1.73) 1.21 (0.72-2.02) 0.69 (0.36-1.30)
Quintile 2 0.92 (0.57-1.49) 0.84 (0.50-1.41) 0.87 (0.49-1.55)
Quintile 3 0.74 (0.48-1.14) 1.03 (0.66-1.63) 0.98 (0.60-1.59)
Quintile 4 1.15 (0.80-1.66) 1.00 (0.68-1.47) 1.01 (0.65-1.56)
Quintile 5 1.00 1.00 1.00 
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Table 14. Association hospital characteristics and 7-day mortality, stratified by diseases (Continued)
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
The number of beds per one doctor
2.5:1 0.94 (0.60-1.48) 1.15 (0.77-1.72) 1.62 (1.03-2.56)
3.5:1 0.83 (0.47-1.48) 0.96 (0.58-1.59) 1.12 (0.62-2.02)
5.5:1 0.70 (0.33-1.46) 0.49 (0.25-0.98) 1.22 (0.61-2.44)
8.5:1 0.72 (0.35-1.47) 0.71 (0.37-1.38) 1.01 (0.45-2.24)
>8.5:1
Ratio of beds per one nurse
2.0:1 1.00 1.00 1.00 
2.5:1 3.60 (0.44-29.31) 0.36 (0.15-0.87) 1.66 (0.47-5.89)
3.0:1 8.23 (1.07-63.41) 0.46 (0.21-1.00) 2.93 (0.89-9.71)
3.5:1 10.07 (1.28-78.99) 0.53 (0.23-1.20) 2.91 (0.86-9.82)
4.0:1 10.90 (1.35-87.92) 0.41 (0.17-0.98) 2.51 (0.71-8.93)
4.5:1 9.71 (1.17-80.87) 0.33 (0.12-0.91) 2.26 (0.55-9.25)
>6.0:1 14.32 (1.74-118.02) 0.66 (0.26-1.69) 2.80 (0.69-11.25)
Hospital function
Superior general hospital 1.00 1.00 1.00 
General hospital 0.71 (0.44-1.14) 1.25 (0.88-1.78) 1.12 (0.74-1.70)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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Table 15. Association hospital characteristics and 30-day mortality, stratified by diseases
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
Characteristic of foundation
Public 1.63 (1.18-2.25) 1.07 (0.77-1.48) 1.14 (0.78-1.66)
Educational foundation 1.27 (1.00-1.62) 1.04 (0.84-1.30) 1.21 (0.93-1.57)
Private 1.00 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 2.03 (1.30-3.16) 2.74 (1.91-3.93) 1.92 (1.18-3.12)
Quintile 2 2.01 (1.34-3.01) 1.40 (1.05-1.87) 1.04 (0.63-1.71)
Quintile 3 1.12 (0.71-1.75) 1.22 (0.92-1.61) 0.87 (0.57-1.34)
Quintile 4 1.11 (0.80-1.56) 1.21 (0.94-1.57) 1.01 (0.75-1.34)
Quintile 5 1.00 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 1.00 
5-9% 1.24 (0.93-1.65) 1.28 (0.87-1.88) 1.31 (0.82-2.11)
10-14% 1.17 (0.77-1.79) 1.02 (0.65-1.58) 0.57 (0.23-1.39)
15-19% 0.99 (0.63-1.56) 1.14 (0.78-1.66) 1.14 (0.49-2.65)
≥20% 1.19 (0.70-2.00) 1.34 (1.00-1.79) 0.90 (0.43-1.86)
The number of beds
Quintile 1 0.87 (0.57-1.34) 0.98 (0.66-1.45) 0.82 (0.50-1.35)
Quintile 2 0.79 (0.54-1.17) 0.84 (0.57-1.21) 0.89 (0.57-1.40)
Quintile 3 0.74 (0.53-1.03) 0.90 (0.64-1.27) 0.99 (0.67-1.46)
Quintile 4 0.97 (0.72-1.29) 0.97 (0.73-1.28) 1.05 (0.74-1.49)
Quintile 5 1.00 1.00 1.00 
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Table 15. Association hospital characteristics and 30-day mortality, stratified by diseases (Continued)
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
The number of beds per one doctor
2.5:1 1.00 1.00 1.00
3.5:1 0.96 (0.68-1.36) 1.09 (0.81-1.47) 1.22 (0.87-1.72)
5.5:1 0.86 (0.55-1.35) 1.01 (0.70-1.46) 0.91 (0.57-1.44)
8.5:1 0.73 (0.42-1.28) 0.76 (0.47-1.24) 0.99 (0.58-1.68)
>8.5:1 0.75 (0.43-1.31) 0.89 (0.54-1.44) 0.94 (0.50-1.75)
Ratio of beds per one nurse
2.0:1 1.00 1.00 1.00 
2.5:1 3.10 (1.03-9.37) 0.65 (0.31-1.39) 1.60 (0.60-4.29)
3.0:1 4.08 (1.38-12.08) 0.77 (0.37-1.60) 2.15 (0.79-5.82)
3.5:1 4.35 (1.44-13.16) 0.82 (0.38-1.74) 2.62 (0.95-7.22)
4.0:1 4.54 (1.45-14.19) 0.68 (0.31-1.49) 1.89 (0.65-5.46)
4.5:1 3.73 (1.15-12.09) 0.69 (0.30-1.60) 1.76 (0.55-5.68)
>6.0:1 5.37 (1.68-17.20) 0.96 (0.42-2.18) 2.40 (0.78-7.39)
Hospital function
Superior general hospital 1.00 1.00 1.00 
General hospital 0.75 (0.52-1.09) 1.28 (0.99-1.66) 1.30 (0.85-1.98)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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Table 16. Association hospital characteristics and in-hospital mortality, stratified by diseases
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
Characteristic of foundation
Public 1.51 (1.11-2.07) 1.08 (0.79-1.46) 1.10 (0.76-1.60)
Educational foundation 1.19 (0.94-1.50) 1.04 (0.85-1.28) 1.20 (0.93-1.55)
Private 1.00 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 1.85 (1.21-2.83) 2.69 (1.90-3.81) 1.88 (1.17-3.01)
Quintile 2 1.98 (1.35-2.90) 1.49 (1.13-1.96) 1.06 (0.66-1.73)
Quintile 3 1.14 (0.75-1.74) 1.19 (0.91-1.56) 0.88 (0.58-1.33)
Quintile 4 1.16 (0.85-1.59) 1.24 (0.97-1.59) 0.96 (0.73-1.28)
Quintile 5 1.00 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 1.00 
5-9% 1.21 (0.92-1.59) 1.40 (0.98-2.02) 1.25 (0.78-2.00)
10-14% 1.03 (0.68-1.56) 1.08 (0.71-1.64) 0.67 (0.29-1.53)
15-19% 0.96 (0.62-1.49) 1.20 (0.84-1.71) 1.12 (0.48-2.59)
≥20% 1.05 (0.63-1.77) 1.31 (1.00-1.74) 1.02 (0.53-1.96)
The number of beds
Quintile 1 0.95 (0.64-1.43) 1.03 (0.71-1.50) 0.82 (0.50-1.33)
Quintile 2 0.83 (0.57-1.20) 0.85 (0.59-1.21) 0.99 (0.64-1.52)
Quintile 3 0.77 (0.56-1.06) 0.97 (0.71-1.34) 0.95 (0.65-1.39)
Quintile 4 0.99 (0.75-1.31) 0.96 (0.73-1.25) 1.04 (0.74-1.47)
Quintile 5 1.00 1.00 1.00 
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Table 16. Association hospital characteristics and in-hospital mortality, stratified by diseases (Continued)
Ischemic Stroke Hemorrhagic Stroke
Acute Myocardial 
Infarction
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI Adjusted* HR 95% CI
The number of beds per one doctor
2.5:1 1.00 1.00 1.00
3.5:1 1.02 (0.73-1.43) 1.11 (0.84-1.49) 1.20 (0.86-1.66)
5.5:1 0.93 (0.60-1.43) 1.03 (0.72-1.47) 0.86 (0.55-1.35)
8.5:1 0.74 (0.43-1.27) 0.75 (0.47-1.19) 0.93 (0.56-1.56)
>8.5:1 0.82 (0.48-1.40) 0.93 (0.59-1.49) 0.94 (0.51-1.72)
Ratio of beds per one nurse
2.0:1 1.00 1.00 1.00 
2.5:1 2.48 (0.90-6.84) 0.66 (0.32-1.35) 1.39 (0.56-3.47)
3.0:1 3.26 (1.21-8.81) 0.77 (0.38-1.55) 1.75 (0.69-4.41)
3.5:1 3.57 (1.30-9.84) 0.83 (0.40-1.71) 2.32 (0.91-5.96)
4.0:1 3.77 (1.33-10.72) 0.72 (0.34-1.53) 1.62 (0.6-4.37)
4.5:1 3.09 (1.05-9.12) 0.71 (0.32-1.59) 1.62 (0.55-4.81)
>6.0:1 4.36 (1.50-12.66) 0.98 (0.45-2.14) 1.87 (0.66-5.36)
Hospital function
Superior general hospital 1.00 1.00 1.00 
General hospital 0.74 (0.52-1.05) 1.20 (0.88-1.63) 1.34 (0.89-2.03)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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(4) The model fitness to identify powerful factors 
   This study was performed with multilevel logistic regression divided into 4 
models. Model 1 was a null model, model 2 was adjusted for patient 
characteristics, model 3 was adjusted for patient and treatment characteristics, and 
model 4 was adjusted for patient, treatment, and hospital characteristics. Table 17
shows the model fitness stratified according to disease.
In ischemic stroke, the AIC score was 2247.35 for model 1, 2206.19 for 
model 2, 1983.62 for model 3, and 1991.05 for model 4. The best model fitness 
for 7-day mortality was model 3, which was adjusted for patient and treatment 
characteristics. The treatment factors were significant factors that affected 7-day 
mortality in ischemic stroke. For 30-day mortality, the best model fitness was 
model 3 and the treatment factors were significant. For in-hospital mortality, the 
best model was model. However, the patient factors significantly affected in-
hospital mortality.
In hemorrhagic stroke, the best model was the full model of model 4 for 7-
day mortality. The AIC score of the null model of model 1 was 1925.15, 1896.22 
for model 2, 1864.78 for model 3, and 1862.36 for model 4. However, the 
difference in AIC score was the greatest in model 4. The treatment factor 
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significantly affected 7-day mortality in hemorrhagic stroke. For 30-day and in-
hospital mortality, the best model was model 4 and the treatment factors 
significantly affected 30-day mortality.
In AMI, the AIC scores of the null model of model 1 were 1943.49. The 
AIC scores of models 2, 3, and 4 were 1972.49, 1698.65, and 1709.99, 
respectively, for 7-day mortality. The best model was model 3 for 7-day mortality 
in AMI. The patient factors significantly affected 7-day mortality in AMI. For 30-
day and in-hospital mortality, the best model fitness was model 3 and the patient 
factors significantly affected 30-day and in-hospital mortality in AMI.
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Table 17. Model fitness for mortality from calculating of multilevel logistic regression, stratified by diseases
Ischemic Stroke Hemorrhagic Stroke Acute Myocardial Infarction
N AIC
-2LL statistics, 
χ2 (p-value)
N AIC
-2LL statistics, 
χ2 (p-value)
N AIC
-2LL statistics, 
χ2 (p-value)
7-day 
mortality
Model 1 7,693 2247.35 2195.63 (0.1094) 2,828 1925.15 1830.86 (0.008) 4,916 1943.49 1908.56 (0.1460)
Model 2 7,693 2206.19 2132.95 (0.2061) 2,828 1896.22 1776.70 (0.020) 4,916 1762.49 1687.61 (0.1214)
Model 3 7,693 1983.62 1901.42 (0.2099) 2,828 1864.78 1724.22 (0.0125) 4,916 1698.65 1616.58 (0.1223)
Model 4 7,693 1991.05 1886.05 (0.4414) 2,828 1862.36 1688.37 (0.0269) 4,916 1709.99 1611.99 (.)
30-day 
mortality
Model 1 7,693 1991.05 1886.05 (0.4414) 2,828 2702.43 2633.42 (0.0289) 4,916 2649.98 2592.59 (0.0679)
Model 2 7,693 3363.95 3264.08 (0.0088) 2,828 2638.99 2545.69 (0.0694) 4,916 2375.05 2295.49 (0.1102)
Model 3 7,693 3274.00 3143.68 (0.0124) 2,828 2574.21 2465.43 (0.0577) 4,916 2239.73 2153.27 (0.1047)
Model 4 7,693 2885.69 2779.51 (0.0812) 2,828 2575.38 2436.76 (0.1406) 4,916 2241.18 2143.18 (.)
In-
hospital 
mortality
Model 1 7,693 3686.57 2565.05 (0.0033) 2,828 2834.78 2752.73 (0.0175) 4,916 2762.49 2675.93 (0.0219)
Model 2 7,693 3262.35 3419.02 (0.0067) 2,828 2762.24 2663.24 (0.0616) 4,916 2470.7 2369.23 (0.0434)
Model 3 7,693 3091.10 2975.86 (0.0617) 2,828 2684.84 2570.48 (0.0526) 4,916 2316.31 2211.62 (0.0494)
Model 4 7,693 3100.48 2982.47 (0.3128) 2,828 2683.23 2549.73 (0.1880) 4,916 2324.22 2219.61 (0.4478)
Model 1: null model
Model 2: adjusted for patient characteristics.
Model 3: adjusted for patient characteristics and treatment characteristics.
Model 4: adjusted for patient characteristics, treatment characteristics and hospital characteristics.
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4. Summary of Main Findings
Table 18 presents a summary of the factors that affected 7-day, 30-day, and 
in-hospital mortality in ischemic stroke, AMI, and hemorrhagic stroke. In all three 
conditions, regardless of 7-day, 30-day, and in-hospital mortality, the patients 
were younger and the risk of mortality was lower. Compared with the women, the 
men had lower risk of mortality after controlling for all covariates. The 
association between individual household income and 7-day mortality was not 
statistically significant for stroke. As length of stay was longer, the risks of 30-day 
and in-hospital mortality were increased for the low-income patients compared 
with the reference group, which was composed of high income earners. In AMI, 
regardless of 7-day, 30-day, and in-hospital mortality, the association between 
individual household income and mortality was not statistically significant. The 
risk of mortality tended to gradually increase as the CCI increased in hemorrhagic 
stroke. Especially in the analysis of 7-day mortality, the adjusted HR was 1.53 (95% 
CI, 1.01–2.34) for the patients with CCIs of >6, relative with patients who had 
CCIs of 0 or 1. For 30-day and in-hospital mortality, the adjusted HRs were 1.38 
(95% CI, 1.01–1.89) and 1.39 (95% CI, 1.04–1.88), respectively. The risk of 
mortality in relation to CCI was highest for 7-day mortality. In ischemic stroke 
and AMI, the risk of mortality tended to gradually increase as CCI increased, but 
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Table 18. Summary factors that affect 7-day, 30-day and in-hospital mortality in ischemic stroke, hemorrhagic stroke and AMI
Patient characteristics Treatment characteristics Hospital characteristics
Ischemic 
stroke
Hemorrhagic 
stroke
Acute 
myocardial 
infarction
Ischemic 
stroke
Hemorrhagic 
stroke
Acute 
myocardial 
infarction
Ischemic 
stroke
Hemorrhagic 
stroke
Acute 
myocardial 
infarction
7-day 
mortality
age
sex
income
Age
CCI
diabetes
age
hypertension
use of ICU 
service,
administratio
n of mannitol
use of ICU, 
PCI
characteristic 
of funding
source, 
the number of 
patients per 
one nurse
hospital 
volume, 
the number of 
patients per 
one doctor
the number of 
patients per 
one nurse
the number 
of patients 
per one 
doctor
30-day 
mortality
age
sex
income
hypertension
disability
Age
CCI
diabetes, 
health 
insurance
type
disability
age
hypertension
diabetes
use of
ICU,
use of ICU, 
administratio
n of mannitol
use of ICU, 
PCI, weekend 
admission 
characteristic 
of funding 
source, 
the number of 
patients per 
one nurse,
hospital 
volume
hospital 
volume, 
transferred rate
hospital 
volume
In-hospital 
mortality
age
sex
income
hypertension
disability
age
health 
insurance 
CCI
hypertension 
disability
sex
age
hypertension
use of
ICU,
use of ICU, 
administratio
n of mannitol
use of ICU, 
PCI, weekend 
admission 
characteristic 
of funding 
source,  
hospital 
volume, 
the number of 
patients per 
one nurse
hospital 
volume, 
transferred rate
hospital 
volume
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the difference was not statistically significant. In the analysis of the association
between mortality and the major risk factors that affected the occurrence of stroke 
and AMI, in ischemic and hemorrhagic stroke, the association between 7-day 
mortality and hypertensive patients with/without hypertensive complication was 
not statistically significant, compared with the patients without hypertension. 
However, the risk of mortality increased for the patients who had hypertension 
with/without hypertensive complication in 30-day and in-hospital mortality. 
Diabetes mellitus and dyslipidemia were not significant factors of mortality in 
stroke. By contrast, the risks of 7-day, 30-day, and in-hospital mortality were
lower for the patients who had hypertension with/without hypertensive than for 
those who did not have hypertension. However, the risk of mortality was higher 
for the patients who had diabetes mellitus without diabetic complications than for 
those who did not have diabetes. The pattern was the same for the patients who 
had diabetes mellitus with diabetic complications, but the difference was not 
significant.
Excluding 7-day mortality in ischemic stroke, the risks of 7-day, 30-day, 
and in-hospital mortality in all three diseases were higher for the patients admitted 
to the intensive care unit than for those not admitted to the intensive care unit. In 
AMI, the risk of 7-day, 30-day, and in-hospital mortality was higher for the patient 
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who did not receive percutaneous coronary intervention (PCI) than for those who 
received PCI. The risk of the patients who received PCI was consistently low for 
7-day, 30-day, and in-hospital mortality relative to those who did not receive PCI. 
In addition, the HR for 30-day mortality was higher for the patients admitted on a 
weekend than for those admitted on a weekday. In ischemic stroke, the association 
between weekend admission and mortality was not statistically significant. 
However, in the analysis of the subset group, stratified according to patients 
admitted to a superior general hospital and those admitted to a general hospital, 
the HR of weekend admission was higher than that of weekday admission for the 
patients admitted to a superior general hospital (Appendix A1-Appendix C3). In 
hemorrhagic stroke, the risk of 7-day, 30-day, and in-hospital mortality was higher 
for the patients who received than for those who did not receive mannitol. The 
risk of mortality decreased as the length of hospital stay increased.
In ischemic stroke, the risk of mortality was higher for the patients whose 
health-care providers had a public source of funding than for those whose health-
care providers had a private source of funding. The risk of mortality tended to 
increase as the patient-to-nurse ratio increased. In AMI and hemorrhagic stroke, 
the risk of mortality was higher for the patients whose health-care providers had a 
volume within quintile 1 or 2 than for the patients whose health-care providers 
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had a volume within quintile 5. However, after excluding health-care providers 
with a patient-to-nurse ratio of 3.5:1 or 6.0:1, the risk of mortality was decreased 
as the patient-to-nurse ratio increased in hemorrhagic stroke. In the analysis of the 
association between hospital characteristics and 30-day mortality, the risk of 30-
day mortality was higher for the patients whose health-care providers had a 
volume within quintile 1 or 2 than for those whose health-care providers had a 
volume within quintile 5. These results showed a similar pattern for all three 
diseases. In addition, the risk of mortality tended to increase as the proportion of 
patients transferred to another hospital increased. However, this was statistically 
significant only for the hospitals with a transfer rate of >20%. In ischemic stroke, 
the dose-response relationship tended to increase the risk of 30-day mortality 
gradually as the patient-to-nurse ratio increased (p for trend < 0.0001). In the 
analysis of the association between the hospital characteristics and in-hospital 
mortality, the association showed a similar pattern with that found in an analysis 
of results between hospital characteristics and 30-day mortality. As the hospital 
volume increased, the risk of mortality decreased for all three diseases. The 
transfer rate to another hospital was associated with mortality in hemorrhagic 
stroke, and the patient-to-nurse ratio and characteristic of funding source were 
associated with mortality.
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V. Discussion
1. Discussion of Study Methods
This study examined the associations of patient, treatment, and hospital 
characteristics with in-hospital mortality by applying an algebra effectiveness 
model by using representative nationwide cohort data. Some issues could be 
raised related with the study methods.
First was an issue related to data source. These data were extracted from a 
national health insurance claims database from 2002 to 2013. These subjects 
represent a stratified random sample selected according to age, sex, region, health 
insurance type, income quintile, and individual total medical cost based on the 
year 2002. These data were not from a representative organization. Therefore, the 
definitions of the hospital characteristics could not be generalized.
Second was the selection of the study sample. The study data were obtained 
from a claims database. To determine the study sample, we used ICD-10 code as 
primary diagnostic criteria. The diagnostic accuracy in the KNHI claims data is 
roughly 70%70. Although this study tried to identify throughout real patients by 
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using medication and clinical test information, the diagnostic accuracy might have 
been compromised in the study. In addition, to identify history of hypertension, 
diabetes, and dyslipidemia as main risk factors that affect stroke and AMI, this 
study used only billing information claimed before the stroke and AMI episode.
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2. Discussion of Study Results
Comparing a cumulative mortality according to diseases, in early stage 
within 20 days, the cumulative mortality was the highest in hemorrhagic stroke. 
The cumulative mortality had started to increase since 20 days in AMI, and 6-
month cumulative mortality was almost 70%. In contrast, the cumulative mortality 
of hemorrhagic stroke was the highest within 20 days, the cumulative mortality 
became steady since 30 days passed, and 6-month cumulative mortality was the 
lowest in all three diseases. In the case of ischemic stroke, the cumulative 
mortality was the lowest within 120 days. The cumulative mortality of 
hemorrhagic stroke was the highest after 120 days passed. And 6-month 
cumulative mortality was almost the same in ischemic stroke and hemorrhagic 
stroke. The cumulative mortality of early stage within 20 days was high in 
hemorrhagic stroke and AMI. All three diseases need specialized interventions. 
Especially, hemorrhagic stroke and AMI need specific interventions such as PCI 
or craniotomy and available personal sources that can do these specific 
interventions. On the other hand, the proportion of patients who needed 
percutaneous cerebrovascular intervention is small than those of patients with the 
other two conditions. Most cases of ischemic stroke can be controlled by 
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medications such as thrombolytic agents. These features of the aforementioned 
diseases likely led to this result. The cumulative mortality in hemorrhagic stroke 
was steady as the length of hospital stay exceeded 40 days. Of the hemorrhagic 
stroke patients, those who had a severe stroke died in the early stage. Thereafter, 
the cumulative mortality was likely steady. By contrast, early cumulative 
mortality in ischemic stroke was relatively lower than those of the other two 
diseases but tended to increased steadily. In case of AMI, early cumulative 
mortality was high and the cumulative mortality increased sharply over time. A 
previous study found that the acute case-fatality of stroke was about 15%, but that 
of AMI ranged from 34% to 43%71. Acute case-fatality was higher in AMI than in 
stroke. Considering these results, in the case of hemorrhagic stroke, acute care is 
likely to be relatively more important than long-term care. In the case of ischemic 
stroke, anything is not more important than acute care and long-term care, but 
overall care is important throughout the hospitalization period. In the case of AMI, 
the 6-month cumulative mortality was almost two-fold higher than those in the 
other two diseases and length of hospital stay was relatively short. This showed 
that acute and long-term care was both important.
In the analysis of the association between patient characteristics and 
mortality, diabetes and dyslipidemia were not statistically significant factors of 
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stroke. However, the risk of mortality was higher for the patients with than for 
those without hypertension. Previous studies found that the population-
attributable risk (PAR) of hypertension was 22.7%–28.5%, but the PAR of 
diabetes was 14.6%72. The difference was >10%. Our results were consistent with 
those of previous studies that showed that the PAR of hypertension was higher 
than the PAR of stroke in diabetes. The PAR of diabetes was 5%73 and that of 
hypertension was 25% for AMI. The PAR of hypertension was higher than that of 
diabetes. Our results showed that the risk of mortality was lower for the patients 
with than for those without hypertension, and the risk of mortality in AMI was 
higher for the patients with than for those without diabetes. As we used claims 
data, we could identify whether patients had hypertension/diabetes, but we could 
not consider medication compliance. In addition, we defined patients without 
hypertension or diabetes who had never claimed I10-I14 and E11-E14 of the ICD-
10 codes. We could not distinguish among these patients those who did not have 
hypertension or diabetes, or those with undiagnosed hypertension or diabetes. 
AMI is a more common disease than stoke and occurs easily in young people. In 
Korea, according to the report of the Korean National Nutrition and Health 
Examination, the perception and treatment rates of hypertension or diabetes are 
low for young people74. Therefore, patients without hypertension or diabetes 
might include patients who do not recognize their diseases. We could not consider
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the dynamic interaction of all three conditions according to medication 
compliance. In 7-day mortality, clinical factors were associated with mortality in
ischemic and hemorrhagic strokes. Non-clinical factors such as health insurance 
type and individual household income were associated with 30-day and in-
hospital mortality. The effects of the non-clinical factors were demonstrated in the 
intermediate and long-term mortality. Previous studies found that the predictors of
stroke included recurrent stroke, increased ICT, increased mass effect and size of 
lesion, or new onset of AMI or aspiration pneumonia during hospital day75-77. Age, 
heart rate, systolic pressure, presentation after cardiac arrest, presentation in 
cardiogenic shock, heart failure, presentation with ST-segment elevation 
myocardial infarction, creatinine clearance, and troponin ratio were associated 
with acute mortality78-81. Patient’s physical condition is more important in short-
term mortality than the use of available resources82. In the case of an unstable 
phase of the patient’s physical condition, patient’s clinical factors were associated 
with mortality. However, patient’s condition became stable over time. From the 
stable phase, access to costly medication, treatment, and advanced care might 
differ according to health insurance coverage and individual household 
income83,84. 
The HR of mortality was higher for the patients admitted to the intensive 
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care unit than for those who were not in all three diseases. Admission in the 
intensive care unit might proxy for disease severity itself. However, the risk of 
mortality among the patients admitted to the intensive care unit was highest in 
ischemic stroke, followed by AMI, and the lowest in hemorrhagic stroke. The 
admission rate to the intensive care unit was 13% in ischemic stroke, 
approximately 60% in AMI, and 80% in hemorrhagic stroke. The difference in 
admission rate between the patients admitted to the intensive care unit and those 
who were not was the greatest in ischemic stroke, followed by AMI and then 
hemorrhagic stroke. We thought the difference likely reflects the difference in 
disease severity between the two patient groups. Performing PCI reduced the risk 
of mortality in AMI85. PCI was one of the most important processes. Moreover, 
considering that the cumulative mortality was the greatest of all three conditions, 
performing PCI was the most effective way of reducing the risk of mortality. For 
the patients admitted to a superior general hospital because of ischemic stroke and 
AMI, we could observe the weekend effect. Especially in the case of AMI, if we 
consider that performing PCI could decrease the risk of mortality, the availability 
of personal resources that can perform a PCI during a weekend or holiday might 
be a critical factor.
In case of ischemic stroke, the risk of mortality was higher for the patients 
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admitted to hospitals with public sources of funding or to hospitals with sources 
of funding for educational purposes than for those admitted to hospitals with 
private funding. The hospitals with public funding tended to be weaker financially
than the other hospitals, which leads to poor quality of care86. We observed a 
steady increase in cumulative mortality regardless of an acute or chronic phase. 
Our findings suggest that the overall hospital quality was more important during 
the whole admission period relative to the other factors of ischemic stroke. 
Hospitals with private funding are likely to invest in improving quality of care. 
Therefore, considering the characteristic of ischemic stroke, we thought that the 
characteristic of funding sources is associated with mortality. The patient-to-nurse 
ratio was associated with mortality in ischemic stroke. We thought this variable 
was likely to represent the overall quality of care provided by hospitals. AMI and 
hemorrhagic stroke are diseases that need specialized techniques such as PCI or 
craniotomy. In these two diseases, hospital volume and transfer rate to another 
hospital were associated with mortality. This finding was consistent with those of 
previous studies87-90. In addition, in the case of AMI, the patient-to-physician ratio 
was associated with mortality for some groups. Considering these results, we 
think organizational or individual competence might be a critical factor. In 
hemorrhagic stroke, the patient-to-nurse or physician ratio was greater, but the 
hazard ratio was smaller. This finding contradicts the general idea. Thus, this 
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study performed two tests to resolve the issues that led to these results. The first 
test excluded patients who died within 7 days to analyze the risk of 30-day 
mortality and patients who died within 30 days to analyze the risk of in-hospital 
mortality. The results of this analysis are presented in Appendixes D1–D3. In 
addition, considering that patients with severe illnesses tend to visit a superior 
hospital, another analysis was performed to improve the homogeneity of the study 
population in terms of disease severity only for hospitals that had volumes within 
the fourth or fifth quintile in terms of total beds. The results of this analysis are 
presented in Appendixes E1–E3. After adjusting for the hospital size, although the
difference was not statistically significant among all the groups, we identified 
greater volume, more physicians, and more nurses to be associated with reduced
risk of mortality. However, in hemorrhagic stroke, the results indicated that the 
risk of mortality decreased as the number of nurses decreased. We examined the 
proportion of patients with severe conditions according to the ratio of beds per 
nurse (Appendix F). The proportion of patients with severe conditions was highest 
in the group with a 2.0:1 ratio.
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3. Implication of Study
Hypertension, diabetes, and dyslipidemia were associated with increased
risk of mortality in stroke and AMI. These factors are preventable; thus, policies 
should focus on primary prevention by changing to healthy lifestyles. In AMI, 
performing PCI was strongly associated with reduced risk of mortality. 
Considering this finding, change of the standard for pay for performance is 
needed from the rate of performing PCI within 90 minutes to the number of 
experts who can provide PCI effectively. There is inequality in the number of 
experts who can provide PCI according to region. Therefore, regarding this 
problem, training programs and providing equal numbers of experts should be 
implemented at the national level. In addition, the risk of mortality varied 
according to day of admission. The standard of hospital accreditation should be 
set to identify which health-care system can provided consistent care regardless of 
day of admission. In hemorrhagic stroke, only 7 quality indicators have been 
currently used. To evaluate quality of hemorrhagic care, development of quality 
indicators might be needed. In AMI and hemorrhagic stroke, which 
individual/organizational competence is more important than organizational 
structures should be identified and a central system for sharing information such 
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as the lists of medical institutions that can manage these diseases will be needed.
This was can be a realistic plan for managing patients with these diseases.
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4. Limitation of Study 
With regard to patients who did not make claims for hypertension, diabetes, 
and dyslipidemia, they might be real individuals who did not have hypertension, 
diabetes, and dyslipidemia, or might have undiagnosed hypertension, diabetes, 
and dyslipidemia. Patients without billing information for hypertension, diabetes, 
and dyslipidemia could be mixed.
In defining dependent variables, this study determined the death date by 
examining whether the patient received discharge medication and/or used medical 
services after discharge. Although the death date month/year and the discharge 
date month/year were identical, it is possible that some patients were discharged 
against medical advice, did not take discharge medication, and did not use
medical services after discharge.
Furthermore, in stroke and AMI, prehospital intervention is one of the most 
important factors. However, this study could not consider prehospital intervention 
because this study used claims data. This study did not include patients who died 
on arrival because they did not use hospital services. Thus, this study could not 
include patients with DOA (death on arrival). To measure disease severity, 
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although this study considered use of intensive care unit service and intervention, 
it could not consider stroke severity and AMI severity such as location of a 
blocked coronary artery and the number of blocked arteries. However, this study 
tried to adjust for patient age, comorbid conditions by using the CCI, and 
medical/surgical intervention, which are also important to adjust for disease 
complexity. Finally, because this study was an observation study, unmeasured bias 
might be present.
Despite these limitations, this study used a representative data and included
all data on all-cause mortality. This study used socioeconomic status, which could 
affect mortality, unlike studies that used administrative data. Finally, this study 
used a robust study design and Cox’s proportional hazard frailty model to 
investigate factors at the individual, treatment, and hospital levels that could 
impact mortality.
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Ⅵ. Conclusion
This study evaluated the factors that affected 7-day (acute), 30-day (sub-
acute), and in-hospital (latent) mortality in patients with ischemic and 
hemorrhagic stroke, and acute myocardial infarction using algebra effectiveness 
model. After adjusting for all independent variables including patient 
characteristics, treatment characteristics and hospital characteristics, in terms of 
patient’s factors, clinical factors such as age, sex, hypertension, and diabetes was 
associated with 7-day mortality among patients with all three diseases, and non-
clinical factors such as individual household income and health insurance type 
was associated with 30-day and in-hospital mortality. In terms of treatment factors, 
performing PCI was associated with reducing the risk of 7-day, 30-day and in-
hospital mortality in AMI.  Use of intensive care unit and weekend admission 
was associated with increasing the risk of mortality in ischemic stroke and AMI. 
In hemorrhagic stroke, the risk of mortality was higher for receiving of surgical 
intervention than receiving of medical intervention. In hospital factors, the ratio of 
number of patient per one nurse was associated with mortality in ischemic stroke. 
The volume was associated with mortality in all three diseases, and the transferred 
rate was associated with mortality in hemorrhagic stroke. This study’s findings 
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suggested that we need policies that focus on primary prevention to change to 
patients’ healthy life style. To secure experts, we need policies that can supply
experts and train the experts at national level who can perform intervention such 
as PCI. In case of diseases that organizational and hospital staff’s competence is 
important, an introduction of system is needed that can share the list of 
organization which can manage patients with these diseases between institutions.
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Table A1-1. Adjusted hazard ratio for association between patient characteristics and 7-day mortality
in ischemic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Patient Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI
Age 
20-39 0.34 (0.05-2.50) -
40-49 0.52 (0.20-1.34) 0.33 (0.10-1.08)
50-59 0.51 (0.25-1.02) 0.47 (0.24-0.93)
60-69 0.58 (0.36-0.93) 0.58 (0.36-0.91)
≥70 1.00 1.00 
Sex
Male 0.79 (0.54-1.16) 0.67 (0.47-0.96)
Female 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00
Medical aid 0.71 (0.28-1.81) 1.07 (0.47-2.41)
Individual household income
Low 1.50 (0.91-2.48) 0.90 (0.57-1.44)
Middle 1.53 (0.98-2.39) 1.29 (0.87-1.91)
High 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 
City 0.94 (0.60-1.47) 0.99 (0.67-1.47)
Rural 0.81 (0.47-1.40) 1.13 (0.66-1.93)
Charlson comorbidity index
0-1 1.00 1.00 
2-3 0.83 (0.47-1.47) 1.37 (0.85-2.21)
4-5 1.11 (0.60-2.06) 1.50 (0.88-2.57)
>5 1.86 (0.98-3.54) 1.19 (0.64-2.21)
Hypertension
No 1.00 1.00 
Without hypertensive 
complication
1.27 (0.72-2.23) 1.08 (0.67-1.74)
With hypertensive complication 1.50 (0.78-2.87) 1.42 (0.81-2.49)
Diabetes Mellitus
No 1.00 1.00
Without diabetic complication 0.98 (0.59-1.62) 1.16 (0.76-1.78)
With diabetic complication 1.05 (0.63-1.73) 0.77 (0.48-1.25)
Dyslipidemia
No 1.00 1.00 
Yes 0.89 (0.57-1.39) 0.81 (0.55-1.19)
Disability
None 1.00 1.00
Mild 0.86 (0.48-1.54) 1.35 (0.83-2.21)
Severe 0.75 (0.34-1.64) 0.65 (0.33-1.25)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics
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Table A1-2. Adjusted hazard ratio for association between patient characteristics and 7-day mortality
in hemorrhagic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Patient Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI
Age 
20-39 0.49 (0.21-1.15) 0.55 (0.23-1.31)
40-49 0.70 (0.40-1.24) 0.69 (0.42-1.13)
50-59 0.88 (0.54-1.43) 0.54 (0.35-0.85)
60-69 0.50 (0.31-0.83) 0.60 (0.40-0.90)
≥70 1.00 1.00 
Sex
Male 1.01 (0.71-1.43) 1.26 (0.92-1.71)
Female 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00
Medical aid 0.42 (0.16-1.11) 1.02 (0.50-2.10)
Individual household income
Low 1.18 (0.77-1.82) 0.96 (0.63-1.45)
Middle 0.90 (0.60-1.36) 1.02 (0.72-1.46)
High 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 
City 0.69 (0.46-1.03) 1.05 (0.74-1.50)
Rural 0.90 (0.54-1.51) 1.02 (0.63-1.65)
Charlson comorbidity index
0-1 1.00 1.00 
2-3 1.11 (0.70-1.75) 1.17 (0.78-1.75)
4-5 1.22 (0.66-2.27) 1.55 (0.96-2.49)
>5 3.27 (1.76-6.06) 1.63 (0.96-2.77)
Hypertension
No 1.00 1.00 
Without hypertensive 
complication
0.69 (0.44-1.07) 1.12 (0.77-1.64)
With hypertensive complication 1.02 (0.57-1.81) 1.36 (0.84-2.21)
Diabetes Mellitus
No 1.00 1.00
Without diabetic complication 0.88 (0.52-1.50) 1.45 (0.94-2.25)
With diabetic complication 1.47 (0.84-2.56) 1.80 (1.11-2.92)
Dyslipidemia
No 1.00 1.00 
Yes 0.85 (0.54-1.32) 0.76 (0.52-1.12)
Disability
None 1.00 1.00
Mild 0.84 (0.46-1.53) 1.12 (0.72-1.76)
Severe 1.05 (0.61-1.82) 0.46 (0.26-0.83)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table A1-3. Adjusted hazard ratio for association between patient characteristics and 7-day mortality
in acute myocardial infarction, stratified to hospital function 
Superior General Hospital General Hospital
Patient Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI
Age 
20-39 0.43 (0.06-3.25) 0.42 (0.10-1.81)
40-49 0.18 (0.04-0.77) 0.13 (0.03-0.57)
50-59 0.47 (0.25-0.91) 0.56 (0.28-1.09)
60-69 0.66 (0.42-1.06) 0.62 (0.37-1.04)
≥70 1.00 1.00 
Sex
Male 1.11 (0.74-1.66) 0.84 (0.57-1.25)
Female 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00
Medical aid 1.07 (0.30-3.77) 0.43 (0.13-1.46)
Individual household income
Low 1.14 (0.63-2.07) 1.14 (0.67-1.92)
Middle 1.05 (0.68-1.62) 0.83 (0.54-1.27)
High 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 
City 0.72 (0.45-1.14) 0.93 (0.62-1.40)
Rural 1.18 (0.69-2.01) 0.95 (0.50-1.82)
Charlson comorbidity index
0-1 1.00 1.00 
2-3 0.80 (0.45-1.40) 1.28 (0.65-2.51)
4-5 0.95 (0.51-1.77) 2.38 (1.20-4.69)
>5 0.85 (0.42-1.72) 2.14 (1.01-4.57)
Hypertension
No 1.00 1.00 
Without hypertensive 
complication
0.83 (0.49-1.42) 0.48 (0.29-0.81)
With hypertensive complication 0.90 (0.48-1.68) 0.43 (0.24-0.79)
Diabetes Mellitus
No 1.00 1.00
Without diabetic complication 1.69 (1.02-2.79) 1.17 (0.72-1.90)
With diabetic complication 1.80 (1.10-2.97) 0.96 (0.59-1.58)
Dyslipidemia
No 1.00 1.00 
Yes 0.73 (0.47-1.15) 0.82 (0.53-1.27)
Disability
None 1.00 1.00
Mild 0.78 (0.38-1.57) 0.79 (0.43-1.43)
Severe 1.27 (0.63-2.57) 1.39 (0.73-2.65)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics
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Table A2-1. Adjusted hazard ratio for association between patient characteristics and 30-day mortality
in ischemic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Patient Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI
Age 
20-39 0.48 (0.15-1.58) - -
40-49 0.42 (0.19-0.92) 0.29 (0.12-0.72)
50-59 0.45 (0.25-0.80) 0.45 (0.27-0.76)
60-69 0.72 (0.51-1.02) 0.59 (0.42-0.83)
≥70 1.00 1.00 
Sex
Male 0.83 (0.62-1.11) 0.75 (0.57-0.98)
Female 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00
Medical aid 0.79 (0.37-1.68) 1.51 (0.78-2.94)
Individual household income
Low 1.29 (0.87-1.90) 1.26 (0.90-1.78)
Middle 1.27 (0.91-1.77) 1.47 (1.09-1.99)
High 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 
City 1.29 (0.93-1.81) 1.00 (0.74-1.35)
Rural 0.97 (0.63-1.49) 1.21 (0.81-1.81)
Charlson comorbidity index
0-1 1.00 1.00 
2-3 0.77 (0.50-1.20) 1.14 (0.79-1.62)
4-5 1.19 (0.76-1.89) 1.23 (0.82-1.84)
>5 1.55 (0.95-2.53) 1.08 (0.68-1.71)
Hypertension
No 1.00 1.00 
Without hypertensive 
complication
1.19 (0.77-1.85) 1.07 (0.75-1.54)
With hypertensive complication 1.58 (0.96-2.59) 1.32 (0.86-2.05)
Diabetes Mellitus
No 1.00 1.00
Without diabetic complication 0.92 (0.63-1.33) 1.00 (0.71-1.40)
With diabetic complication 0.91 (0.62-1.34) 0.98 (0.69-1.40)
Dyslipidemia
No 1.00 1.00 
Yes 0.99 (0.70-1.39) 0.75 (0.56-1.01)
Disability
None 1.00 1.00
Mild 0.68 (0.43-1.09) 1.06 (0.71-1.58)
Severe 0.60 (0.33-1.09) 0.62 (0.38-1.01)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table A2-2. Adjusted hazard ratio for association between patient characteristics and 30-day mortality
in hemorrhagic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Patient Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI
Age 
20-39 0.62 (0.34-1.14) 0.58 (0.32-1.07)
40-49 0.67 (0.43-1.03) 0.65 (0.45-0.95)
50-59 0.87 (0.60-1.27) 0.59 (0.42-0.81)
60-69 0.62 (0.43-0.89) 0.55 (0.40-0.76)
≥70 1.00 1.00 
Sex
Male 1.03 (0.79-1.34) 1.27 (1.00-1.60)
Female 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00
Medical aid 0.29 (0.11-0.73) 0.79 (0.44-1.43)
Individual household income
Low 1.08 (0.78-1.49) 1.00 (0.73-1.36)
Middle 0.81 (0.59-1.11) 1.08 (0.83-1.42)
High 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 
City 0.73 (0.54-0.99) 0.97 (0.75-1.26)
Rural 0.66 (0.43-1.02) 0.96 (0.67-1.37)
Charlson comorbidity index
0-1 1.00 1.00 
2-3 1.00 (0.71-1.42) 1.03 (0.76-1.39)
4-5 1.19 (0.75-1.87) 1.42 (0.98-2.04)
>5 2.76 (1.73-4.41) 1.69 (1.12-2.53)
Hypertension
No 1.00 1.00 
Without hypertensive 
complication
0.88 (0.63-1.22) 1.19 (0.90-1.59)
With hypertensive complication 1.18 (0.76-1.82) 1.33 (0.91-1.94)
Diabetes Mellitus
No 1.00 1.00
Without diabetic complication 0.92 (0.62-1.37) 1.15 (0.81-1.64)
With diabetic complication 1.55 (1.02-2.35) 1.65 (1.13-2.40)
Dyslipidemia
No 1.00 1.00 
Yes 0.85 (0.61-1.19) 0.81 (0.60-1.08)
Disability
None 1.00 1.00
Mild 0.85 (0.54-1.34) 0.91 (0.63-1.31)
Severe 0.75 (0.48-1.17) 0.51 (0.34-0.79)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table A2-3. Adjusted hazard ratio for association between patient characteristics and 30-day mortality
in acute myocardial infarction, stratified by hospital function 
Superior General Hospital General Hospital
Patient Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI
Age 
20-39 0.28 (0.04-2.10) 0.47 (0.14-1.57)
40-49 0.20 (0.06-0.65) 0.16 (0.05-0.52)
50-59 0.44 (0.25-0.78) 0.47 (0.26-0.87)
60-69 0.60 (0.41-0.89) 0.61 (0.40-0.93)
≥70 1.00 1.00 
Sex
Male 0.98 (0.71-1.34) 0.86 (0.63-1.18)
Female 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00
Medical aid 0.89 (0.30-2.63) 0.57 (0.24-1.31)
Individual household income
Low 0.89 (0.56-1.43) 1.37 (0.89-2.11)
Middle 0.87 (0.62-1.23) 0.92 (0.65-1.32)
High 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 
City 0.87 (0.60-1.26) 0.98 (0.70-1.36)
Rural 1.26 (0.82-1.95) 0.97 (0.58-1.63)
Charlson comorbidity index
0-1 1.00 1.00 
2-3 0.58 (0.36-0.92) 1.09 (0.62-1.90)
4-5 0.91 (0.56-1.47) 1.88 (1.07-3.31)
>5 0.65 (0.38-1.13) 1.80 (0.97-3.35)
Hypertension
No 1.00 1.00 
Without hypertensive 
complication
0.86 (0.55-1.35) 0.63 (0.41-0.99)
With hypertensive complication 1.03 (0.62-1.71) 0.62 (0.37-1.03)
Diabetes Mellitus
No 1.00 1.00
Without diabetic complication 1.52 (1.02-2.27) 1.20 (0.81-1.78)
With diabetic complication 1.50 (1.02-2.22) 0.95 (0.64-1.42)
Dyslipidemia
No 1.00 1.00 
Yes 0.81 (0.57-1.17) 0.78 (0.54-1.13)
Disability
None 1.00 1.00
Mild 0.92 (0.54-1.55) 1.00 (0.64-1.54)
Severe 0.98 (0.55-1.75) 1.51 (0.92-2.49)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics
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Table A3-1. Adjusted hazard ratio for association between patient characteristics and in-hospital
mortality in ischemic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Patient Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI
Age 
20-39 0.44 (0.14-1.45) - -
40-49 0.48 (0.24-0.97) 0.29 (0.13-0.68)
50-59 0.41 (0.23-0.73) 0.43 (0.26-0.71)
60-69 0.69 (0.50-0.97) 0.54 (0.38-0.75)
≥70 1.00 1.00 
Sex
Male 0.89 (0.67-1.17) 0.77 (0.60-1.00)
Female 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00
Medical aid 0.80 (0.39-1.65) 1.23 (0.69-2.18)
Individual household income
Low 1.28 (0.88-1.86) 1.23 (0.89-1.70)
Middle 1.22 (0.89-1.68) 1.43 (1.07-1.89)
High 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 
City 1.32 (0.96-1.81) 0.98 (0.74-1.29)
Rural 0.93 (0.61-1.42) 1.13 (0.76-1.66)
Charlson comorbidity index
0-1 1.00 1.00 
2-3 0.85 (0.56-1.29) 1.10 (0.78-1.54)
4-5 1.31 (0.85-2.02) 1.33 (0.91-1.93)
>5 1.63 (1.03-2.59) 1.11 (0.72-1.69)
Hypertension
No 1.00 1.00 
Without hypertensive 
complication
1.28 (0.83-1.95) 1.10 (0.78-1.56)
With hypertensive complication 1.64 (1.01-2.64) 1.30 (0.86-1.97)
Diabetes Mellitus
No 1.00 1.00
Without diabetic complication 0.96 (0.67-1.36) 0.91 (0.66-1.26)
With diabetic complication 0.89 (0.62-1.28) 0.97 (0.70-1.34)
Dyslipidemia
No 1.00 1.00 
Yes 0.95 (0.69-1.31) 0.82 (0.62-1.09)
Disability
None 1.00 1.00
Mild 0.73 (0.48-1.13) 1.02 (0.71-1.48)
Severe 0.55 (0.31-0.98) 0.58 (0.38-0.91)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table A3-2. Adjusted hazard ratio for association between patient characteristics and in-hospital
mortality in hemorrhagic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Patient Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI
Age 
20-39 0.62 (0.35-1.12) 0.52 (0.29-0.95)
40-49 0.70 (0.46-1.07) 0.62 (0.43-0.90)
50-59 0.85 (0.59-1.23) 0.55 (0.40-0.75)
60-69 0.65 (0.46-0.91) 0.55 (0.41-0.74)
≥70 1.00 1.00 
Sex
Male 1.12 (0.87-1.45) 1.35 (1.08-1.69)
Female 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00
Medical aid 0.33 (0.14-0.77) 0.72 (0.41-1.28)
Individual household income
Low 1.08 (0.79-1.48) 1.00 (0.75-1.35)
Middle 0.82 (0.61-1.11) 1.03 (0.80-1.33)
High 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 
City 0.76 (0.57-1.01) 1.00 (0.78-1.28)
Rural 0.69 (0.46-1.04) 1.05 (0.75-1.48)
Charlson comorbidity index
0-1 1.00 1.00 
2-3 1.02 (0.73-1.42) 0.99 (0.74-1.33)
4-5 1.21 (0.79-1.87) 1.47 (1.05-2.07)
>5 2.62 (1.67-4.13) 1.68 (1.14-2.47)
Hypertension
No 1.00 1.00 
Without hypertensive 
complication
0.93 (0.68-1.28) 1.30 (0.99-1.70)
With hypertensive complication 1.13 (0.74-1.73) 1.33 (0.92-1.91)
Diabetes Mellitus
No 1.00 1.00
Without diabetic complication 0.92 (0.63-1.36) 1.09 (0.78-1.52)
With diabetic complication 1.49 (1.00-2.22) 1.62 (1.14-2.32)
Dyslipidemia
No 1.00 1.00 
Yes 0.89 (0.64-1.23) 0.78 (0.59-1.03)
Disability
None 1.00 1.00
Mild 0.82 (0.53-1.27) 0.96 (0.69-1.35)
Severe 0.71 (0.46-1.09) 0.51 (0.35-0.76)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table A3-3. Adjusted hazard ratio for association between patient characteristics and in-hospital
mortality in acute myocardial infarction, stratified by hospital function 
Superior General Hospital General Hospital
Patient Characteristics Adjusted HR* 95% CI Adjusted HR* 95% CI
Age 
20-39 0.24 (0.03-1.77) 0.47 (0.14-1.56)
40-49 0.19 (0.06-0.60) 0.20 (0.07-0.56)
50-59 0.40 (0.23-0.70) 0.47 (0.26-0.86)
60-69 0.58 (0.40-0.84) 0.61 (0.40-0.92)
≥70 1.00 1.00 
Sex
Male 1.02 (0.75-1.39) 0.85 (0.62-1.16)
Female 1.00 1.00 
Health insurance type
National health insurance 1.00 1.00
Medical aid 0.89 (0.30-2.61) 0.63 (0.28-1.40)
Individual household income
Low 0.84 (0.52-1.34) 1.43 (0.94-2.20)
Middle 0.87 (0.62-1.22) 0.98 (0.70-1.39)
High 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 
City 0.82 (0.57-1.18) 1.06 (0.76-1.47)
Rural 1.20 (0.78-1.85) 1.08 (0.66-1.78)
Charlson comorbidity index
0-1 1.00 1.00 
2-3 0.58 (0.37-0.93) 1.09 (0.63-1.88)
4-5 0.94 (0.58-1.50) 1.79 (1.02-3.13)
>5 0.67 (0.39-1.15) 1.78 (0.97-3.28)
Hypertension
No 1.00 1.00 
Without hypertensive 
complication
0.79 (0.51-1.22) 0.62 (0.40-0.96)
With hypertensive complication 1.01 (0.62-1.65) 0.62 (0.38-1.02)
Diabetes Mellitus
No 1.00 1.00
Without diabetic complication 1.43 (0.96-2.12) 1.22 (0.84-1.79)
With diabetic complication 1.41 (0.96-2.06) 0.95 (0.64-1.41)
Dyslipidemia
No 1.00 1.00 
Yes 0.83 (0.58-1.19) 0.77 (0.54-1.11)
Disability
None 1.00 1.00
Mild 0.87 (0.51-1.47) 1.01 (0.66-1.54)
Severe 1.05 (0.62-1.78) 1.37 (0.85-2.24)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous 
transcatheter placement of intracoronary stent, percutaneous transluminal coronary atherectomy, 
percutaneous transluminal cerebral angioplasty, percutaneous cerebral angioplasty with drug 
(installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table B1-1. Adjusted hazard ratio for association between treatment characteristics and 7-day 
mortality in ischemic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Treatment Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Intensive care unit service
No use 1.00 1.00
Use 5.45 (3.64-8.15) 8.76 (6.19-12.39)
Intravenous thrombolytic agents
No 1.00 1.00
Yes 1.02 (0.56-1.87) 1.32 (0.87-2.01)
Percutaneous coronary/
cerebrovascular interventiona
No 1.00 1.00 
Yes 1.48 (0.59-3.68) 0.87 (0.30-2.52)
Weekend admissionb
Weekday admission 1.00 1.00
Weekend admission 1.48 (1.01-2.18) 1.02 (0.71-1.46)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
NA
NA
Use of mannitol
Endovascular coiling
Trephination
Craniotomy 
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ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous 
transcatheter placement of intracoronary stent, percutaneous transluminal coronary atherectomy, 
percutaneous transluminal cerebral angioplasty, percutaneous cerebral angioplasty with drug 
(installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table B1-2. Adjusted hazard ratio for association between treatment characteristics and 7-day 
mortality in hemorrhagic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Treatment Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Intensive care unit service
No use 1.00 1.00 
Use 0.80 (0.52-1.21) 1.28 (0.81-2.00)
Intravenous thrombolytic agents
No NA NA
Yes
Percutaneous coronary/
cerebrovascular interventiona
No NA NA
Yes
Weekend admissionb
Weekday admission 1.00 1.00 
Weekend admission 1.32 (0.92-1.91) 1.05 (0.75-1.48)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
1.00 1.00 
Use of mannitol 5.57 (2.16-14.32) 2.82 (1.55-5.15)
Endovascular coiling 1.97 (0.54-7.15) 0.93 (0.29-2.98)
Trephination 6.03 (2.25-16.20) 1.92 (0.96-3.82)
Craniotomy 5.76 (1.54-21.48) 1.41 (0.44-4.50)
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ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous 
transcatheter placement of intracoronary stent, percutaneous transluminal coronary atherectomy, 
percutaneous transluminal cerebral angioplasty, percutaneous cerebral angioplasty with drug 
(installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table B1-3. Adjusted hazard ratio for association between treatment characteristics and 7-day 
mortality in acute myocardial infarction, stratified by hospital function 
Superior General Hospital General Hospital
Treatment Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Intensive care unit service
No use 1.00 1.00
Use 2.22 (1.44-3.44) 2.26 (1.44-3.54)
Intravenous thrombolytic agents
No 1.00 1.00
Yes 0.80 (0.28-2.27) 2.08 (1.03-4.18)
Percutaneous coronary/
cerebrovascular interventiona
No 1.00 1.00 
Yes 0.35 (0.23-0.55) 0.43 (0.27-0.67)
Weekend admissionb
Weekday admission 1.00 1.00
Weekend admission 1.30 (0.86-1.96) 1.25 (0.83-1.90)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
NA
NA
Use of mannitol
Endovascular coiling
Trephination
Craniotomy 
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ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous 
transcatheter placement of intracoronary stent, percutaneous transluminal coronary atherectomy, 
percutaneous transluminal cerebral angioplasty, percutaneous cerebral angioplasty with drug 
(installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table B2-1. Adjusted hazard ratio for association between treatment characteristics and 30-
day mortality in ischemic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Treatment Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Intensive care unit service
No use 1.00 1.00
Use 4.77 (3.53-6.43) 7.00 (5.39-9.09)
Intravenous thrombolytic agents
No 1.00 1.00
Yes 1.35 (0.89-2.05) 0.98 (0.69-1.37)
Percutaneous coronary/
cerebrovascular interventiona
No 1.00 1.00 
Yes 1.20 (0.65-2.18) 0.84 (0.35-1.99)
Weekend admissionb
Weekday admission 1.00 1.00
Weekend admission 1.38 (1.02-1.86) 1.02 (0.77-1.34)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
NA
NA
Use of mannitol
Endovascular coiling
Trephination
Craniotomy 
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ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous 
transcatheter placement of intracoronary stent, percutaneous transluminal coronary atherectomy, 
percutaneous transluminal cerebral angioplasty, percutaneous cerebral angioplasty with drug 
(installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table B2-2. Adjusted hazard ratio for association between treatment characteristics and 30-
day mortality in hemorrhagic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Treatment Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Intensive care unit service
No use 1.00 1.00 
Use 4.81 (3.58-6.46) 6.96 (5.37-9.03)
Intravenous thrombolytic agents
No NA NA
Yes
Percutaneous coronary/
cerebrovascular interventiona
No NA NA
Yes
Weekend admissionb
Weekday admission 1.00 1.00 
Weekend admission 1.07 (0.81-1.43) 1.00 (0.77-1.31)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
1.00 1.00 
Use of mannitol 3.38 (1.73-6.62) 2.61 (1.63-4.16)
Endovascular coiling 1.82 (0.78-4.25) 0.86 (0.37-2.00)
Trephination 4.56 (2.27-9.16) 2.33 (1.39-3.92)
Craniotomy 7.50 (3.23-17.44) 1.65 (0.71-3.82)
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ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous 
transcatheter placement of intracoronary stent, percutaneous transluminal coronary atherectomy, 
percutaneous transluminal cerebral angioplasty, percutaneous cerebral angioplasty with drug 
(installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table B2-3. Adjusted hazard ratio for association between treatment characteristics and 30-
day mortality in hemorrhagic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Treatment Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Intensive care unit service
No use 1.00 1.00
Use 1.86 (1.31-2.64) 2.16 (1.51-3.11)
Intravenous thrombolytic agents
No 1.00 1.00
Yes 0.82 (0.35-1.92) 1.82 (1.00-3.31)
Percutaneous coronary/
cerebrovascular interventiona
No 1.00 1.00 
Yes 0.38 (0.27-0.55) 0.44 (0.30-0.65)
Weekend admissionb
Weekday admission 1.00 1.00
Weekend admission 1.49 (1.08-2.05) 1.34 (0.96-1.88)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
NA
NA
Use of mannitol
Endovascular coiling
Trephination
Craniotomy 
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ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous 
transcatheter placement of intracoronary stent, percutaneous transluminal coronary atherectomy, 
percutaneous transluminal cerebral angioplasty, percutaneous cerebral angioplasty with drug 
(installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table B3-1. Adjusted hazard ratio for association between treatment characteristics and in-
hospital mortality in ischemic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Treatment Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Intensive care unit service
No use 1.00 1.00
Use 4.95 (3.72-6.60) 6.09 (4.76-7.79)
Intravenous thrombolytic agents
No 1.00 1.00
Yes 1.27 (0.85-1.91) 0.98 (0.72-1.36)
Percutaneous coronary/
cerebrovascular interventiona
No 1.00 1.00 
Yes 1.09 (0.60-1.95) 0.97 (0.45-2.10)
Weekend admissionb
Weekday admission 1.00 1.00
Weekend admission 1.27 (0.95-1.70) 1.02 (0.79-1.32)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
NA
NA
Use of mannitol
Endovascular coiling
Trephination
Craniotomy 
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ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous 
transcatheter placement of intracoronary stent, percutaneous transluminal coronary atherectomy, 
percutaneous transluminal cerebral angioplasty, percutaneous cerebral angioplasty with drug 
(installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table B3-2. Adjusted hazard ratio for association between treatment characteristics and in-
hospital mortality in hemorrhagic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Treatment Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Intensive care unit service
No use 1.00 1.00 
Use 1.18 (0.84-1.67) 1.47 (1.04-2.09)
Intravenous thrombolytic agents
No NA NA
Yes
Percutaneous coronary/
cerebrovascular interventiona
No NA NA
Yes
Weekend admissionb
Weekday admission 1.00 1.00 
Weekend admission 1.13 (0.86-1.48) 0.93 (0.72-1.20)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
1.00 1.00 
Use of mannitol 2.42 (1.36-4.32) 2.71 (1.70-4.32)
Endovascular coiling 1.41 (0.66-2.99) 0.96 (0.43-2.17)
Trephination 3.30 (1.80-6.04) 2.52 (1.51-4.21)
Craniotomy 5.27 (2.49-11.17) 1.77 (0.81-3.89)
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ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous 
transcatheter placement of intracoronary stent, percutaneous transluminal coronary atherectomy, 
percutaneous transluminal cerebral angioplasty, percutaneous cerebral angioplasty with drug 
(installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Table B3-3. Adjusted hazard ratio for association between treatment characteristics and in-
hospital mortality in hemorrhagic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Treatment Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Intensive care unit service
No use 1.00 1.00
Use 1.89 (1.34-2.67) 2.01 (1.42-2.86)
Intravenous thrombolytic agents
No 1.00 1.00
Yes 0.82 (0.35-1.93) 1.75 (0.97-3.14)
Percutaneous coronary/
cerebrovascular interventiona
No 1.00 1.00 
Yes 0.39 (0.27-0.55) 0.46 (0.32-0.67)
Weekend admissionb
Weekday admission 1.00 1.00
Weekend admission 1.48 (1.08-2.03) 1.39 (1.00-1.93)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
NA
NA
Use of mannitol
Endovascular coiling
Trephination
Craniotomy 
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Table C1-1. Adjusted hazard ratio for association between hospital characteristics and 7-day 
mortality in ischemic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Characteristic of foundation
Public 0.59 (0.06-5.48) 1.41 (0.87-2.30)
Educational foundation 1.43 (0.89-2.29) 1.05 (0.63-1.76)
Private 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 13.34 (2.59-68.78) 1.85 (0.95-3.62)
Quintile 2 1.57 (0.36-6.82) 1.76 (0.94-3.28)
Quintile 3 - 1.41 (0.74-2.68)
Quintile 4 0.80 (0.28-2.28) 0.99 (0.57-1.73)
Quintile 5 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 
5-9% 0.83 (0.50-1.36) 1.30 (0.66-2.57)
10-14% 0.85 (0.43-1.72) 0.66 (0.15-2.79)
15-19% 0.58 (0.21-1.65) 0.92 (0.36-2.33)
≥20% 1.50 (0.46-4.93) 0.61 (0.24-1.56)
The number of beds
Quintile 1 0.61 (0.21-1.79) 1.12 (0.54-2.33)
Quintile 2 1.15 (0.54-2.44) 0.75 (0.35-1.61)
Quintile 3 0.99 (0.51-1.91) 0.51 (0.25-1.06)
Quintile 4 1.71 (0.91-3.19) 0.81 (0.47-1.40)
Quintile 5 1.00 1.00 
The number of beds per one doctor
2.5:1 1.00 1.00 
3.5:1 0.97 (0.58-1.62) 0.64 (0.11-3.70)
5.5:1 0.71 (0.33-1.54) 0.57 (0.10-3.10)
8.5:1 1.28 (0.14-11.63) 0.51 (0.09-2.88)
>8.5:1 - 0.50 (0.09-2.66)
Ratio of beds per one nurse
2.0:1 1.00 1.00 
2.5:1 2.09 (0.23-19.31) 2.10 (0.27-16.47)
3.0:1 4.76 (0.54-41.89) 3.43 (0.45-26.39)
3.5:1 4.82 (0.53-44.1) 3.12 (0.39-25.04)
4.0:1 7.06 (0.70-71.12) 2.75 (0.32-23.71)
4.5:1 6.09 (0.59-62.95) 4.20 (0.52-34.06)
>6.0:1 - 0.98 (0.45-2.14)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table C1-2. Adjusted hazard ratio for association between hospital characteristics and 7-day 
mortality in hemorrhagic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Characteristic of foundation
Public 0.43 (0.13-1.50) 1.40 (0.87-2.24)
Educational foundation 0.74 (0.48-1.14) 1.14 (0.74-1.76)
Private 1.00 1.00 
Volume of emergent stroke patient
Quintile 1
5.20 
(1.77-
15.23)
2.06 (1.19-3.56)
Quintile 2 2.21 (1.15-4.27) 1.13 (0.70-1.83)
Quintile 3 2.11 (1.21-3.68) 0.88 (0.54-1.44)
Quintile 4 1.36 (0.82-2.26) 0.86 (0.52-1.43)
Quintile 5 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 
5-9% 1.83 (1.03-3.27) 0.23 (0.03-1.71)
10-14% 1.05 (0.50-2.24) 0.40 (0.09-1.67)
15-19% 1.55 (0.87-2.76) 1.26 (0.48-3.30)
≥20% 0.78 (0.39-1.55) 1.82 (1.13-2.94)
The number of beds
Quintile 1 1.71 (0.63-4.66) 1.04 (0.50-2.18)
Quintile 2 1.24 (0.46-3.36) 0.65 (0.31-1.37)
Quintile 3 1.15 (0.42-3.13) 1.10 (0.63-1.94)
Quintile 4 1.68 (0.66-4.28) 0.79 (0.50-1.26)
Quintile 5 1.00 1.00 
The number of beds per one doctor
2.5:1 1.00 1.00 
3.5:1 1.49 (0.67-3.34) 1.38 (0.36-5.33)
5.5:1 0.73 (0.31-1.72) 1.13 (0.30-4.28)
8.5:1 0.74 (0.36-1.54) 0.62 (0.15-2.51)
>8.5:1 0.89 (0.44-1.80) 0.94 (0.25-3.55)
Ratio of beds per one nurse
2.0:1 1.00 
2.5:1 0.17 (0.05-0.56) 1.00
3.0:1 0.23 (0.07-0.78) 0.89 (0.33-2.42)
3.5:1 0.28 (0.08-1.01) 1.05 (0.38-2.89)
4.0:1 0.22 (0.06-0.89) 0.79 (0.27-2.30)
4.5:1 0.10 (0.02-0.62) 0.92 (0.27-3.14)
>6.0:1 - 1.32 (0.44-3.96)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table C1-3. Adjusted hazard ratio for association between hospital characteristics and 7-day 
mortality in acute myocardial infarction, stratified by hospital function 
Superior General Hospital General Hospital
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Characteristic of foundation
Public 1.24 (0.30-5.18) 1.21 (0.68-2.14)
Educational foundation 1.41 (0.85-2.34) 1.02 (0.60-1.73)
Private 1.00 1.00 
Volume of emergent stroke patient
Quintile 1
3.24 
(0.62-
17.06)
1.64 (0.81-3.32)
Quintile 2 0.48 (0.06-3.76) 0.92 (0.44-1.94)
Quintile 3 0.91 (0.38-2.19) 0.77 (0.40-1.52)
Quintile 4 1.18 (0.71-1.95) 0.73 (0.43-1.27)
Quintile 5 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 
5-9% 1.88 (0.99-3.58) 0.58 (0.13-2.54)
10-14% 0.42 (0.10-1.75) -
15-19% 0.47 (0.06-3.68) 1.32 (0.30-5.79)
≥20% 1.56 (0.44-5.53) 0.76 (0.22-2.59)
The number of beds
Quintile 1 1.38 (0.44-4.30) 0.28 (0.09-0.89)
Quintile 2 1.36 (0.45-4.13) 0.64 (0.26-1.61)
Quintile 3 1.28 (0.44-3.77) 0.97 (0.51-1.83)
Quintile 4 1.82 (0.67-4.99) 0.75 (0.41-1.37)
Quintile 5 1.00 1.00 
The number of beds per one doctor
2.5:1 1.00 1.00 
3.5:1 1.60 (0.95-2.71) 1.30 (0.29-5.83)
5.5:1 1.06 (0.44-2.58) 0.88 (0.19-3.99)
8.5:1 - 1.13 (0.25-5.22)
>8.5:1 - 0.98 (0.20-4.80)
Ratio of beds per one nurse
2.0:1 1.00 
2.5:1 0.91 (0.22-3.75) 1.00
3.0:1 1.48 (0.34-6.50) 0.53 (0.18-1.58)
3.5:1 1.40 (0.29-6.68) 0.52 (0.17-1.58)
4.0:1 1.48 (0.28-7.96) 0.48 (0.15-1.54)
4.5:1 1.15 (0.18-7.57) 0.43 (0.10-1.89)
>6.0:1 - 0.65 (0.18-2.32)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table C2-1. Adjusted hazard ratio for association between hospital characteristics and 30-
day mortality in ischemic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Hospital Characteristics Adjusted*
HR
95% CI Adjusted*
HR
95% CI
Characteristic of foundation
Public 1.37 (0.47-3.97) 1.54 (1.05-2.24)
Educational foundation 1.35 (0.94-1.93) 1.04 (0.70-1.54)
Private 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 14.91 (3.75-59.33) 2.05 (1.23-3.42)
Quintile 2 2.12 (0.63-7.10) 2.17 (1.35-3.47)
Quintile 3 1.34 (0.81-2.20)
Quintile 4 0.70 (0.30-1.64) 1.27 (0.85-1.91)
Quintile 5 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 
5-9% 1.16 (0.81-1.67) 1.26 (0.74-2.15)
10-14% 1.32 (0.81-2.15) 0.85 (0.30-2.37)
15-19% 0.82 (0.40-1.69) 1.20 (0.64-2.23)
≥20% 1.55 (0.56-4.35) 1.08 (0.58-2.01)
The number of beds
Quintile 1 0.58 (0.26-1.30) 0.91 (0.51-1.62)
Quintile 2 0.91 (0.51-1.64) 0.69 (0.37-1.26)
Quintile 3 0.91 (0.55-1.50) 0.61 (0.36-1.04)
Quintile 4 1.20 (0.73-1.99) 0.81 (0.53-1.22)
Quintile 5 1.00 1.00 
The number of beds per one doctor
2.5:1 1.00 1.00 
3.5:1 1.02 (0.69-1.50) 0.63 (0.16-2.45)
5.5:1 0.76 (0.41-1.41) 0.66 (0.18-2.49)
8.5:1 0.89 (0.17-4.55) 0.52 (0.13-2.02)
>8.5:1 - 0.51 (0.14-1.92)
Ratio of beds per one nurse
2.0:1 1.00 1.00 
2.5:1 2.59 (0.78-8.62) 2.37 (0.54-10.38)
3.0:1 3.43 (1.02-11.51) 3.11 (0.72-13.45)
3.5:1 3.28 (0.93-11.54) 3.01 (0.67-13.48)
4.0:1 3.65 (0.92-14.6) 2.67 (0.57-12.58)
4.5:1 2.23 (0.51-9.73) 3.50 (0.77-15.82)
>6.0:1 - 0.98 (0.45-2.14)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table C2-2. Adjusted hazard ratio for association between hospital characteristics and 30-
day mortality in hemorrhagic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Characteristic of foundation
Public 0.52 (0.18-1.54) 1.31 (0.92-1.87)
Educational foundation 0.97 (0.70-1.34) 1.20 (0.88-1.63)
Private 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 3.40 (1.36-8.51) 2.57 (1.69-3.89)
Quintile 2 1.48 (0.90-2.42) 1.35 (0.94-1.95)
Quintile 3 1.39 (0.90-2.14) 1.02 (0.70-1.48)
Quintile 4 1.17 (0.81-1.68) 1.16 (0.80-1.69)
Quintile 5 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 
5-9% 1.45 (0.92-2.29) 0.69 (0.27-1.77)
10-14% 1.03 (0.58-1.84) 0.98 (0.48-2.00)
15-19% 1.17 (0.73-1.87) 1.24 (0.63-2.45)
≥20% 1.12 (0.71-1.77) 1.51 (1.02-2.22)
The number of beds
Quintile 1 1.92 (0.89-4.16) 0.78 (0.45-1.37)
Quintile 2 1.77 (0.84-3.73) 0.57 (0.33-0.98)
Quintile 3 1.52 (0.71-3.26) 0.84 (0.55-1.27)
Quintile 4 1.85 (0.91-3.77) 0.79 (0.57-1.09)
Quintile 5 1.00 1.00 
The number of beds per one doctor
2.5:1 1.00 1.00 
3.5:1 1.16 (0.83-1.62) 1.02 (0.42-2.48)
5.5:1 1.07 (0.64-1.77) 0.94 (0.39-2.24)
8.5:1 0.92 (0.11-7.52) 0.81 (0.33-2.02)
>8.5:1 - 0.96 (0.40-2.31)
Ratio of beds per one nurse
2.0:1 1.00 
2.5:1 0.30 (0.11-0.78) 1.00
3.0:1 0.34 (0.13-0.89) 0.93 (0.43-2.01)
3.5:1 0.36 (0.13-1.00) 0.95 (0.44-2.07)
4.0:1 0.32 (0.11-0.96) 0.76 (0.34-1.71)
4.5:1 0.25 (0.07-0.86) 0.98 (0.39-2.43)
>6.0:1 - 1.15 (0.49-2.65)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table C2-3. Adjusted hazard ratio for association between hospital characteristics and 30-
day mortality in acute myocardial infarction, stratified to hospital function 
Superior General Hospital General Hospital
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Characteristic of foundation
Public 0.82 (0.26-2.57) 1.51 (0.97-2.35)
Educational foundation 1.35 (0.91-1.99) 1.21 (0.79-1.85)
Private 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 2.86 (0.60-13.77) 1.91 (1.08-3.39)
Quintile 2 0.97 (0.28-3.43) 0.98 (0.53-1.79)
Quintile 3 0.74 (0.35-1.58) 0.81 (0.46-1.42)
Quintile 4 1.21 (0.81-1.81) 0.79 (0.50-1.24)
Quintile 5 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 
5-9% 1.72 (1.01-2.94) 0.66 (0.20-2.22)
10-14% 0.60 (0.24-1.50) -
15-19% 0.95 (0.27-3.30) 1.44 (0.43-4.84)
≥20% 0.81 (0.24-2.78) 0.84 (0.33-2.16)
The number of beds
Quintile 1 1.43 (0.59-3.48) 0.47 (0.21-1.03)
Quintile 2 1.60 (0.68-3.77) 0.50 (0.24-1.05)
Quintile 3 1.35 (0.58-3.12) 0.92 (0.55-1.56)
Quintile 4 1.88 (0.85-4.16) 0.75 (0.46-1.22)
Quintile 5 1.00 1.00 
The number of beds per one doctor
2.5:1 1.00 1.00 
3.5:1 1.21 (0.81-1.80) 1.29 (0.38-4.40)
5.5:1 0.94 (0.48-1.86) 0.96 (0.28-3.28)
8.5:1 - 1.25 (0.37-4.31)
>8.5:1 - 1.20 (0.33-4.38)
Ratio of beds per one nurse
2.0:1 1.00 
2.5:1 0.97 (0.32-2.93) 1.00
3.0:1 1.00 (0.30-3.34) 0.57 (0.21-1.51)
3.5:1 1.31 (0.37-4.60) 0.58 (0.22-1.53)
4.0:1 0.96 (0.24-3.83) 0.45 (0.16-1.26)
4.5:1 0.84 (0.17-4.14) 0.40 (0.11-1.38)
>6.0:1 - 0.58 (0.19-1.76)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
129
Table C3-1. Adjusted hazard ratio for association between hospital characteristics and in-
hospital mortality in ischemic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Characteristic of foundation
Public 1.55 (0.56-4.24) 1.42 (0.99-2.04)
Educational foundation 1.33 (0.94-1.89) 0.98 (0.68-1.42)
Private 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 14.12 (3.63-54.96) 1.82 (1.12-2.96)
Quintile 2 2.05 (0.62-6.82) 2.06 (1.32-3.20)
Quintile 3 1.31 (0.82-2.08)
Quintile 4 0.78 (0.36-1.67) 1.30 (0.89-1.89)
Quintile 5 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 
5-9% 1.17 (0.83-1.65) 1.16 (0.69-1.94)
10-14% 1.17 (0.72-1.89) 0.66 (0.24-1.84)
15-19% 0.78 (0.39-1.54) 1.15 (0.64-2.08)
≥20% 1.37 (0.49-3.82) 0.97 (0.52-1.79)
The number of beds
Quintile 1 0.56 (0.26-1.21) 1.06 (0.62-1.83)
Quintile 2 0.96 (0.54-1.68) 0.70 (0.39-1.26)
Quintile 3 0.87 (0.53-1.41) 0.70 (0.43-1.15)
Quintile 4 1.17 (0.71-1.91) 0.85 (0.58-1.25)
Quintile 5 1.00 1.00 
The number of beds per one doctor
2.5:1 1.00 1.00 
3.5:1 1.03 (0.70-1.50) 0.71 (0.19-2.72)
5.5:1 0.84 (0.47-1.52) 0.75 (0.20-2.79)
8.5:1 0.79 (0.15-4.06) 0.56 (0.15-2.12)
>8.5:1 - 0.59 (0.16-2.17)
Ratio of beds per one nurse
2.0:1 1.00 
2.5:1 2.34 (0.77-7.06) 1.00
3.0:1 3.03 (0.99-9.25) 2.85 (0.66-12.37)
3.5:1 3.31 (1.04-10.59) 3.46 (0.80-14.89)
4.0:1 3.45 (0.95-12.52) 3.56 (0.80-15.77)
4.5:1 1.85 (0.46-7.50) 3.23 (0.70-14.95)
>6.0:1 - 4.00 (0.90-17.82)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table C3-2. Adjusted hazard ratio for association between hospital characteristics and in-
hospital mortality in hemorrhagic stroke, stratified by hospital function 
Superior General Hospital General Hospital
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Characteristic of foundation
Public 0.69 (0.25-1.91) 1.25 (0.89-1.75)
Educational foundation 1.00 (0.73-1.37) 1.15 (0.85-1.54)
Private 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 3.36 (1.35-8.33) 2.49 (1.67-3.71)
Quintile 2 1.43 (0.88-2.32) 1.43 (1.02-2.02)
Quintile 3 1.35 (0.88-2.06) 0.99 (0.69-1.41)
Quintile 4 1.28 (0.90-1.82) 1.08 (0.75-1.55)
Quintile 5 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 
5-9% 1.73 (1.13-2.67) 0.62 (0.24-1.57)
10-14% 1.03 (0.59-1.81) 1.17 (0.61-2.24)
15-19% 1.27 (0.81-1.97) 1.23 (0.64-2.36)
≥20% 1.17 (0.75-1.83) 1.46 (1.00-2.14)
The number of beds
Quintile 1 2.21 (1.04-4.69) 0.84 (0.50-1.42)
Quintile 2 1.93 (0.93-3.99) 0.60 (0.36-1.00)
Quintile 3 1.81 (0.86-3.79) 0.87 (0.59-1.29)
Quintile 4 1.97 (0.98-3.97) 0.77 (0.56-1.05)
Quintile 5 1.00 1.00 
The number of beds per one doctor
2.5:1 1.00 1.00 
3.5:1 1.19 (0.86-1.64) 1.12 (0.46-2.68)
5.5:1 1.07 (0.66-1.73) 1.04 (0.44-2.45)
8.5:1 0.85 (0.11-6.81) 0.83 (0.34-2.05)
>8.5:1 - 1.03 (0.44-2.44)
Ratio of beds per one nurse
2.0:1 1.00 
2.5:1 0.31 (0.12-0.78) 1.00
3.0:1 0.36 (0.14-0.91) 0.94 (0.44-2.02)
3.5:1 0.38 (0.14-1.03) 0.99 (0.46-2.13)
4.0:1 0.35 (0.12-1.00) 0.85 (0.38-1.89)
4.5:1 0.24 (0.07-0.80) 1.10 (0.45-2.67)
>6.0:1 - 1.21 (0.53-2.76)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table C3-3. Adjusted hazard ratio for association between hospital characteristics and in-
hospital mortality in acute myocardial infarction, stratified by hospital function 
Superior General Hospital General Hospital
Hospital Characteristics Adjusted* HR 95% CI Adjusted* HR 95% CI
Characteristic of foundation
Public 0.73 (0.24-2.25) 1.43 (0.93-2.22)
Educational foundation 1.28 (0.88-1.89) 1.21 (0.80-1.84)
Private 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 2.81 (0.59-13.39) 1.89 (1.09-3.27)
Quintile 2 1.20 (0.38-3.73) 0.97 (0.54-1.76)
Quintile 3 0.68 (0.32-1.45) 0.86 (0.50-1.49)
Quintile 4 1.13 (0.76-1.68) 0.78 (0.50-1.22)
Quintile 5 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 
5-9% 1.62 (0.95-2.76) 0.71 (0.21-2.37)
10-14% 0.70 (0.30-1.63) -
15-19% 0.98 (0.28-3.40) 1.32 (0.40-4.40)
≥20% 1.02 (0.34-3.05) 0.87 (0.36-2.09)
The number of beds
Quintile 1 1.49 (0.62-3.57) 0.45 (0.20-0.98)
Quintile 2 1.74 (0.75-4.05) 0.64 (0.33-1.26)
Quintile 3 1.43 (0.63-3.24) 0.87 (0.52-1.45)
Quintile 4 1.90 (0.87-4.14) 0.79 (0.49-1.26)
Quintile 5 1.00 1.00 
The number of beds per one doctor
2.5:1 1.00 1.00 
3.5:1 1.22 (0.83-1.80) 1.14 (0.34-3.87)
5.5:1 0.89 (0.46-1.75) 0.80 (0.23-2.75)
8.5:1 - 1.03 (0.30-3.53)
>8.5:1 - 1.02 (0.28-3.71)
Ratio of beds per one nurse
2.0:1 1.00 
2.5:1 0.84 (0.29-2.38) 1.00
3.0:1 0.81 (0.26-2.54) 0.71 (0.26-1.95)
3.5:1 1.08 (0.32-3.63) 0.82 (0.30-2.25)
4.0:1 0.77 (0.20-2.93) 0.62 (0.22-1.79)
4.5:1 0.70 (0.15-3.32) 0.64 (0.19-2.21)
>6.0:1 - 0.75 (0.24-2.30)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
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Table D1. Adjusted hazard ratio for association between patient characteristics and 30-day mortality, stratified by diseases 
except patients who were dead within 7-day
Ischemic stroke 
(N=7,437)
Hemorrhagic stroke 
(N=2,523)
Acute myocardial infarction 
(N=4,672)
Patient Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Age 
20-39 0.32 (0.08-1.33) 0.84 (0.46-1.56) 0.39 (0.05-3.16)
40-49 0.22 (0.07-0.71) 0.71 (0.44-1.13) 0.20 (0.05-0.83)
50-59 0.43 (0.23-0.82) 0.72 (0.48-1.07) 0.25 (0.09-0.65)
60-69 0.78 (0.54-1.13) 0.61 (0.41-0.89) 0.52 (0.31-0.87)
≥70 1.00 1.00 1.00 
Sex
Male 0.83 (0.61-1.13) 1.04 (0.78-1.38) 0.82 (0.56-1.18)
Female 1.00 1.00 1.00 
Health insurance type
Medical aid 0.59 (0.24-1.41) 0.16 (0.05-0.53) 1.00 
National health insurance 1.00 1.00 0.74 (0.26-2.12)
Individual household income
Low 1.45 (0.97-2.16) 1.30 (0.86-1.98) 1.12 (0.66-1.89)
Middle 1.38 (0.97-1.95) 1.05 (0.76-1.45) 0.81 (0.53-1.23)
High 1.00 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 
City 1.32 (0.93-1.86) 0.89 (0.66-1.2) 1.26 (0.82-1.92)
Rural 1.11 (0.68-1.80) 0.65 (0.40-1.05) 1.37 (0.78-2.38)
Charlson comorbidity index 1.00 1.00
0-1 1.00 1.00 1.00 
2-3 0.91 (0.59-1.41) 1.01 (0.70-1.45) 0.43 (0.22-0.81)
4-5 1.25 (0.78-1.99) 1.46 (0.94-2.28) 0.88 (0.49-1.61)
>5 1.17 (0.71-1.96) 2.13 (1.29-3.53) 0.58 (0.29-1.15)
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Table D1. Adjusted hazard ratio for association between patient characteristics and 30-day mortality, stratified by diseases 
except patients who were dead within 7-day (Continued)
Ischemic stroke
(N=7,437)
Hemorrhagic stroke 
(N=2,523)
Acute myocardial infarction 
(N=4,672)
Patient Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Hypertension
No 1.00 1.00 1.00 
Without hypertensive 
complication
0.96 (0.62-1.49)
1.21 (0.86-1.70)
1.39 (0.45-4.34)
With hypertensive 
complication
1.21 (0.73-2.01)
1.25 (0.78-2.00)
1.10 (0.30-4.02)
Diabetes Mellitus
No 1.00 1.00 1.00 
Without diabetic complication 0.81 (0.54-1.20) 0.83 (0.54-1.28) 0.94 (0.40-2.23)
With diabetic complication 1.00 (0.67-1.48) 1.36 (0.86-2.16) 0.84 (0.38-1.83)
Dyslipidemia
No 1.00 1.00 1.00 
Yes 0.89 (0.63-1.26) 0.77 (0.54-1.11) 0.97 (0.49-1.96)
Disability
None 1.00 1.00 1.00 
Mild 0.65 (0.40-1.08) 0.81 (0.51-1.29) 1.11 (0.47-2.62)
Severe 0.51 (0.29-0.91) 0.48 (0.29-0.80) 0.30 (0.10-0.91)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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Table D2. Adjusted hazard ratio for association between treatment characteristics and 30-day mortality, stratified by 
diseases except patients who were dead within 7-day
Ischemic stroke
(N=7,437)
Hemorrhagic stroke 
(N=2,523)
Acute myocardial 
infarction (N=4,672)
Treatment Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Intensive care unit service
No use 1.00 1.00 1.00 
Use 4.55 (3.34-6.18) 2.17 (1.35-3.49) 1.62 (1.05-2.51)
Intravenous thrombolytic agent
No 1.00 1.00 1.00 
Yes 0.90 (0.58-1.39) 0.93 (0.69-1.26) 1.21 (0.47-3.10)
Percutaneous cerebrovascular interventiona
No 1.00 1.00 
Yes 1.01 (0.50-2.02) 0.42 (0.27-0.67)
Weekend admissionb
Weekday admission 1.00 1.00 
Weekend admission 1.10 (0.79-1.52) 1.70 (1.15-2.52)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
1.00 
Use of mannitol 2.05 (1.14-3.69)
Endovascular coiling 1.20 (0.54-2.66)
Trephination 3.10 (1.67-5.76)
Craniotomy 4.47 (2.07-9.69)
ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous transcatheter placement of 
intracoronary stent, percutaneous transluminal coronary atherectomy, percutaneous transluminal cerebral angioplasty, percutaneous 
cerebral angioplasty with drug (installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
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Table D3. Adjusted hazard ratio for association between hospital characteristics and 30-day mortality, stratified by diseases 
except patients who were dead within 7-day 
Ischemic stroke
(N=7,437)
Hemorrhagic stroke 
(N=2,523)
Acute myocardial 
infarction (N=4,672)
Hospital Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Characteristic of foundation
Public 1.43 (0.63-3.27) 1.06 (0.60-1.88) 1.46 (0.75-2.86)
Educational foundation 0.93 (0.64-1.37) 1.48 (1.05-2.08) 1.41 (0.89-2.24)
Private 1.00 1.00 1.00 
Volume of emergent stroke 
patient
Quintile 1 0.50 (0.06-4.16) 2.48 (0.75-8.26) 1.28 (0.28-5.87)
Quintile 2 2.37 (0.91-6.15) 2.15 (0.86-5.40) 2.68 (0.78-9.26)
Quintile 3 2.47 (1.22-4.97) 1.55 (0.77-3.13) 1.15 (0.42-3.20)
Quintile 4 0.97 (0.56-1.67) 1.29 (0.85-1.95) 0.78 (0.42-1.44)
Quintile 5 1.00 1.00 1.00 
Proportion of transferred 
patient to other hospital
<5% 1.00 1.00 1.00 
5-9% 1.33 (0.88-2.03) 0.95 (0.57-1.58) 0.58 (0.31-1.11)
10-14% 1.48 (0.88-2.50) 1.11 (0.69-1.81) 1.14 (0.46-2.85)
15-19% 1.03 (0.43-2.45) 1.63 (0.95-2.80) 2.64 (0.95-7.34)
≥20% 1.02 (0.47-2.21) 0.72 (0.41-1.26) 0.39 (0.13-1.20)
The number of beds
Quintile 1 0.45 (0.15-1.31) 0.46 (0.16-1.28) 0.73 (0.20-2.59)
Quintile 2 0.53 (0.21-1.31) 0.52 (0.22-1.23) 0.61 (0.17-2.25)
Quintile 3 0.40 (0.18-0.88) 0.51 (0.25-1.04) 1.63 (0.68-3.90)
Quintile 4 0.84 (0.49-1.42) 0.58 (0.34-1.00) 1.17 (0.66-2.10)
Quintile 5 1.00 1.00 1.00 
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Table D3. Adjusted hazard ratio for association between hospital characteristics and 30-day mortality, stratified by diseases 
except patients who were dead within 7-day (Continued)
Ischemic stroke
(N=7,437)
Hemorrhagic stroke 
(N=2,523)
Acute myocardial 
infarction (N=4,672)
Hospital Characteristics
Adjuste
d HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted
HR*
95% CI
The number of beds per one 
doctor
2.5:1 1.00 1.00 1.00 
3.5:1 0.98 (0.59-1.64) 0.96 (0.61-1.50) 0.72 (0.41-1.25)
5.5:1 1.11 (0.54-2.26) 0.96 (0.54-1.71) 0.62 (0.28-1.38)
8.5:1 0.92 (0.37-2.30) 1.21 (0.58-2.52) 0.76 (0.30-1.93)
>8.5:1 0.95 (0.36-2.49) 1.49 (0.65-3.38) 1.11 (0.36-3.43)
Ratio of beds per one nurse
2.0:1 1.00 1.00 1.00 
2.5:1 2.54 (0.68-9.47) 5.47 (0.69-43.51) 2.11 (0.40-11.21)
3.0:1 1.88 (0.51-6.95) 4.86 (0.62-37.88) 1.99 (0.38-10.50)
3.5:1 1.63 (0.42-6.32) 4.46 (0.57-35.26) 3.44 (0.64-18.42)
4.0:1 1.80 (0.43-7.45) 4.15 (0.52-33.40) 1.56 (0.26-9.35)
4.5:1 1.15 (0.25-5.32) 5.33 (0.64-44.46) 1.35 (0.18-9.97)
>6.0:1 1.83 (0.42-7.98) 5.44 (0.65-45.70) 1.88 (0.28-12.43)
Hospital function
Superior general hospital 1.00 1.00 
General hospital 1.03 (0.60-1.77) 1.23 (0.79-1.90) 1.25 (0.64-2.44)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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Table E1. Adjusted hazard ratio for association between patient characteristics and in-
hospital mortality, stratified by diseases except patients who were dead within 30-day
Ischemic stroke
(N=7,253)
Hemorrhagic stroke
(N=2,306)
Patient Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Age 
20-39 - 0.21 (0.02-1.98)
40-49 0.53 (0.13-2.12) 0.47 (0.13-1.68)
50-59 - 0.21 (0.06-0.74)
60-69 0.30 (0.12-0.78) 0.47 (0.20-1.13)
≥70 1.00 1.00
Sex
Male 1.34 (0.69-2.59) 3.18 (1.51-6.70)
Female 1.00 1.00
Health insurance type
Medical aid 2.02 (0.49-8.25) 0.50 (0.08-3.26)
National health insurance 1.00 1.00
Individual household income
Low 0.79 (0.29-2.13) 1.04 (0.35-3.06)
Middle 0.81 (0.38-1.69) 0.65 (0.28-1.49)
High 1.00 1.00
Residential area
Metropolitan 1.00 
City 1.06 (0.53-2.11) 1.45 (0.62-3.41)
Rural 0.42 (0.11-1.65) 2.74 (0.90-8.36)
Charlson comorbidity index 1.00 1.00
0-1 1.00 1.00
2-3 1.91 (0.66-5.51) 1.11 (0.45-2.73)
4-5 3.68 (1.21-11.16) 2.19 (0.77-6.22)
>5 3.27 (1.04-10.29) 1.83 (0.49-6.88)
Hypertension
No 1.00 1.00 
Without hypertensive 
complication
1.39 (0.45-4.34) 2.37 (0.98-5.72)
With hypertensive 
complication
1.10 (0.30-4.02) 0.90 (0.23-3.47)
Diabetes Mellitus
No 1.00 1.00 
Without diabetic complication 0.94 (0.40-2.23) 0.87 (0.29-2.59)
With diabetic complication 0.84 (0.38-1.83) 1.16 (0.36-3.74)
Dyslipidemia
No 1.00 1.00 
Yes 0.97 (0.49-1.96) 0.60 (0.24-1.48)
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Table E1. Adjusted hazard ratio for association between patient characteristics and in-
hospital mortality, stratified by diseases except patients who were dead within 30-day 
(Continued)
Ischemic stroke
(N=7,253)
Hemorrhagic stroke
(N=2,306)
Patient Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Disability
None 1.00 1.00 
Mild 1.11 (0.47-2.62) 0.72 (0.24-2.20)
Severe 0.30 (0.10-0.91) 0.44 (0.16-1.20)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
Note: could not calculate the hazard ratio for in-hospital mortality in patients with AMI.
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Table E2. Adjusted hazard ratio for association between treatment characteristics and in-
hospital mortality, stratified by diseases except patients who were dead within 30-day
Ischemic stroke
(N=7,253)
Hemorrhagic stroke
(N=2,306)
Treatment Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Intensive care unit service
No use 1.00 1.00 
Use 3.59 (1.83-7.01) 2.66 (0.72-9.83)
Intravenous thrombolytic agent
No 1.00 1.00 
Yes 0.92 (0.38-2.21) 0.93 (0.69-1.26)
Percutaneous cerebrovascular 
interventiona
No 1.00 
Yes 1.53 (0.33-7.04)
Weekend admissionb
Weekday admission 1.00 1.00 
Weekend admission 0.79 (0.37-1.68) 0.91 (0.43-1.91)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
1.00 
Use of mannitol 0.69 (0.18-2.54)
Endovascular coiling 0.86 (0.16-4.81)
Trephination 1.32 (0.35-4.99)
Craniotomy 1.01 (0.18-5.69)
ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous 
transcatheter placement of intracoronary stent, percutaneous transluminal coronary atherectomy, 
percutaneous transluminal cerebral angioplasty, percutaneous cerebral angioplasty with drug 
(installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
Note: could not calculate the hazard ratio for in-hospital mortality in patients with AMI.
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Table E3. Adjusted hazard ratio for association between hospital characteristics and in-
hospital mortality, stratified by diseases except patients who were dead within 30-day
Ischemic stroke
(N=7,253)
Hemorrhagic stroke
(N=2,306)
Hospital Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Characteristic of foundation
Public 2.16 (0.38-12.36) 2.99 (0.76-11.77)
Educational foundation 1.75 (0.70-4.37) 1.72 (0.65-4.57)
Private 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 0.05 (0.01-2.09) 2.60 (0.17-39.23)
Quintile 2 0.38 (0.03-4.73) 1.89 (0.24-15.28)
Quintile 3 2.13 (0.56-8.09) 2.23 (0.43-11.68)
Quintile 4 1.16 (0.41-3.29) 1.04 (0.32-3.37)
Quintile 5 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 
5-9% 0.95 (0.38-2.36) 3.32 (0.82-13.51)
10-14% 1.26 (0.42-3.78) 1.71 (0.44-6.73)
15-19% 1.54 (0.33-7.29) 0.63 (0.12-3.42)
≥20% 1.30 (0.34-4.89) 1.48 (0.38-5.76)
The number of beds
Quintile 1 3.67 (0.60-22.38) 2.63 (0.30-22.87)
Quintile 2 3.72 (0.71-19.56) 0.89 (0.12-6.67)
Quintile 3 1.43 (0.34-6.03) 1.75 (0.33-9.27)
Quintile 4 0.57 (0.17-1.99) 0.90 (0.22-3.72)
Quintile 5 1.00 1.00 
The number of beds per one doctor
2.5:1 1.00 1.00 
3.5:1 1.73 (0.43-6.87) 1.36 (0.33-5.57)
5.5:1 0.67 (0.10-4.62) 1.02 (0.18-5.74)
8.5:1 0.43 (0.05-3.63) 0.77 (0.08-7.28)
>8.5:1 0.47 (0.06-3.73) 2.15 (0.23-20.49)
Ratio of beds per one nurse
2.0:1 1.00 1.00 
2.5:1 0.73 (0.04-12.39) 0.63 (0.02-17.26)
3.0:1 1.09 (0.08-14.66) 0.40 (0.02-8.33)
3.5:1 2.00 (0.14-29.16) 0.75 (0.03-16.97)
4.0:1 3.27 (0.19-56.29) 1.33 (0.06-31.90)
4.5:1 2.52 (0.12-52.04) 0.61 (0.02-19.28)
>6.0:1 2.29 (0.13-40.84) 0.73 (0.03-19.59)
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Table E3. Adjusted hazard ratio for association between hospital characteristics and in-
hospital mortality, stratified by diseases except patients who were dead within 30-day 
(Continued)
Ischemic stroke
(N=7,253)
Hemorrhagic stroke
(N=2,306)
Hospital Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Hospital function
Superior general hospital 1.00 1.00 
General hospital 0.67 (0.18-2.49) 1.05 (0.29-3.72)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital 
characteristics.
Note: could not calculate the hazard ratio for in-hospital mortality in patients with AMI.
142
Table F1-1. Adjusted hazard ratio for association between patient characteristics and mortality in ischemic stroke who 
utilized only hospital size≥4 quintile
7-day mortality 30-day mortality In-hospital mortality
Patient Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Age 
20-39 0.18 (0.03-1.34) 0.27 (0.08-0.85) 0.24 (0.08-0.77)
40-49 0.40 (0.18-0.89) 0.33 (0.17-0.63) 0.38 (0.21-0.68)
50-59 0.48 (0.28-0.81) 0.49 (0.32-0.73) 0.45 (0.30-0.67)
60-69 0.60 (0.41-0.86) 0.67 (0.51-0.89) 0.63 (0.49-0.82)
≥70 1.00 1.00 1.00 
Sex
Male 0.74 (0.55-1.00) 0.79 (0.63-0.98) 0.82 (0.66-1.02)
Female 1.00 1.00 1.00 
Health insurance type
Medical aid 1.02 (0.51-2.03) 0.84 (0.48-1.47) 0.89 (0.53-1.49)
National health insurance 1.00 1.00 1.00 
Individual household income
Low 1.69 (1.14-2.49) 1.58 (1.18-2.11) 1.56 (1.18-2.07)
Middle 1.64 (1.16-2.31) 1.51 (1.17-1.94) 1.46 (1.14-1.86)
High 1.00 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 1.00 
City 1.08 (0.78-1.49) 1.21 (0.95-1.55) 1.25 (0.99-1.59)
Rural 0.74 (0.47-1.18) 0.89 (0.63-1.26) 0.85 (0.60-1.20)
Charlson comorbidity index
0-1 1.00 1.00 1.00 
2-3 1.15 (0.76-1.75) 1.03 (0.75-1.41) 1.06 (0.78-1.44)
4-5 1.17 (0.73-1.88) 1.15 (0.81-1.63) 1.31 (0.94-1.82)
>5 1.31 (0.78-2.22) 1.29 (0.88-1.89) 1.41 (0.98-2.03)
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Table F1-1. Adjusted hazard ratio for association between patient characteristics and mortality in ischemic stroke who 
utilized only hospital size≥4 quintile (Continued)
7-day mortality 30-day mortality In-hospital mortality
Patient Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Hypertension
No 1.00 1.00 1.00 
Without hypertensive 
complication
0.94 (0.62-1.42) 0.94 (0.69-1.29) 0.99 (0.73-1.33)
With hypertensive 
complication
1.21 (0.75-1.96) 1.26 (0.87-1.81) 1.22 (0.86-1.74)
Diabetes Mellitus
No 1.00 1.00 1.00 
Without diabetic complication 1.02 (0.71-1.48) 0.88 (0.66-1.16) 0.86 (0.65-1.12)
With diabetic complication 0.89 (0.60-1.34) 0.88 (0.66-1.19) 0.83 (0.62-1.10)
Dyslipidemia
No 1.00 1.00 1.00 
Yes 0.96 (0.68-1.35) 0.97 (0.75-1.25) 0.97 (0.76-1.24)
Disability
None 1.00 1.00 1.00 
Mild 1.02 (0.66-1.58) 0.80 (0.57-1.13) 0.88 (0.64-1.21)
Severe 0.53 (0.27-1.04) 0.50 (0.31-0.80) 0.47 (0.30-0.74)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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Table F1-2. Adjusted hazard ratio for association between treatment characteristics and mortality in ischemic stroke who 
utilized only hospital size≥4 quintile
7-day mortality 30-day mortality In-hospital mortality
Treatment Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Intensive care unit service
No use 1.00 1.00 1.00 
Use
7.49 
(5.55-
10.10)
5.83 (4.66-7.29) 5.64 (4.55-7.00)
Intravenous thrombolytic agent
No 1.00 1.00 1.00 
Yes 1.11 (0.74-1.68) 1.12 (0.82-1.52) 1.09 (0.81-1.46)
Percutaneous cerebrovascular interventiona
No 1.00 1.00 1.00 
Yes 1.19 (0.60-2.37) 1.07 (0.65-1.74) 1.05 (0.66-1.68)
Weekend admissionb
Weekday admission 1.00 1.00 1.00 
Weekend admission 1.46 (1.08-1.96) 1.28 (1.02-1.61) 1.19 (0.95-1.48)
ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous transcatheter placement of 
intracoronary stent, percutaneous transluminal coronary atherectomy, percutaneous transluminal cerebral angioplasty, percutaneous 
cerebral angioplasty with drug (installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
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Table F1-3. Adjusted hazard ratio for association between hospital characteristics and mortality in ischemic stroke who 
utilized only hospital size≥4 quintile
7-day mortality 30-day mortality In-hospital mortality
Hospital Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Characteristic of foundation
Public 1.66 (0.46-5.99) 1.45 (0.63-3.34) 1.41 (0.62-3.19)
Educational foundation 0.70 (0.50-0.99) 0.77 (0.59-0.99) 0.78 (0.61-1.01)
Private 1.00 1.00 1.00 
Volume of emergent stroke 
patient
Quintile 1 4.66 (0.62-34.88) 2.32 (0.32-17.00) 2.30 (0.31-16.9)
Quintile 2 0.84 (0.11-6.42) 1.76 (0.53-5.86) 1.75 (0.52-5.83)
Quintile 3 0.48 (0.16-1.46) 1.26 (0.67-2.37) 1.28 (0.68-2.40)
Quintile 4 0.66 (0.39-1.11) 0.73 (0.49-1.07) 0.80 (0.55-1.16)
Quintile 5 1.00 1.00 1.00 
Proportion of transferred 
patient to other hospital
<5% 1.00 1.00 1.00 
5-9% 1.48 (1.03-2.11) 1.35 (1.01-1.79) 1.30 (0.98-1.72)
10-14% 1.25 (0.74-2.11) 1.32 (0.90-1.94) 1.28 (0.87-1.87)
15-19% 1.19 (0.52-2.75) 1.03 (0.54-1.98) 0.99 (0.52-1.88)
≥20% 0.54 (0.17-1.75) 0.74 (0.34-1.63) 0.56 (0.25-1.26)
The number of beds per one 
doctor
2.5:1 1.00 1.00 1.00 
3.5:1 1.03 (0.67-1.60) 1.00 (0.72-1.40) 1.05 (0.76-1.46)
5.5:1 1.17 (0.65-2.10) 1.11 (0.70-1.75) 1.10 (0.70-1.73)
8.5:1 1.29 (0.57-2.95) 0.98 (0.51-1.87) 0.92 (0.49-1.72)
>8.5:1 1.21 (0.45-3.22) 1.26 (0.61-2.62) 1.08 (0.53-2.20)
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Table F1-3. Adjusted hazard ratio for association between hospital characteristics and mortality in ischemic stroke who 
utilized only hospital size≥4 quintile (Continued)
7-day mortality 30-day mortality In-hospital mortality
Hospital Characteristics
Adjuste
d HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Ratio of beds per one nurse
2.0:1 1.00 1.00 1.00 
2.5:1 2.74 (0.33-22.79) 2.59 (0.87-7.71) 2.15 (0.79-5.85)
3.0:1 8.29 (1.08-63.59) 3.43 (1.18-9.99) 2.89 (1.09-7.65)
3.5:1 8.46 (1.08-66.3) 3.23 (1.08-9.67) 2.88 (1.06-7.83)
4.0:1 10.23 (1.25-83.62) 3.91 (1.25-12.21) 3.48 (1.22-9.93)
4.5:1 9.09 (1.05-78.37) 2.40 (0.69-8.31) 2.19 (0.70-6.90)
>6.0:1 8.93 (0.96-83.03) 2.58 (0.73-9.08) 2.67 (0.84-8.49)
Hospital function
Superior general hospital 1.00 1.00 1.00 
General hospital 0.83 (0.55-1.26) 0.91 (0.66-1.27) 0.87 (0.63-1.20)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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Table F2-1. Adjusted hazard ratio for association between patient characteristics and mortality in hemorrhagic stroke
who utilized only hospital size≥4 quintile
7-day mortality 30-day mortality In-hospital mortality
Patient Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Age 
20-39 0.51 (0.26-0.99) 0.61 (0.38-0.98) 0.60 (0.38-0.95)
40-49 0.73 (0.48-1.10) 0.72 (0.52-0.99) 0.70 (0.52-0.96)
50-59 0.64 (0.44-0.93) 0.66 (0.50-0.88) 0.64 (0.49-0.85)
60-69 0.49 (0.34-0.71) 0.55 (0.42-0.73) 0.57 (0.44-0.73)
≥70 1.00 1.00 1.00 
Sex
Male 1.09 (0.83-1.42) 1.11 (0.91-1.35) 1.18 (0.97-1.43)
Female 1.00 1.00 1.00 
Health insurance type
Medical aid 0.56 (0.28-1.14) 0.37 (0.20-0.68) 0.40 (0.22-0.72)
National health insurance 1.00 1.00 1.00 
Individual household income
Low 1.09 (0.74-1.61) 1.14 (0.84-1.53) 1.16 (0.87-1.54)
Middle 0.90 (0.67-1.21) 0.95 (0.76-1.19) 0.94 (0.76-1.17)
High 1.00 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 1.00 
City 0.85 (0.63-1.15) 0.88 (0.71-1.09) 0.91 (0.74-1.12)
Rural 0.82 (0.54-1.23) 0.70 (0.50-0.96) 0.74 (0.54-1.01)
Charlson comorbidity index
0-1 1.00 1.00 1.00 
2-3 1.24 (0.88-1.75) 1.13 (0.87-1.46) 1.14 (0.89-1.46)
4-5 1.24 (0.80-1.92) 1.27 (0.92-1.75) 1.31 (0.96-1.78)
>5 2.04 (1.28-3.25) 2.09 (1.47-2.95) 2.08 (1.49-2.91)
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Table F2-1. Adjusted hazard ratio for association between patient characteristics and mortality in hemorrhagic stroke who 
utilized only hospital size≥4 quintile (Continued)
7-day mortality 30-day mortality In-hospital mortality
Patient Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Hypertension
No 1.00 1.00 1.00 
Without hypertensive 
complication
0.91 (0.65-1.26) 1.03 (0.81-1.32) 1.05 (0.83-1.34)
With hypertensive complication 1.32 (0.87-2.00) 1.36 (0.99-1.88) 1.33 (0.97-1.82)
Diabetes Mellitus
No 1.00 1.00 1.00 
Without diabetic complication 1.14 (0.78-1.66) 1.03 (0.77-1.38) 1.03 (0.78-1.36)
With diabetic complication 1.37 (0.89-2.11) 1.41 (1.03-1.95) 1.42 (1.05-1.93)
Dyslipidemia
No 1.00 1.00 1.00 
Yes 0.86 (0.62-1.20) 0.83 (0.64-1.07) 0.83 (0.65-1.06)
Disability
None 1.00 1.00 1.00 
Mild 1.00 (0.67-1.49) 0.95 (0.70-1.30) 0.93 (0.69-1.25)
Severe 0.69 (0.44-1.08) 0.56 (0.39-0.80) 0.52 (0.37-0.74)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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Table F2-2. Adjusted hazard ratio for association between treatment characteristics and mortality in hemorrhagic stroke
who utilized only hospital size≥4 quintile
7-day mortality 30-day mortality In-hospital mortality
Treatment Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Intensive care unit service
No use 1.00 1.00 1.00 
Use 0.95 (0.68-1.33) 1.23 (0.93-1.62) 1.26 (0.96-1.64)
Weekend admissionb
Weekday admission 1.00 1.00 1.00 
Weekend admission 1.30 (1.00-1.70) 1.19 (0.97-1.46) 1.18 (0.97-1.44)
Intervention for reducing ICP
Intravenous antihypertensive 
agents
1.00 1.00 1.00 
Use of mannitol 3.98 (2.21-7.16) 3.04 (1.97-4.69) 2.63 (1.76-3.94)
Endovascular coiling 1.40 (0.58-3.39) 1.39 (0.76-2.54) 1.29 (0.73-2.28)
Trephination 3.72 (1.96-7.05) 3.39 (2.13-5.40) 3.01 (1.95-4.65)
Craniotomy 3.42 (1.41-8.28) 4.43 (2.44-8.06) 3.78 (2.16-6.62)
ICP denotes intracranial pressure; NA, not applicable.
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous transcatheter placement of 
intracoronary stent, percutaneous transluminal coronary atherectomy, percutaneous transluminal cerebral angioplasty, percutaneous 
cerebral angioplasty with drug (installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
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Table F2-3. Adjusted hazard ratio for association between hospital characteristics and mortality in hemorrhagic stroke who 
utilized only hospital size≥4 quintile
7-day mortality 30-day mortality In-hospital mortality
Hospital Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Characteristic of foundation
Public 0.84 (0.46-1.54) 0.74 (0.48-1.16) 0.81 (0.53-1.24)
Educational foundation 0.91 (0.65-1.28) 1.10 (0.87-1.4) 1.11 (0.89-1.40)
Private 1.00 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 4.23 (0.48-37.62) 6.09 (1.61-22.97) 4.50 (1.21-16.76)
Quintile 2 1.91 (0.39-9.32) 2.57 (1.00-6.62) 2.65 (1.09-6.42)
Quintile 3 1.39 (0.67-2.86) 1.36 (0.81-2.26) 1.37 (0.85-2.20)
Quintile 4 1.50 (0.98-2.29) 1.25 (0.93-1.67) 1.26 (0.95-1.66)
Quintile 5
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 1.00 
5-9% 1.54 (0.90-2.65) 1.27 (0.88-1.82) 1.33 (0.94-1.87)
10-14% 1.70 (0.99-2.91) 1.38 (0.97-1.98) 1.38 (0.98-1.94)
15-19% 1.70 (0.93-3.11) 1.67 (1.12-2.50) 1.61 (1.10-2.37)
≥20% 1.00 (0.51-1.97) 0.93 (0.60-1.45) 0.83 (0.54-1.28)
The number of beds per one doctor
2.5:1 1.00 1.00 1.00 
3.5:1 1.25 (0.81-1.93) 1.20 (0.88-1.64) 1.22 (0.90-1.64)
5.5:1 0.87 (0.50-1.53) 1.04 (0.70-1.55) 1.02 (0.70-1.50)
8.5:1 0.63 (0.28-1.43) 0.93 (0.53-1.64) 0.92 (0.54-1.59)
>8.5:1 0.70 (0.25-1.95) 1.04 (0.51-2.14) 1.11 (0.57-2.17)
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Table F2-3. Adjusted hazard ratio for association between hospital characteristics and mortality in hemorrhagic stroke who 
utilized only hospital size≥4 quintile (Continued)
7-day mortality 30-day mortality In-hospital mortality
Hospital Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Ratio of beds per one nurse
2.0:1 1.00 1.00 1.00 
2.5:1 0.37 (0.15-0.95) 0.73 (0.35-1.52) 0.72 (0.36-1.46)
3.0:1 0.39 (0.16-0.94) 0.73 (0.36-1.46) 0.72 (0.37-1.41)
3.5:1 0.53 (0.22-1.31) 0.83 (0.41-1.68) 0.84 (0.43-1.66)
4.0:1 0.43 (0.16-1.11) 0.73 (0.35-1.53) 0.77 (0.38-1.57)
4.5:1 0.14 (0.03-0.58) 0.47 (0.19-1.15) 0.43 (0.18-1.03)
>6.0:1 0.43 (0.13-1.43) 0.65 (0.26-1.65) 0.77 (0.32-1.82)
Hospital function
Superior general hospital 1.00 1.00 1.00 
General hospital 1.57 (1.04-2.37) 1.32 (0.99-1.76) 1.27 (0.96-1.68)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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Table F3-1. Adjusted hazard ratio for association between patient characteristics and mortality in acute myocardial 
infarction who utilized only hospital size≥4 quintile
7-day mortality 30-day mortality In-hospital mortality
Patient Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Age 
20-39 0.42 (0.13-1.37) 0.41 (0.15-1.12) 0.38 (0.14-1.04)
40-49 0.15 (0.05-0.41) 0.16 (0.07-0.37) 0.18 (0.08-0.38)
50-59 0.49 (0.31-0.77) 0.41 (0.27-0.63) 0.39 (0.26-0.59)
60-69 0.64 (0.46-0.91) 0.60 (0.45-0.79) 0.58 (0.44-0.76)
≥70 1.00 1.00 1.00 
Sex
Male 0.99 (0.75-1.30) 0.93 (0.75-1.15) 0.94 (0.76-1.16)
Female 1.00 1.00 1.00 
Health insurance type
Medical aid 1.00 1.00 1.00 
National health insurance 0.56 (0.23-1.34) 0.93 (0.75-1.15) 0.65 (0.34-1.22)
Individual household income
Low 1.10 (0.75-1.61) 1.10 (0.81-1.50) 1.11 (0.82-1.50)
Middle 0.92 (0.68-1.24) 0.88 (0.69-1.12) 0.90 (0.71-1.14)
High 1.00 1.00 1.00 
Residential area
Metropolitan 1.00 1.00 1.00 
City 0.88 (0.66-1.19) 0.99 (0.78-1.26) 0.99 (0.79-1.25)
Rural 1.10 (0.74-1.64) 1.17 (0.85-1.62) 1.18 (0.86-1.62)
Charlson comorbidity index
0-1 1.00 1.00 1.00 
2-3 0.96 (0.63-1.48) 0.73 (0.52-1.04) 0.74 (0.52-1.04)
4-5 1.44 (0.92-2.24) 1.20 (0.84-1.71) 1.18 (0.83-1.68)
>5 1.30 (0.79-2.14) 1.00 (0.67-1.50) 1.00 (0.68-1.49)
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Table F3-1. Adjusted hazard ratio for association between patient characteristics and mortality in acute myocardial 
infarction who utilized only hospital size≥4 quintile (Continued)
7-day mortality 30-day mortality In-hospital mortality
Patient Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Hypertension
No 1.00 1.00 1.00 
Without hypertensive 
complication
0.62 (0.43-0.89) 0.71 (0.52-0.97) 0.68 (0.51-0.92)
With hypertensive complication 0.59 (0.38-0.91) 0.75 (0.53-1.07) 0.77 (0.55-1.08)
Diabetes Mellitus
No 1.00 1.00 1.00 
Without diabetic complication 1.37 (0.97-1.94) 1.33 (1.01-1.76) 1.30 (0.99-1.71)
With diabetic complication 1.34 (0.95-1.90) 1.23 (0.94-1.62) 1.18 (0.90-1.54)
Dyslipidemia
No 1.00 1.00 1.00 
Yes 0.79 (0.58-1.08) 0.81 (0.63-1.05) 0.82 (0.64-1.05)
Disability
None 1.00 1.00 1.00 
Mild 0.81 (0.51-1.27) 0.93 (0.67-1.30) 0.93 (0.67-1.29)
Severe 1.28 (0.81-2.03) 1.14 (0.79-1.63) 1.14 (0.82-1.60)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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Table F3-2. Adjusted hazard ratio for association between treatment characteristics and mortality in acute myocardial 
infarction who utilized only hospital size≥4 quintile
7-day mortality 30-day mortality In-hospital mortality
Treatment Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Intensive care unit service
No use 1.00 1.00 1.00 
Use 2.17 (1.59-2.95) 1.93 (1.51-2.48) 1.90 (1.49-2.42)
Intravenous thrombolytic agent
No 1.00 1.00 1.00 
Yes 1.47 (0.84-2.57) 1.37 (0.85-2.21) 1.34 (0.84-2.14)
Percutaneous coronary interventiona
No 1.00 1.00 1.00 
Yes 1.21 (0.91-1.62) 1.36 (1.08-1.71) 1.37 (1.10-1.71)
Weekend admissionb
Weekday admission 1.00 1.00 1.00 
Weekend admission 0.39 (0.29-0.54) 0.42 (0.33-0.54) 0.43 (0.33-0.55)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
a, was included the following as percutaneous transluminal coronary angioplasty, percutaneous transcatheter placement of 
intracoronary stent, percutaneous transluminal coronary atherectomy, percutaneous transluminal cerebral angioplasty, percutaneous 
cerebral angioplasty with drug (installation of metallic stent), and percutaneous intravascular atherectomy.
b, included weekend admission plus national official holidays.
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Table F3-3. Adjusted hazard ratio for association between hospital characteristics and mortality in acute myocardial 
infarction who utilized only hospital size≥4 quintile
7-day mortality 30-day mortality In-hospital mortality
Hospital Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Characteristic of foundation
Public 1.16 (0.72-1.87) 1.24 (0.85-1.80) 1.20 (0.83-1.73)
Educational foundation 1.17 (0.85-1.60) 1.23 (0.95-1.58) 1.23 (0.96-1.57)
Private 1.00 1.00 1.00 
Volume of emergent stroke patient
Quintile 1 1.56 (0.52-4.74) 1.47 (0.62-3.50) 1.66 (0.74-3.74)
Quintile 2 1.24 (0.51-3.02) 1.45 (0.74-2.84) 1.61 (0.84-3.05)
Quintile 3 1.41 (0.76-2.62) 1.26 (0.74-2.13) 1.33 (0.79-2.22)
Quintile 4 1.13 (0.78-1.63) 1.03 (0.76-1.40) 1.08 (0.80-1.45)
Quintile 5 1.00 1.00 1.00 
Proportion of transferred patient to 
other hospital
<5% 1.00 1.00 1.00 
5-9% 1.11 (0.75-1.63) 0.92 (0.67-1.26) 0.93 (0.68-1.26)
10-14% 1.06 (0.53-2.14) 1.22 (0.72-2.07) 1.15 (0.68-1.92)
15-19% 0.62 (0.22-1.74) 1.11 (0.55-2.20) 1.19 (0.62-2.29)
≥20% 1.28 (0.72-2.30) 0.97 (0.58-1.61) 0.96 (0.58-1.57)
The number of beds per one doctor
2.5:1 1.00 1.00 1.00 
3.5:1 1.57 (1.00-2.46) 1.19 (0.85-1.66) 1.15 (0.83-1.60)
5.5:1 1.10 (0.61-1.96) 0.89 (0.57-1.41) 0.83 (0.53-1.31)
8.5:1 1.21 (0.61-2.41) 1.03 (0.60-1.75) 0.93 (0.55-1.57)
>8.5:1 1.00 (0.46-2.22) 0.97 (0.52-1.82) 0.95 (0.52-1.74)
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Table F3-3. Adjusted hazard ratio for association between hospital characteristics and mortality in acute myocardial 
infarction who utilized only hospital size≥4 quintile (Continued)
7-day mortality 30-day mortality In-hospital mortality
Hospital Characteristics
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Adjusted 
HR*
95% CI
Ratio of beds per one nurse
2.0:1 1.00 1.00 1.00 
2.5:1 1.37 (0.39-4.88) 1.72 (0.64-4.61) 1.44 (0.58-3.57)
3.0:1 2.25 (0.67-7.59) 2.27 (0.87-5.92) 1.77 (0.73-4.28)
3.5:1 2.26 (0.66-7.71) 2.74 (1.04-7.23) 2.34 (0.96-5.70)
4.0:1 2.03 (0.57-7.22) 2.01 (0.73-5.54) 1.66 (0.65-4.25)
4.5:1 1.99 (0.49-8.07) 1.83 (0.59-5.62) 1.60 (0.57-4.52)
>6.0:1 2.69 (0.69-10.43) 2.46 (0.83-7.25) 1.85 (0.67-5.05)
Hospital function
Superior general hospital 1.00 1.00 1.00 
General hospital 1.33 (0.88-2.00) 1.33 (0.95-1.86) 1.34 (0.97-1.87)
*, adjusted for all covariates including patient characteristics, treatment characteristics and hospital characteristics.
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Appendix G. The proportion of patient who received intervention to reduce ICP, according to the ratio of patients per one nurse/doctor 
in hemorrhagic stroke (N=2,828)
Use of Intravenous 
antihypertensive agent
Use of mannitol
Endovascular 
coiling
Trephination Craniotomy
(N=352) (N=1,691) (N=229) (N=459) (N=97)
Total N (%) N (%) N (%) N (%) N (%)
Ratio of beds per 
one nurse
2.0:1 73 22 (30.1) 33 (45.2) 4 (5.5) 13 (17.8) 1 (1.4)
2.5:1 247 33 (13.4) 139 (56.3) 32 (13.0) 33 (13.4) 10 (4.1)
3.0:1 914 124 (13.6) 475 (52.0) 121 (13.2) 156 (17.1) 38 (4.2)
3.5:1 771 82 (10.6) 492 (63.8) 42 (5.5) 127 (16.5) 28 (3.6)
4.0:1 421 42 (10.0) 287 (68.2) 17 (4.0) 64 (15.2) 11 (2.6)
4.5:1 421 42 (10.0) 287 (68.2) 17 (4.0) 64 (15.2) 11 (2.6)
>6.0:1 277 39 (14.1) 179 (64.6) 6 (2.2) 46 (16.6) 7 (2.5)
The number of beds 
per one doctor
2.5:1 549 74 (13.5) 294 (53.6) 65 (11.8) 90 (16.4) 26 (4.7)
3.5:1 1,019 119 (11.7) 606 (59.5) 98 (9.6) 164 (16.1) 32 (3.1)
5.5:1 627 88 (14.0) 369 (58.9) 46 (7.3) 101 (16.1) 23 (3.7)
8.5:1 218 23 (10.6) 140 (64.2) 13 (6.0) 34 (15.6) 8 (3.7)
>8.5:1 415 48 (11.6) 282 (68.0) 7 (1.7) 70 (16.9) 8 (1.9)
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Korean Abstract
뇌졸중 및 급성심근경색증 환자에서 원내 사망에
영향을 미치는 요인
: Algebra Effectiveness Model 적용
서론: 심뇌혈관질환은 전체사망의 사분의 일을 자치하는 질환으로서, 향후 한국
의 고령화를 감안할 때, 질병부담은 더욱 커질 것으로 예상된다. 뇌졸중과 급성
심근경색증으로 인한 사망을 줄이고자, 정부와 의료기관의 끊임없는 노력을 해왔
음에도 불구하고, 여전히 병원 내 사망률이 높다. 
연구목적: Algebra Effectiveness Model를 적용하여 뇌졸중과 심근경색증 환자에
서 환자요인, 치료요인, 병원요인이 단기사망 (S hort-term mortality), 중기사
망 (intermediate mortality), 장기사망 (long-term mortality)에 어떠한 영향을
미쳤는지를 평가하고자 하였다.  
연구방법: 이 연구는 2002년부터 2013년까지의 국민건강보험공단 표본코흐트 자
료를 이용하여 분석하였다. 연구대상자는 혈성 뇌졸중, 출혈성 뇌졸중, 급성심근
경색증을 주진단으로 응급실을 통해 입원한 환자로서, 종합병원급 이상의 의료기
관을 이용하고, 다른 의료기관을 경유하거나 전원되지 않은 환자로 한정하였다. 
허혈성뇌졸중 환자 7,693명, 출혈성뇌졸중 환자 2,828명, 급성심근경색증 환자
4,916명을 연구대상자로 하였다. 통계분석방법은 개인수준과 병원수준을 동시에
고려하기 위해 Cox’s Proportional Frailty Model을 이용하였다. 
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연구결과: 7,693명의 허혈성 뇌졸중 환자 중 500명 (6.5%), 2,828명의 출혈성 뇌
졸중 환자 중 569명 (20.1%)이, 4,916명의 급성심근경색증 환자 중 399명  (8.1%)
이 병원 내 사망하였다. 환자요인과 사망과의 관련성은 세 개의 모든 질환에서, 
연령, 성별, 고혈압 및 당뇨병 같은 임상적 요인이 7일내 사망과 관련이 있었고, 
소득이나 건강보험유형 같은 비임상 요인은 30일내 사망과 병원 내 사망과 관련
성이 있었다. 치료요인과 사망과의 관련성 분석에서, 급성심근경색증 환자에서
PCI의 수행이 7일내사망, 30일내 사망, 병원 내 사망 모두에서 보정사망의 위험
이 감소하였다 (aHR,0.40; 95% CI,0.29-0.54; aHR, 0.35; 95% CI, 0.23-0.55; 
aHR, 0.43; 95% CI, 0.27-0.67, 순서대로). 급성심근경색과 허혈성 뇌졸중에서
중환자실을 이용한 사람들이 그렇지 않은 사람들에 비해서 7일내 사망, 30일내
사망, 병원 내 사망의 보정 사망위험이 높았고, 출혈성 뇌졸중 환자군 에서 뇌압
상승을 조절하기 위해 만니톨 투여와 같은 내과적 중재보다 천두술이나 개두술과
같은 외과적 중재를 받는 환자들의 7일내 사망, 30일내 사망, 병원 내 사망의 보
정 사망위험이 높았다 (eg, 30일내 사망; 만니톨 사용군의 aHR, 2.42; 95% CI, 
1.36-4.32  vs 천두술 중재군 aHR, 3.30; 95% CI, 1.80-6.04; 개두술 중재군 aHR, 
5.27; 95% CI, 2.49-11.17).  병원요인과 사망과의 관련성은 허혈성 뇌졸중에서
간호사수가 커질수록 7일내사망, 30일내사망, 병원 내 사망의 보정위험 사망비가
감소하였다. 세 개의 모든 질환에서 진료량과 사망과 관련성이 있었고, 출혈성
뇌졸중환자에서 전원량이 사망과 관련성이 있었다. 
결론: 건강한 생활습관으로 전환할 수 있도록 일차예방에 초점을 둔 정책과 아울
러, PCI와 같은 중요한 시술을 수행할 수 있는 전문의를 확보를 위해 국가차원에
서의 노력이 필요하며, 의사 및 의료기관의 능숙함이 중요한 급성심근경색과 출
혈성 뇌졸중환자 관리를 위해 이런 환자들을 관리할 수 있는 의료기관 리스트에
대한 정보 공유를 위한 중앙시스템이 마련되어야 할 것이다.
핵심어: 뇌졸중, 급성심근경색증, 원내사망, algebra effectiveness model
